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Sum m ary
The present research work investigates the results observed in the management 
of those patients diagnosed with Upper Gastro-Intestinal Cancers subsequent to the 
use of algorithms of referral and clinical services such as Open Access Endoscopy and 
Rapid Opinion Clinic. This is a retrospective analysis based on the auditing 
methodology which looks to the experience gained in two NHS Trust hospitals in 
South Wales over a period o f six calendar years.
An uncensored cohort of 440 patients diagnosed with various forms of Upper 
Gastro-Intestinal cancers are examined and their referral pathway, positive diagnosis, 
investigation and staging, as well as treatment and 5-year follow up is analyzed. The 
traditional methods of referring patients from the Primary Care sector are compared 
with the new open-access type of clinical services such as Open Access Endoscopy 
and Rapid Opinion Clinic in the context of the "two week rule" for cancer referral. It 
has been found that using the open access services the median delay for appointments 
is reduced to 11 days which is below the required threshold imposed by The NHS 
Cancer Plan. The mean GP delay interval remains slightly higher at 17.09 days mainly 
due to cases with atypical clinical picture; the same applies to the mean treatment 
delay which at 44.43 days is related with the staging investigations.
The results of these referral methods are also discussed from the perspective of 
patients' outcome as a measure of the benefits gained through the introduction of these 
clinical services. It has been noted that the rate of newly diagnosed early stage cancers 
has not increased and there was no gained benefit in diagnosing patients with more 
favourable stage of the disease. There was a hint that patients diagnosed through Open 
Access Endoscopy may have a less advanced disease with a higher rate of operability 
and a smaller benefit in survival probability.
This study concludes that new open-access style clinical services backed up by 
clear referral algorithms may increase the speed of patients' appointments and 
diagnosis in the Secondary Care sector but there is only little clinical and statistical 
evidence of benefits such as early cancer detection, operability and survival 
probability.
Areas of improvement in referral algorithm such as the combination of "alarm 
symptoms", exclusion of uncomplicated dyspepsia as a referral criterion in young 
adults, pooling all patients at risk with gastroenterological symptoms under the open 
access style of referral and streamlining of the staging and treatment pathway are 
amongst recommendations made at the end of this study.
Keywords: Upper Gastro-Intestinal Cancer, malignancy, clinical
services, Open Access Endoscopy, Rapid Opinion Clinic, 
referral, two week rule, speed of referral, speed of 
diagnosis, delay in referral, positive diagnosis, operability, 
TNM, stage, survival
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INTRODUCTION
Oesophageal, Gastric and Duodenal cancers, but excluding 
pancreatic and biliary localizations, are commonly grouped and 
known as Upper Gastro-Intestinal Cancers; they represent a 
distinctive entity with common epidemiological, diagnostic, 
therapeutic and prognostic features. The clinical common ground 
between these topographic entities remains the late presentation and 
late diagnosis, translated in advanced TNM staging, as well as poor 
long term therapeutic results after uni- or multifactorial 
treatment35*3545*7196''102. These cancers appear to be diseases associated 
with highly developed countries, in both the eastern and western 
hemispheres, with evidence that within various regions the lower 
socio-economic groups are more frequently affected by the 
disease255355715113.
The socio-economic and populational importance of these 
cancers reside in their progressively increased absolute numbers over 
the last four decades or So45567;81:113 with heavy burden onto the health 
providers, changes in the topographic distribution within the upper
s o  atiP etmicAt ac*wee& work
7Q W A R & 3  IM S ' «7WO *££4? R tiL G *  A N O  H O W ?
*1*
C hapter I : Introduction Serhatn L Q heorgktu
gastrointestinal tract, with adenocarcinoma of the lower oesophagus 
gaining ground against the more traditional prevalence of squamous 
carcinoma42179*1 and some improvement of life expectancy after radical 
treatment, but with significant overall mortality and high 
postoperative mortality rates34*3190*’1285144.
Despite widespread efforts for quicker diagnosis and treatment, 
as well as improved surgical and anaesthetic equipment, technique 
and facilities, the most disappointing revelation by far remains that of 
the advanced stage of the disease at the time of positive diagnosis. 
Here, the reality contrasts painfully between Japan and the rest of the 
world. Whilst the Japanese experience shows "early carcinoma" 
detection rate in excess of 40%43, in the US and Europe these figures 
are well below 30%; for example, over 56% of patients with 
oesophageal carcinomas are diagnosed in the United States in stages 
III and IV, which makes curative treatment impossible35*3. Bearing in 
mind this difference between Japan and the rest of the western world, 
both health providers and medical professionals alike tried not only to 
replicate the services and methods used by the Japanese 
counterparts, but also to understand the reasons behind their 
successes in diagnosing so many cancers in curative stages.
The clinical and pathological importance of the gastro- 
oesophageal cancers has been discussed in a multitude of studies, all 
of which invariably show that in Western European countries the 
diagnosis and management, and as a consequence, the outcome of the
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patients with such conditions is far poorer than in Japan35;43;4S. Over 
the last four decades or so Japan has leapt forward in the diagnosis 
and treatment of Upper G astrointestinal Cancers, mainly because of 
its greater efforts directed at combating these conditions through 
widespread use of mass screening using double-contrast barium meal 
and, more recently, using endoscopy. These methods have shown to 
be veiy effective in the Japanese setting for diagnosing Upper Gastro­
intestinal Cancers in early stages and, combined with aggressive 
standardized surgical and adjuvant treatment, offered extremely good 
5-year survival rates in excess of 60%15;45. Whilst Japan employed 
during this process both mass and targeted screening procedures, 
western countries were more reluctant to introduce such measures, 
mainly because of the consideration given to issues such as incidence, 
cost and patients' compliance3*11*127.
As such, the early diagnosis of Upper Gastro-Intestinal Cancers 
in Europe and North America remains a far reaching dream; it is 
accepted that the main contributor to this failure is the late stage of 
the tumour when patients initially present with symptoms34;35:141:144. To 
improve both the staging at diagnosis time, as well as the long term 
outcome after treatment, most authors agree that two categories of 
actions should be considered:
a) one category of actions targets the period before the 
presentation of patients to their doctor, - the so called "incubation" 
period -; this period of the natural history of the disease (see Appendix
u p p g r  o A O V R O tN V G o r tN A L  c a n c g r ?
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A01: Natural History & Defined Intervals) includes both the time when 
the disease is asymptomatic and the interval when the patients, 
already symptomatic, fail either voluntarily or involuntarily to make 
their way to the family doctor. Essentially, most authors agree that 
Upper Gastro-Intestinal Cancers diagnosis as "early cancer" can be 
achieved only during this period; here, the Japanese experience made 
significant inroads by mass screening or, at least, targeted screening 
of high risk groups. These methods of early diagnosis seem to be the 
only ones currently available, that can feasibly to be applied on a 
community-wide scale, at least until other means of early diagnosis 
become available, such as genetic testing and mapping93,148;
b) the second category of actions which may improve the 
diagnosis of Upper Gastro-Intestinal Cancers in early stages, at least 
on a logical basis, is targeting the segment of the natural history of 
the disease after the patients seek first consultation; this segment is 
closely linked with the provision of health care in the primary and 
secondary care sector5017*135 and is mostly targeted by health care 
providers; the aim is to speed up the patients "journey" through 
investigations, positive diagnosis, staging and treatment, with the 
declared goal of speeding up the clinical management as well as 
improving patients' satisfaction both in the health care system and in 
the outcome of the treatment of their disease71105.
Whilst the diagnosis of early gastro-intestinal cancers during 
their asymptomatic phase represents the ideal answer to treating this
Uf*«*CR 8A9TMIMTff37(KA& C A N C & R i 
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condition751109, with many efforts understandably being channelled in 
this direction, the second segment of the natural history of this 
pathology has attracted a lot of interest from clinicians and politicians 
alike in an attempt to limit the delay between presentation and 
treatment4;40;65;67;80. The efforts made in this respect may vary from 
country to country due to the structure of their health care system 
and the perceived popular and political impression of failure in 
"speeding the patients through the system"65. Japan fares best by far, 
where the mass screening and targeted risk-group screening programs 
have been in place for decades; with their "walk-in centres" for one- 
stop consultation and radiological /  endoscopic assessment90, the 
Japanese medical system is able to limit to a minimum the delays 
between presentation and positive diagnosis as well as reducing the 
pre-surgical interval as a whole90.
In Western Europe the situation is more complicated, with 
delays occurring in different countries at various levels of the 
diagnostic and treatment pathway; for example Siewert90 
acknowledged that Germany is delaying their patients at family doctor 
level with often unnecessaxy treatment for symptoms like dyspepsia or 
anaemia instead of referring the patients for investigation; once the 
patient has been referred, Siewert and Stein90'*144 found that German 
patients are going through the process of diagnosis and treatment 
quicker then other European counterparts. In the UK it was found 
that delays occur both at family practice level as well as at the
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hospital level5019019*119112211371159; these findings confirmed the general 
perception of the population, politicians and medical professionals 
alike that the British system is slower in diagnosing and submitting 
patients to curative treatment4;50:65:90;96;122;139. It is therefore easily 
explained why most of the reports related to delays in diagnosis and 
treatment of Upper Gastro-intestinal Cancers during the last decade 
emanate from Britain6*'9*9*137. However, there is no clear cut 
consensus amongst British authors as to whether these delays would 
influence the outcome of these patients and, even if they do, how to 
improve the situation9*11*127513*14*159.
In the absence of nationally funded - Japanese style - programs 
for mass screening or at least targeted screening, gastroenterologists 
and surgeons in Britain have tried to find ways to speed up the 
processes of diagnosis, staging and treatment of these patients. In the 
last decade many UK hospitals started to use the benefits of Open 
Access Endoscopy and One-Stop or Rapid Opinion clinics to speed up 
the process of diagnosis of patients with upper gastro-intestinal 
malignancies2*3*60. Whilst these new methods were introduced 
initially in the 1980's with the specific aim of eliminating patients' 
waiting time for an outpatient appointment, soon it appeared 
reasonable for physicians to use the same setting for reducing the 
inherent delay in seeing patients with worrying symptoms as well as 
improving the pick-up rate of gastro-intestinal cancers.
tiRPSR OAOJROtmSOWtHAt. CANCC&i 
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Given the background of worse survival rates in England and 
Wales comparative with the rest of the European countries for various 
forms of cancer in general and gastro-oesophageal in particular33, and 
given the public discontent in the UK with the continuous perceived 
deterioration of health care facilities, the UK government has "pledged” 
to address the issue of waiting times for cancer diagnosis and 
treatment80. To achieve that, the same assumption applied, which is 
that reduced waiting times will inevitably lead to more rapid 
diagnosis, earlier instigation of treatment and care, reduced morbidity 
and increased life expectancy in these patients40*51139. In the UK, with 
its particular structure of health care delivery, this issue remains 
controversial amongst medical staff; most clinicians are not sure 
whether the scarce resources will be wisely used in this way without 
clear evidence that reducing waiting times from the previous level of 
24 days for oesophagus and 27 days for stomach respectively139 to the 
target of the "two-week rule" interval would actually improve the early 
diagnosis in these cancers, and more importantly, would induce an 
increase in the survival rate as an ultimate goal for such actions1351149.
The majority of hospitals in the UK are running, in one form or 
another, services such as Open Access Endoscopy, One-Stop Clinic, 
Rapid Opinion Clinic, etc.; these services are widely used by the 
Primary Care sector for referral of patients with digestive symptoms 
and most of the gastroenterologists consider them a good method to 
speed up the process of positive diagnosis for cancers; if the health
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care professionals have to comply with the government's "two week 
rule" for cancer appointment, it is important to see if such methods 
can actually make a difference in the early diagnosis and in the 
outcome of these patients. It is unclear yet if such methods of referral 
and diagnosis, besides reducing the waiting time, could actually pick­
up cancers in earlier phases and ultimately improve the outcome of 
such patients.
There is very little information in the medical literature with 
reference to the effect of these new methods of referral and diagnostic 
services upon the improvement of early management and outcome of 
patients with Upper Gastro-intestinal Cancers alone. Whilst it is at 
least logical that for these patients the impact of the new services and 
referral methods on waiting times is beneficial, albeit ignoring their 
associated costs, it is still unclear whether the evidence supports the 
"two week rule" with regard to early stage diagnosis and better 
prognosis of these cancers; it is also unclear whether these services 
can actually contribute positively to improved outcome for those 
patients with Upper Gastro-intestinal Cancers, be this outcome 
measured in survival ratios, quality of life indicators or indeed 
patients' satisfaction with regard to their speedy clinical management. 
Also, in view of the limited financial and infrastructural capacity of the 
health care providers, concerns have been raised in respect of the 
"boomerang” effect upon waiting times as a whole due to clogging up 
the system by increased referral ratios. It is therefore worthwhile to
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look to the experience gained in two of such units where these 
services were in place for a period of time long enough to enable valid 
evidence-based conclusions.
The aim of this work was to assess the impact of such new 
services on the speed of diagnosis, treatment and outcome of the 
patients with upper gastro-intestinal cancers alone. Whilst both the 
costs associated with the implementation of these services and 
patients' satisfaction indexes are more complex issues to assess40 and 
remain outside the clinical remit of this study, several other 
parameters and variables might be more feasible to be interpreted, 
such as the speed of patients' throughput, staging and treatment 
measures and, not least, outcome after treatment and survival rates. 
Although there is sufficient quantitative and qualitative data to 
suggest that the implementation of these services is followed by 
increased patients' satisfaction in terms of waiting times 80;82;ll0;121:140, 
it is important to ascertain whether all these efforts are followed or not 
by encouraging results in stage levels, operability and ultimately, 
better survival for these patients diagnosed with Upper Gastro­
intestinal Cancers.
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Chapter H
E A R L Y  DIAGNOSIS vs. DIAGNOSE E A R L Y
Summary: Based on the medical literature, this chapter m akes
an attem pt to sum m arize the efforts sustained in diagnosing the Upper 
Gastro Intestinal Cancers early. A fter a brief overview o f the current 
situation in gastrointestinal cancer diagnosis, in both the eastern and 
w estern hem isphere, the two realities in diagnostic capabilities are 
exam ined. This w ay the dichotomy betw een "Early D iagnosis” and the 
"Diagnose Early" aspiration is established. The comparison between 
Japan and the W estern World provide much o f the basis fo r  the 
superiority o f the realities and successes o f the Japanese setting. The 
screening procedures so popular in Japan are discussed together w ith 
the reasons w hy these procedures have not taken o ff in the W estern 
World. Until the advent o f genetic mapping and testing through 
screening programs, other possible strategies were em ployed in the 
early diagnosis and these are discussed here; these strategies are 
based on the expertise gained in clinical settings which were established  
fo r  general non-specific G astro-intestinal pathology. New clinical services 
such a s Open A ccess Endoscopy is seen  as a solution to both decrease 
in the waiting time and increase the potential benefit in picking up early 
cancers and improving outcomes.
Subheadings in th is Chapter:
A. Overview
B. E arly  or Late D iagnosis?
a) La te  d iagnosis m eans advanced  cancer
b) E arly  cancer is  th e  idea l stage  fo r  d iagnosis
c) "Diagnose Early" is  w ha t we a im  to do
C. S tra teg ies to  d iagnose early
a) G enetic te s tin g  s tra teg y
b) M ass-screening & targeted-screening program s
c) Im proving hea lthcare  provision - a lgorithm s  &  services
The Upper Gastro-intestinal Cancers are neoplasms that appear 
either as primary tumours or as secondary involvement of the 
oesophagus, stomach and first two segments of the duodenum. In the 
majority of cases - more than 95% 69;100;108;152 - these cancers are
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adenocarcinomas and arise from the epithelial lining of the upper 
gastro-intestinal tract; they will reflect therefore, subject to certain 
degree of differentiation, the epithelial tissue they are arising from. 
Only in a minority of cases are these cancers arising from other 
structures of the oesophago-gastro-duodenal wall and thus the 
histological type would mirror more or less these wall structures: 
sarcomas, lymphomas, Gastro-intestinal Stromal Tumours, malignant 
angiomas, schwanomas, etc. With extreme rarity69198 and mostly 
suspected as secondaiy involvement, other forms of cancers have also 
been reported in the literature as cancers of the Upper Gastro­
intestinal Tract: melanomas, small cell carcinomas, desmoid and 
carcinoid tumours, etc.108:137;152;157. Due to this incidence, the majority 
of the studies and series reports incorrectly incorporate all Upper 
Gastro-intestinal Cancers under a common name of gastro-intestinal 
carcinomas or oesophago-gastric carcinomas. Due to their prevalence 
and despite clear differences between all these cancers, the impact of 
non-carcinomas upon the statistical results of any study involving 
large case-mix series is quite minimal. As such, vexy few studies 
examining large gastro-oesophageal case-mix will make specific 
reference to the different forms of Upper Gastro-intestinal Cancers, 
perhaps with the notable exception of oesophageal squamous 
carcinomas and gastric lymphomas37198.
The socio-economic and epidemiological importance of these 
cancers reside in their progressively increased occurrence in absolute
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figures over the last four decades or so45;67;81;113, changes in the 
topographic distribution within the upper Gastro-intestinal Tract, 
with adenocarcinoma of the lower oesophagus gaining ground against 
the more traditional prevalence of squamous carcinoma3414*721791811134 
and some improvement of life expectancy after radical treatment, with 
significant mortality and postoperative mortality rates34**4*90112*144.
A. Overview
To understand the huge medical and social importance and 
implications of these cancer localizations it is sufficient to briefly 
quote the reported incidence and prevalence figures. When cancer 
mortality is examined on a world scale, gastric cancer ranks second, 
ju st below lung cancer, with considerable geographic variation; 
oesophageal cancer ranks fifth as a cause of cancer mortality; most of 
these cases occur in the developing countries, with pockets of high 
incidence in some areas of China, South Africa and Iran.
In Japan the incidence and prevalence of gastro-oesophageal 
cancer is the highest in the world; it is noted that the prevalence in 
Japan can exceed 25%™ making it the number one priority for the 
national health policy.
In the United States in 1995 alone Daly M. et al.35 reported 
through the National Cancer Data Base NCDB an incidence of 12100 
new cases of oesophageal cancer and an estimated death toll from this 
localization of more than 10000 cases. Looking to The American
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Cancer Registry, Lambert79 found an age-specific incidence of gastric 
cancer in the US of 7.5/100000 cases. This incidence appears much 
closer to the published European figure than to the Japanese Osaka 
Cancer Registiy data.
In contrast with Japan and the United States, the incidence and 
prevalence of the Upper Gastrointestinal Cancers in Europe is 
situated somewhere in the middle. The most authoritative source of 
data for the European region remains the EUROCARE II Study23 based 
upon the EUCAN1 Database22145. For the period 1978 to 1990 this 
registiy published information on more than 86500 gastro- 
oesophageal cancers for the population of 17 European member 
states, underlining the importance of these cancer localizations in 
comparison with other cancers. However, it is likely though that the 
number of patients with malignant tumours of the upper digestive 
tract is much higher, as the database contains only primary tumours 
and excludes cancers in-situ and lymphomas also. In addition, some 
country-specific registry reports did not cover the whole population, as 
is the case of the United Kingdom's registry reports, covering only 50% 
of its population45. Based on this register, Lambert79 found in Europe 
for the interval 1983-1990 a crude rate of incidence of 5.7/100000 for 
oesophageal and 21.5/100000 for stomach localization.
1 EUCAN Database: 1996 estimates, version 3.1 (Created 29-09-2000)
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In Britain gastro-oesophageal cancer remains a significant 
health care problem; it causes in excess of 10000 deaths per annum 
in England and Wales alone, placing it as the fourth and fifth 
respectively amongst the most common causes of cancer death1*3. The 
Scottish Cancer Intelligence Unit in Edinburgh24 reported more than 
8000 cases diagnosed in a five year period. For the whole of the United 
Kingdom the EUROCARE II Study22*3 shows during the period 1990- 
1996 a crude incidence rate of 11.80/100000 for oesophagus and 
16.32/100000 for stomach respectively; the prevalence rates for the 
UK are for the oesophagus 8.0/100000 and for the stomach 
25.7/100000 respectively79.
A simple look to these rates in comparison with the other 
European countries shows Britain as having one of the highest crude 
incidence and prevalence rates throughout the European Union for 
the oesophageal cancers, with only Portugal, Austria and France 
trailing it for the stomach localization. It is also easy to spot the trend 
over a decade, as seen in the EUCAN databases I and II23, with the 
decrease in incidence of gastric localization in favour of the 
oesophageal localization - gastric incidence rates from 21.5 to 16.32 
per 100000 compared with the oesophageal incidence from 10.4 to 
11.80 per 100000 respectively. The crude mortality rates present 
similar data, situating Britain towards the bottom of the league in the 
EUROCARE II Study23 with mortality rates of 11.48/100000 for the 
oesophagus and 13.11/100000 for the stomach.
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In Wales carcinoma of the oesophagus, cardia and stomach is 
the fourth most common cause of malignancy15114. For a country with 
a population of nearly 3 million people, it is sufficient to mention the 
number of patients registered during the year 1992 at 15816 in order 
to understand the implications for the health care providers in 
struggling with the management of these patients114. The crude 
incidence rate of 31.4 per 100000 population ranks Wales worse off 
than the UK average and well below the European average. Monitoring 
the incidence rates for a period of 10 years to 1992, Pye et al.114 found 
that Wales followed the pattern seen in the rest of the Western World 
with a slight decrease of the incidence of gastric cancer - 29.8 to 24.9 
per 100000 population - and a modest increase in the incidence of 
oesophageal carcinomas - 9.8 to 13.8 per 100000 population.
Before completing this overview on the current epidemiological 
data, a word is necessary about the most recent population trends in 
the world noted during the last two decades in relation with the 
incidence of the Upper Gastro-Intestinal Cancers. These 
epidemiological trends are not only mentioned by many reviewers, 
but also appear to play a more and more important role in the process 
of diagnosing the patients with Upper Gastro-Intestinal Cancers; also, 
these trends are currently taken into consideration and have direct 
implications in the design of various methods of referral or screening, 
as well as offering variable prognostic significance in assessing an 
individual's suitability for one or another method of treatment.
£iR R G R  G A 3 1 R a tN 7 G 3 7 tH A L  C A N G G R i
O O  O U R  G G iN tC A t 3 G R W G E 3  W O R K
7 0 W A R 0 3  7 H 3  "TWO WGGR R U L E * A N O  H O W ?
- 1 8 -
C hapter Hi E arly D iagnosis us* Diagnose E ariy Eerhan L Qheorghiu
One of the most visible trends since the early 1980's was noted 
as being related to a perceived ever increasing incidence of the 
oesophageal carcinoma. Many authors24;25;35;45;51;79:81;111;113;117;134 noted 
that the incidence of oesophageal carcinoma started to rise in the 
Western World progressively and sometimes at alarming speed. For 
instance Daly et al. concluded that the rate of increase of the 
oesophageal carcinoma in the US may be as high as 10% per annum 
or from 33% incidence to 43% over a  period of 5 years. Similar trends 
were seen in Europe too111:117;129;133;142:153.
One statistical observation in respect of this topographic trend 
is the progressive reduction in distal gastric forms of cancer. Not only 
in Britain11*114, but also in Europe,77;11I;13°, there are significant reports 
suggesting a drop in the incidence of distal gastric cancers. Beside the 
statistical relevance, this trend may suggest that the balance in 
clinical management and post-treatment morbidity and mortality may 
have to change in the future.
Although not certain yet, many authors43;79;154 suggest that this 
rise may have sociological and behavioural causes such as gastro- 
oesophageal reflux, smoking and obesity2512*154, whilst many others 
consider that the rise is only relative and due to a progressive decline 
in the prevalence of distal stomach localizations45;67;81;113. However, 
Okabayashi et al.109, in contrast to the reports from the Western World 
mentioned above, found in a large study that the incidence of early 
cardia carcinoma in Japan was veiy low and obesity, smoking,
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drinking, Barrett's oesophagus or GORD were not related to its 
occurrence. Similarly, Kitamura72 found that the chronological 
changes in gastric cancer patients over the past 27 years have 
included an increase in the incidence of earlier-staged gastric cancers, 
which has had a significant impact not only on the ratio of 
oesophageal /  gastric localizations, but also on the improved post­
operative survival rate.
Extensive studies3*5*5*13*154 also raised suspicions in relation to 
Barrett's metaplasia in the lower oesophagus as being a precursor for 
carcinomatous changes. The estimated incidence of adenocarcinoma 
in Barrett's oesophagus ranges from 1 in 52 to 1 in 441 patients 
years, representing an increased risk of 30 to 125- fold49. Although 
being accepted that Barrett's oesophagus carries a 30-fold to 40-fold 
increased risk of carcinoma, Van der Burgh154 found that these 
patients might not have benefited from surveillance. This is a  very 
significant study showing that most of Barrett's patients he looked at 
had multiple unwarranted endoscopies and despite these, all but one 
died of unrelated deaths. Other authors 54;49;158 found the incidence of 
carcinoma transformation in Barrett’s oesophagus much higher, and 
from here advocated the idea of endoscopic surveillance.
In relation with this increase in incidence of the oesophageal 
adenocarcinoma, it is important to mention the changing perspective 
to the cardia as an anatomical region. Here the work of Siewert et 
aj 77;i3o:i32 g^fo et aL141-144 is essential in redefining and
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reclassifying this segment of the upper gastro-intestinal tract. Whilst 
many authors consider cardia a separate segment and others include 
cancers of the cardia with the stomach localization, Siewert 
introduced the concept of type I, II and III tumour of the cardia; he 
based his classification on topographical localization of the centre of 
the tum our in the clinico-radiological studies of the relevant patient; 
as such, Type III of cardia carcinoma may have much more in 
common with the fundus of the stomach than with the oesophagus. 
This classification tends to eliminate the confusion related to the 
topography of the cardia and paves the way to structured algorithmic 
approach to the management of these patients based on evidence- 
based data12*142.
The different way to classify cancers in this segment under the 
ICD-9 and ICD-101 classification may introduce variations in the 
case-mix and may be responsible for the change in the oesophageal 
carcinoma prevalence we have seen in the Western world11*14*144 over 
the last few years. However, there are many authors who have 
expressed reservations in respect of the possibility of establishing 
accurate topographic diagnosis; the reason used to defend this 
position was the size of the tumour and the advanced TNM staging of 
the disease, which may require more extensive anatomical dissection 
and more extensive oncological security margin.
1 International Classification of the Diseases, ver.9 and ver. 10
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Another important trend to highlight is the slowly progressive 
age-standardized incidence521154. Although this trend is not as 
spectacular as the previous one, it may have important implications 
not only in the diagnostic methodology employed by the health care 
providers, but also significant consequences in treatment and 
survival. A few papers1541156 are already published suggesting that an 
increased number of patients followed-up in various trials died of 
unrelated deaths. Although various environmental factors may not be 
ruled out, most authors agree that this trend may be related with a 
progressive ageing population. In fact, simply looking at the patients' 
mean and median age figures reported in various papers, it transpires 
that the Upper Gastro-Intestinal Cancers affect mostly people in the 
third generation, whilst being seen quite rarely below the age of 45.
When taking into consideration crude figures, it appears that in 
most Western countries the mean age at diagnosis is somewhere 
around 68 to 69 years. One of the highest figure was reported by 
Barchielli18 in a large study from Italy where the mean age at 
diagnosis was quoted as being 70.5 years. Looking at the data 
obtained from 41 EUROCARE cancer registries in 17 European 
countries and 9 U.S. SEER registries, Gatta et al.52 have found that 
survival declines with the increasing age at diagnosis for most cancers 
in both the U.S. and Europe, but was more marked in Europe. What 
is interesting though is that the studies taking into consideration 
early Upper Gastro-Intestinal Cancers alone39;43;62;104 are offering much
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reduced figures for mean age at diagnosis; as such, in his Japanese 
series from Fukuoka, Ikeda62 reported a mean age of 59.9 years and 
Everett43, looking at the European papers, found similar figure for 
early cancers; Everett43 concluded in his study that patients with early 
gastric cancer are a number of years younger than those with 
advanced cancer; this appeared not too surprising as, for those 
patients deemed unable to sustain any surgical approach, the 
estimated median duration of early cancers was only 37 months 
before becoming advanced ones.
These facts raised at least two major questions for clinicians: 
one is related to the age of the patients submitted to treatment, where 
their co-morbidities may play a significant role both in designing their 
treatment methodology and in the postoperative morbidity, mortality 
and prognosis rates4*52; the second question refers to the hypothesis 
that early cancers are only an initial phase in the natural history of 
Upper Gastro-Intestinal Cancers 15:43:79;95; incidental diagnosis of early 
gastro-intestinal cancers, as well as non-treated cases due to clinical 
co-morbidities seem to suggest that the asymptomatic period in these 
cancers' natural history may be in excess of 5 years 43;73-75; based on 
the median age difference between early and advanced cancers, as 
well as on the fact that the results in the treatment of the cancers in 
early stages are far better, several authors901128 suggested that one way 
to improve the prognosis of these patients would be to move the 
emphasis from late diagnosis to early diagnosis.
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B. Early or Late Diagnosis?
A longstanding aim of the clinician dealing with cancers of the 
Upper Gastro-intestinal Tract is that of diagnosing these patients at 
as early a stage as possible during the natural history of the disease. 
In keeping with this aim, the concept of early and late diagnosis has 
been introduced as a potential ticket to curable treatment. However, 
the problem appeared to be not as simple due to the devious character 
of cancer as a disease and due to the current diagnostic means 
applicable on a populational scale. A clear example is the number of 
asymptomatic patients who are incidentally diagnosed in the 
advanced stages of the disease, or indeed, the large proportion of 
patients still diagnosed in stage II and beyond just after the onset of 
the symptoms. Whilst the term late diagnosis becomes day by day 
more clearer and unambiguous from diagnostic and prognostic points 
of view, signifying either a  diagnosis established late or in the late 
stage of the disease - i.e. advanced cancer -, the same does not apply 
to the term of "early diagnosis". As such, the term Early Diagnosis is 
occasionally used to mean either the diagnosis was established as 
soon as possible after the onset of the symptoms - i.e. diagnose the 
condition early -, or indeed as that of early cancer - i.e. diagnose the 
condition in early stage -.
Ideally, it would be of great benefit to bring the two situations as
s
close together as possible, whereby an early diagnosis would ensure
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the diagnosis of an early cancer. Unfortunately, as real life and 
statistical data show, this is not always the case. Based on the 
assumption that, by "diagnosing early", these patients would be at a 
lower stage of the disease at treatment time, it was a  matter of 
judgement to find ways to obviate the "bottlenecks" in their referral 
and treatment pathway and try to improve them.
Therefore, before adopting any new strategy to diagnose these 
cancers as early as possible, both clinicians and healthcare providers 
need to justly assess in clinical, infrastructural, financial and medico­
legal terms the implications and the potential benefits of such 
strategies in order to achieve the early diagnosis at a stage as early as 
possible. Bearing this aim in mind, it appears interesting to dissect 
the connotation of the two entities in Upper Gastro-intestinal Cancers 
- Early Diagnosis and Early Gastro-intestinal Cancer - and highlight 
the areas of action where the two entities can be forced to come close 
to each other; in other words, to find a common course of action 
where the methods employed to diagnose early can actually improve 
the ratio of early cancers diagnosed. To have a wider comprehension 
of the importance of issues such as early cancer and early diagnosis 
and before having an overview of their prevalence in the Western 
World, it is worthwhile to briefly revisit the topic of late diagnosis as 
an unfortunate reality of present times.
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af Late diagnosis means advanced cancer
Undoubtedly one of the major disappointments in our daily 
practice is the moment when we realise that a patient recently 
diagnosed with Upper Gastro-intestinal Cancers may have an 
advanced form of disease which cannot sustain curative treatment 
This disappointment however, may turn into despair, depression, 
sorrow or even denial for the patient himself or his family, although 
some patients may present a positive approach to the news and 
actively fight the disease, albeit with little hope of survival. The 
advanced form of cancer of the gastro-intestinal tract painfully 
translates the reality of late diagnosis, irrespective of the incriminated 
cause of delay. Most of the time late diagnosis and advanced cancer go 
hand in hand. This is due to the length of time elapsed between the 
moment of the first carcinogenetic changes that escape immunologic 
suppressive control and the moment when the diagnosis is 
established, when the Muscularis Propria is penetrated by the tumour 
and/or dissemination occurred.
Due to the devious character of this condition, much of the 
beginning of the growth process takes place "behind the scenes", quite 
insidiously and with or without minimal symptoms961122. It is this 
period of the natural histoiy of the disease which is the most suitable 
for curative treatment. Once this opportunity is lost, the tumour 
growth penetrates and invades structures of the gut wall and/or
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disseminates through blood or lymph channels, becoming advanced 
cancer.
Several studies attempted to establish what length of time is 
needed for a cancer to become advanced. This was a difficult task, but 
essential in establishing the "plage" of interaction between disease and 
the measures or actions to be taken to establish an early diagnosis. 
The "in vitro" laboratory results are not always confirmed by "in vivo" 
clinical observations. Based on laboratory results, many authors 
agreed with what appears to be the "doubling time" of a tumour; 
although variations can occur from tissue to tissue and indeed, from 
individual to individual, it appears that it will take approx. 12 weeks 
for a tumour to double its size5*7*7*94. However, it is still not clear yet 
what happens in this interval with the other feature of cancerous 
cells, which is that of dissemination through blood /  lymph channels.
The situation is less clear on clinical grounds. The difficulty 
resides in the ethical approach to such studies by the impossibility to 
create randomised trials. However, several studies43 have been 
released where some patients diagnosed with early cancers were not 
submitted on clinical grounds to the surgical therapeutic algorithm. 
Based on these types of observations, it has been postulated that it 
may take approx. 37 months for a tumour to grow from the stage of 
early cancer to the stage of advanced cancer. Other studies5*7*75 have 
postulated that the rate of doubling is variable; whilst early gastro­
intestinal cancers appear to have a doubling time between 1.5 and 10
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years, the advanced gastro-intestinal cancers might have a much 
shorter period of doubling, between 2 months and one year. In fact, 
these clinical observations go hand in hand with the paradoxical 
observation whereby the longer the symptomatic history is, the more 
likelihood there is of diagnosing a less advanced form of gastro­
intestinal cancer9*11*127.
Although the interval early - advanced cancer sequence is only 
observational, there may be a multitude of variables which may 
influence the growth process from case to case: age, gender, hormonal 
status, environmental factors, nutrition, immune defence, etc. Beside 
the importance of such studies showing the length of time before 
which a tumour's chance to be treated curatively diminishes 
considerably, these studies also highlight the interval of time where 
positive diagnosis is delayed for one reason or another.
Both physicians and healthcare systems are adopting a self- 
confessed criticism when assessing the crude reality of advanced 
cancer. Whilst Japanese reports sound much more optimistic, with 
continuous decreases of cases in advanced stages, the Western 
experience is plagued by far poorer results. In Japan the ratio early vs. 
advanced cancer, - i.e. T0+Ti vs. T 2 + T 3 + T 4 1 cases, where T represents 
the Tumour and the indexes represent the degrees of penetration of
1 Stages of the Tumour as defined in TNM Classification o f Malignant Tumours
(UICC) (Paperback), Union Internationale Contre Cancer, Geneve, Switzerland, 1990
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the tum our within the wall of the viscuses concerned -, is continually 
increasing, based on increasing num bers of early cancers diagnosed.
Fig. 2 .0 1  - The  In c id e n c e  o f  E a r ly  a n d  A d v a n c e d  C a n cers  in  J a p a n 1
There may be many reasons behind this situation and they include 
not only the provision of healthcare services as a response to a clearly 
populational health problem, but also individual factors such as 
public awareness, genetics issues or indeed the genetics of the 
tum ours in the Japanese population. Many papers highlight this 
diagnostic trend10;62:72:90;151 and the work of Ikeda et al.62 clearly shows 
this reality (Fig. 2.01).
In the Western World late diagnosis and implicitly advanced 
cancer diagnosis is unfortunately the norm. In the United States 
around 56% of all cases of Upper Gastrointestinal Cancers diagnosed 
are in stages III and IV according to the TNM Classification, whilst
1 Courtesy of Ikeda et al., Br. J. Cancer62
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stages 0 and I (i.e. T0+Ti and N0) are found in less than 40%3*138. In 
Europe the situation is not much better with early cancers diagnosed 
in between 15% to 26% of all cases, but these figures refer to 
surveillance protocols118. There is no perceived evidence that 
symptoms or localization play a role in late diagnosis, however if 
cumulative conditions are considered such as staging, medical co­
morbidity, nutritional status, etc, then it appears oesophageal cancers 
as being less favourable in their presentation and subsequent offered 
therapeutic possibilities 96:122.
At first glance, in Britain the situation appears much worse due 
to very poor figures offered by the EUROCARE II study2*23 in respect 
of outcome and survival rates. Until recently both oesophageal and 
stomach cancer were regarded as fatal conditions due to the stage in 
which the diagnostic and treatment was instituted. Martin et al.90 
appreciated that, when finally the diagnosis of cancer of the Upper 
Gastro-intestinal Tract is established, this is late and surgery is less 
extensive than in Japan. He postulated this purely on evidence 
grounds, although the authors acknowledged that the situation is 
largely due the more advanced age of the patients in Britain as well as 
the more advanced staging of their disease90. He also noted that, even 
with his hospital being a tertiary centre for referrals, the unit was still 
diagnosing more than 80% of Upper Gastro-intestinal Cancers in 
stages II, III and IV where curative treatment is not achievable. 
Similarly, Renehan and Tweedle118 found that up to 74% of cases in
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their experience are diagnosed as advanced. More depressing still, 
Mikulin et al.96 found that in their experience only 13% of patients 
were diagnosed as early cancers.
In Wales there were several reports showing the high rate of 
cancers presenting beyond surgical possibilities. Pye et al.114 found 
that only a third of cases in his Welsh review were suitable for 
resection and the CRC database23 for England and Wales showed a 
high rate of advanced cancers putting the Welsh figures well below the 
European average1.
It is therefore possible to say that, particularly in the case of 
advanced cancer of the gastro-intestinal tract, late diagnosis may be 
regarded as a failure of the system, which is inefficient in its approach 
to the diagnosis and treatment of the malignant process; be it from an 
educational point of view or indeed due to the absence of implemented 
pathways and methodology to pick-up cancers at an earlier stage, it is 
the healthcare system which is blamed for the poor results.
Due to this unacceptable incidence and outcome, no wonder 
that a  strong alarm signal has been raised recently for Britain to 
improve the current situation. The topic was embraced both by 
patients' groups and politicians alike and recently came more to the 
centre stage of the politico-social debate. Whilst many accept that in 
Britain the number of cases diagnosed as advanced is higher and the 
survival somehow poorer than in the rest of Europe2*2*6*135 due to 
several factors such as patients' late presentation, reduced public
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awareness of non-specific symptomatology and absence of alarm 
symptoms in the early stages of the disease, the causes of this 
situation and the answers to this problem are not so clear. Some 
authors651135 consider that the principal cause is the under-investment 
in the healthcare infrastructure and the services for health 
provisioning, including targeted screening and adequate public 
awareness campaign, whilst others9*9*12*145 raise questions regarding 
the delay in diagnosis as the main cause for discrepancies between 
the healthcare systems71140.
Nevertheless, many clinicians were ready to accept both 
explanations and, whilst the financial side of the argument was left to 
the politicians and health managers to deal with, the clinicians started 
to introduce clinical services and innovative methods of referral, as 
well as algorithms for diagnosis of Upper Gastro-intestinal Cancers in 
an attempt to establish the this diagnosis earlier.
b) Early cancer is the ideal stage for diagnosis
Early Gastro-Oesophageal Cancer was defined as a diagnostic 
entity by the Japanese Society of Gastroenterological Endoscopy in 
1962 as the adenocarcinoma confined to the mucosa and submucosa, 
irrespective of lymph-node involvement. The starting ppint for this 
definition was based on the observation that these cancers have a 
more favourable prognosis. The detection of early cancer in gastro- 
intestinal localization is currently common in the majority of the
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Japanese hospitals and the rate of the early cancer detection exceeds 
the 50% mark. This process has apparently contributed the most to 
the improved postoperative survival rate and this observation has 
been unequivocally acknowledged by physicians worldwide72.
However, this definition may be contradicted by the current 
observations whereby one paramount criterion for prognosis remains 
lymph-node involvement. Indeed, many authors*5*6*72 have reported 
that lymph-node involvement, and particularly the topography of the 
lymph-stations affected, represent the most important factor in 
assessing the postoperative prognosis57. It follows that, at least in a 
few cases reported as early cancers according to the Japanese 
definition but with lymph-node dissemination in stations 6 to 13, the 
prognosis may be translated more closely to an advanced cancer 
rather then an early one. In fact, the classification issued by the 
UICC1 considers the involvement of these lymph-node stations as 
loco-regional dissemination and assigns, based on prognostic factors, 
advanced stages II or indeed III as staging of the disease. Based on 
these observations, particularly linked with the outcome issues, the 
question arises as to whether we should use the term "early cancer" 
for cases diagnosed as invasive to the submucosa only and overlook 
the lymph-node involvement or, indeed classify the extent of cancer 
involvement clinically and based on prognostic criteria61?
1 Union Internationale Contre Cancer, Geneve, Switzerland, 1990
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In contrast with Japan, the Western World does use the TNM 
classification issued by UICC which takes account of both T size and 
N category of lymph-node dissemination. According to the TNM 
Classification of Cancers, stage 0 and I are made up solely of T0 and Ti 
categories, but only as associated with N0 dissemination. As such, this 
observation may be only one of the explanations as to why the rate of 
detected Early Gastro-intestinal Cancers is higher in Japan than the 
rest of the Western World.
Another factor which may play a very important role rests on 
histo-pathological grounds: whilst Western pathologists disregard mild 
and moderately dysplastic lesions as cancers, Japanese counterparts 
include these lesions as Well15:57;126;lsl, with the obvious consequence of 
an improved index in respect of nearly all of the parameters 
considered; for instance, once recorded as cancers and operated upon, 
these cases may actually improve significantly the statistical overall 
figures for morbidity, mortality, survival and quality of life issues. 
Schlemper et al.126 concluded in their histo-pathological study that the 
difference in diagnostic practice may contribute to the relatively high 
incidence rate and good prognosis of superficial carcinoma in Japan. 
However, Kitamura et al.72 is reporting as a " like for like " example 
that stage I gastric cancers are diagnosed in Japan in excess of 54%, 
whilst the Western experience does not go beyond the 20% figure17543; 
Kitamura also demonstrated that gastric cancers are being diagnosed 
earlier in Japan, even within the same stage of classification. It
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appeared that in the Japanese settings the incidence of lymph-node 
metastasis has decreased in Stage II patients and the depth of 
invasion has become more superficial in Stage II patients. On 
epidemiological grounds it is difficult to interpret this trend otherwise 
than accepting that these cancers are diagnosed at an increasingly 
early stage when lymph dissemination still does not yet occur.
Having said all that, one fact is widely acknowledged: it appears 
that the Japanese patients are diagnosed at an earlier stage in the 
Gastro-intestinal cancers’ natural history compared with the Western 
patients and their overall outcome such as mortality and 5-year and 
10-year survival ratios are better1*1*4*63. The importance of diagnosing 
an early cancer is paramount. It relies upon several factors with 
proven track record in the medical literature. Firstly is the fact that 
due to the natural histoxy of these cancers, the patients tend to be 
younger and fitter and thus suited to multi-modal treatment, 
including D3 type of surgery43572. Secondly, the depth of invasion is 
much reduced725104 and lymph-node metastasis is likely not to have 
occurred yet72. Thirdly, the postoperative morbidity and mortality tend 
to be much reduced151 and, more importantly, the 5 and 10 years 
survival rate is in excess of 54%15;4*72;104.
Many authors have described the just balance in the infra­
structural provisions of the healthcare system in Japan, based on the
* f
existence of mass screening programmes for the high risk population, 
particularly employed people, and backed up by *walk-in centres" with
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on-the-spot Barium Meal or Endoscopy facilities for patients 
presenting any gastroenterological symptoms90; on top of this, 
particularities such as the Japanese speediness of the results- 
reporting process, direct referred to the tertiary centre - including the 
by-pass of the General Practitioner link - and the wide availability of 
space in the specialized centres have contributed to the 
implementation of a very short delay between the presentation and 
treatment. Beside the human and financial cost put in place to create 
such a network, the improvement in the general awareness of the 
population for gastro-intestinal malignancy induced by educational 
programs has also contributed towards an improved compliance with 
the rigour of the gastroenterological diagnosis algorithm and 
consequently better results translated by a better pick-up rate.
No wonder that due to such of an extensive network and 
continuous learning curve over the last three decades, in Japan the 
balance has tilted in favour of diagnosing the cancers of the Gastro­
intestinal Tract in early stages, reaching a ratio of nearly four to one 
for early stage cancers. As a consequence of this approach, many 
Japanese papers72 currently report rates in excess of 60% of early 
cancers diagnosed during the last decade, although some tertiaxy 
centres may report figures aiming for 90%151. The consequence of such
exercises is automatically translated in several results which may be
*
the envy of the whole world: the age of patients reported by Japanese 
authors appear to be lower than the Western patients, somewhere
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between 59 and 6443; also, the postoperative morbidity and mortality 
is amongst the lowest in the world with figures for mortality around 
0.6% to 2%39:72, although Japanese surgeons are renowned for their 
surgical aggressiveness in lymph-node clearance during their D2 and 
D3 types of gastrectomies; and most of all, the survival rate at 5 and 
10 years is the highest in the world9;86;103. To this results may 
contribute not only the more favourable staging at diagnosis time, but 
also possible different structure of patient group such as different age 
bracket, co-morbidities, reduced obesity ratios, etc.
Having said that, the statistical figures from the Japanese 
National Records show that the incidence of early Gastro-intestinal 
Cancers rose year on year from 40% in 1985 to more than 60% at 
present43172. This trend was also mirrored by improved figures for 5 
and 10 years survival. Not only the Japanese trend in diagnosing 
more and more early Gastro-intestinal Cancers was responsible for 
better post-therapeutic survival rate, but also, as Kitamura et al.72 
suggested, the perceived trend of gastric cancers to be diagnosed in 
more superficial and small-sized form, as well as less frequent lymph- 
node dissemination contributed to the result. Many authors however, 
accept nowadays that the improved survival rate in Japan is largely 
due to the process of diagnosing early cancer, although constant use 
of more aggressive treatment protocols might be responsible for this 
effect as well43;72;104. It may well be that, based on the natural history
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of these cancers, an early cancer does not have the time to produce 
distant lymph-node metastasis.
However, the Japanese approach to the issue of diagnosing 
early cancers appeared highly impractical to both physicians and 
healthcare providers in the Western World42. There were many reasons 
which counterweighted the balance. Firstly, it has been accepted that, 
based upon the incidence rate of gastroenterological cancer and in 
contrast with other cancers such as breast, lung or colorectal cancer, 
the Gastro-intestinal Cancer pathology cannot be considered more 
important than other conditions which might gain greater benefit from 
the energy and financial resources spent by the system. Another 
viewpoint refers to the number of patients with Upper Gastro­
intestinal Cancer who will actually be submitted to radical treatment 
compared to the number of newly diagnosed cases; however, it is 
suggested that the increase in the ratio of early cancers diagnosed 
may be subsequently followed by a higher operativity ratio which, as a 
consequence, may backup the spiralling costs of treatment 
infrastructure. Secondly, the spectrum, prevalence and dynamics of 
Gastro-intestinal Cancer pathology makes the increase in 
infrastructure provisions impractical and also raises some questions 
in respect of the balance between results obtained and staffing 
requirements32;39;123.
It is no wonder then why none of the Western countries have 
implemented the Japanese model and introduced services compatible
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with mass screening, limited screening for working population, walk- 
in centres and fast-track treatment in tertiary centres90. With its 
infrastructure in place and appropriate dissemination of guidelines 
and pathways of care, Japan is prepared, better then anyone else, to 
absorb the burden of an expected 25% crude incidence rate of gastro­
intestinal malignancies79.
One entity, particularly pertinent to gastric localization, was 
recently much debated and needs to be mentioned. It was named by 
the Japanese researchers as "mp cancer" or Muscularis Propria 
carcinoma104. It is agreed that this form of carcinoma is an 
intermediate form between early cancer and advanced cancer. 
Nakamura et al.104 looked at this entity from a pathological point of 
view and found that the overall parameters like resectability, 
mortality, and survival rates are veiy similar to the results obtained in 
early cancer treatment; this was a surprise since, if strict definitions 
criteria are being applied, the "mp" cancer as a pathological entity may 
belong to the advanced cancer rather than early cancer due to the 
penetration of the Muscularis Propria layer.
Leaving aside the hypothesis, not proven yet, that patients 
diagnosed with early cancers may have a totally different type of 
cancer43 and to achieve results similar with the Japanese figures, one 
would need to look to other options such as: methodology and speed 
of diagnosis, aggressiveness of treatment and quality of "after care" 
settings. These options bring us to the current reality which is the
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attempt to pick-up early cancers by trying to diagnose them early after 
the onset of the symptoms.
c) "Diagnose Early" is what we aim to do
The issue of methodology and speed of diagnosis introduces the 
second face of the early diagnosis issue, which is the "diagnose early" 
option. Due to the higher costs, patients' compliance and required 
infra-structure necessary to be implemented to achieve the "early 
cancer" diagnosis in the pre-symptomatic phase of cancer 
development, the "diagnose early" approach was considered, by many 
at least, an interim way of aiming towards diagnosing cancers in early 
stage - i.e. as early cancers15 -. This approach was based on the logic 
that throughout their natural history these cancers would evolve from 
a small, containable lesion, to a much larger and certainly 
disseminated disease. Several reports15143 back up this hypothesis by 
observing the time lag between diagnosis and death in cases with 
early cancers which for one reason or another were not submitted to 
radical treatment.
An important role in advancing the hypothesis that the 
"diagnose early" approach may shorten the natural history of the 
disease is also offered by the laboratory results; after researching the 
doubling time of tumour cells, which is translated on clinical grounds 
by the calculation of the time taken by the tumour to double its size, it 
was postulated according to some research that a "diagnose early"
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approach in these cases would obviously submit patients to the multi­
modal treatment in earlier stages where the results may be more 
acceptable.
The conclusion which transpires after all these studies is the 
one that every day lost in establishing the positive diagnosis of Gastro­
intestinal Cancer takes its toll on the stage of the disease with which 
these patients are found at treatment time and with important 
consequences upon survival chances. It is this conclusion which 
triggered the interest given to the issue of delay in diagnosis and 
treatment and perhaps the reason why certain innovative modalities 
of referral and services were introduced to tackle this matter. It must 
be added though that the patients themselves contributed also to this 
imperative by voicing their expectation to be treated quicker. In an 
attempt to diagnose these cancers early, medical professionals and 
healthcare providers tried to find ways to speed up the "journey" these 
patients face through the referral, diagnosis and treatment pathway. 
Various organizations contributed to the debate and several areas 
were identified where the speed of patients' management could be 
optimised. Pressure has been put on the health care providers and 
medical staff to improve the delivery of improved waiting times to 
diagnosis and treatment for those patients suspected of developing 
malignancies.
Based on the assumption that through "diagnosing early" these 
patients during the natural history of their disease, one can lower the
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cancer stage at diagnostic time, it was a matter of judgement to 
scrutinize the delays in diagnosis and treatment and their causes. 
Although some authors voiced their concems65;135;149 that this 
approach is not entirely researched and bringing the diagnosis 
forward by weeks rather than months is not necessarily increasing the 
numbers of early cancers diagnosed, health providers in Britain 
increased locally the funding for the provision of the diagnosis 
sequence in an attempt to please both sides of the argument. 
However, in the absence of hard core evidence that certain measures, 
services or educational programmes may actually increase the 
absolute figures of early cancers diagnosed, the increase in funding 
was unstructured and without a major redesign of the upper gastro­
intestinal service. It involved new but fringe measures such as 
contractual allocation of programmed activities for multi-disciplinary 
assessment of cancer patients or indeed moderate infra-structural 
expansion of services implicated in the diagnostic algorithm.
The issue of delays in the diagnosis and treatment of cancer in 
general 29147:139 and gastro-oesophageal in particular114 is monitored 
closely by every medical community, although it seems it has become 
more recently a prominent political and social awareness entity in 
Britain, where it goes hand in hand with the debate of adequacy of the 
financial and infrastructure provisions.
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C. Strategies to diagnose early
Most of authors nowadays believe that one of the potential keys 
to improve the outcome of those patients with Upper Gastro-intestinal 
Cancers is to practise "early diagnosis", i.e. to diagnose as early as 
possible either any lesion which may progress to full blown cancer or, 
even better, to pick-up those lesions which are at risk of developing 
such a dreadful disease before any carcinomatous change takes place. 
It is also aired that a very important step supporting the latter action 
would be genetic mapping and testing8*94. Until this method of 
diagnosing early gastro-intestinal cancers becomes clinically and 
epidemiologically feasible and widely available, clinicians have put to 
use other methods which tried to pick up cancers in early stages. 
These are mass screening, targeted screening of certain groups of 
individuals and other methods attempting to speed up the patients' 
diagnosis and treatment.
a) Genetic testing strategy
The hypothesis that the Gastro-intestinal Cancer has a 
conditional genetic occurrence was long debated. Advocates of this 
hypothesis showed in many studies that Eastern immigrants, such as 
patients of Asian origin in the United States, maintain their 
statistically increased risk of gastric cancer even after a long period of 
time spent in the Western World2*148. In addition to this, many studies 
have shown that, for the same stage of the disease, Japanese patients
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seem to live longer than their Western counterparts, with a 
significantly higher percentage of 5-year and 10-year survival ratios15, 
even if this result may be influenced by other factors, such as more 
aggressive surgical approach and better designed aggressive adjuvant 
therapies in Japan90 comparative with the rest of the Western World. 
Also, it has been observed that the prevalence of early-stage cancers 
diagnosed in Japanese setting appears to be higher than in the 
Western World, although a few authors tried to find a reasonable 
infrastructural explanation for this conclusion, such as the effect of 
mass and/or targeted mass screening policy and differences in 
pathology reporting pattern, with Japanese pathologists considering 
severe dysplastic lesions as early cancers151109.
Based on the above observations, many authors suggested that 
Japanese patients may have a different gastro-oesophageal cancer 
altogether8*94. From here to the genetic hypothesis of carcinogenesis 
was only a small step to be considered. McCulloch et al.92 looking to 
the genetic expression of cancer cells in Japanese and British patients 
concluded that there are certain similarities; for instance, they found 
similar molecular genetics, including p53 expression9*132. However, a 
significantly greater proportion of tumours in Japanese patients 
expressed the "anti-metastasis factor" mm23, whilst the mean 
proliferating cell nuclear antigen index was quite reduced83194. 
Although further studies are needed to compare tumours between 
Eastern and Western patients and to define genetic differences94, one
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thing becomes clearer: the diagnostic pathway for oesophago-gastric 
cancer, with special emphasis on early diagnosis, has to move from 
the clinical setting to the preclinical and genetic means.
Once the genetic features of these cancers are known and in 
particular if the genetic risk of developing these cancers in an 
individual can be assessed, the diagnosis of upper gastro-intestinal 
cancers can be brought forward from the current clinical phase. 
Under these circumstances it is believed that the screening process for 
such conditions will be much improved, perhaps narrowed through 
targeting towards high risk groups, with the expected end result of 
diagnosing these cancers in early, subclinical stages. The aim is not 
unreachable as very good results have already been obtained in 
Britain in various other forms of cancers where the "genetic stamp" 
was deciphered to a certain extent, such as in certain forms of colon 
cancer in FAP patients or certain forms of breast cancer.
Until such time, it was necessary to design other methods and 
strategies which may help clinicians to diagnose these cancers early, 
preferably at a stage as close as possible to the early cancer.
b) Mass-screening & targeted-screening programmes
These are almost exclusively the feature of the Japanese 
medical system. With its high incidence and prevalence of the disease, 
Japan spared little cost in the early 1960's to set up a national 
network of centres which were dealing exclusively with the upper
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gastro-intestinal localization of cancers. These were not only 
therapeutic secondary and tertiary centres, but also units dedicated to 
the early diagnosis of these clinical entities. In parallel, Japanese 
health authorities funded national programs for active screening to 
help identify those patients carrying the disease in an as early stage 
as possible1*6*90.
Like any new programme that rolls out on a national basis, the 
aim was initially to include certain groups or sections of the 
population. The term "targeted screening" was bom based on the 
initial impossibility to start screening the whole population and relied 
on several epidemiological features such as age standardized 
groups121147, profession related cohorts such as it was the case of 
fishermen, second generation of Hawaiians emigrants, etc. Following 
the assessment of the initial results, targeted mass screening was 
extended to the rest of working population. The rational behind this 
approach was observational and relied on the age corrected incidence 
of the disease amongst Japanese patients99,108. The modalities of 
screening at the beginning included Double Contrast Barium Meal 
techniques and Japanese radiologists became masters at identifying 
the various types I,II and III of gastro-intestinal cancers79. With the 
advances in endoscopy from technical and skills points of view, the 
accent has moved from the early 1980’s to this method of 
investigation which allows for direct visualization and tissue diagnosis
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as well. It must be said however, that targeted screening was only one 
face of the coin.
As targeted screening cannot cover the whole of the population, 
a different approach was introduced for patients who became 
symptomatic. This way the "walk-in centres* or the "one-stop units" 
have been bom where symptomatic patients could benefit "on the 
spot" from a radiological, or more recently, an endoscopic 
examination. To shorten the time taken to definitive treatment, these 
centres had the facility of by-passing the patients' general practitioner 
and offering direct referral to secondary or tertiary units specialized in 
upper gastro-intestinal pathology. As a consequence of these facilities 
and supporting infrastructure, the number of cases in early stage had 
progressively increased in Japan and the outcome and survival figures 
have subsequently improved considerably.
Several authors have questioned the possibility to import such 
an approach to the Western World1*2*93. Whilst the Japanese model 
was not questioned as to its reliability and potential to guarantee 
better outcome figures, there were several stumbling blocks that 
prevented western health providers embarking on the same road79. 
The first reason was related to the compliance of the population at 
large with such of an invasive examination which was supposed to be 
done on a regular basis at certain intervals. A second reason was 
purely economical and related to the financial burden associated with 
creating the necessary infrastructure and staff requirements. Another
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option taken into consideration was that of a targeted screening of 
certain age groups where the disease is more prevalent or where there 
are risk factors associated with a benign condition such as GORD or 
Barrett's311116;131;150;155. After examining a cohort of 92 patients for 
epidemiological, pathological and clinical features Koea73 
recommended that, based on the high frequency of a positive family 
history in young patients, an opportunity exists to identify a high-risk 
population for screening. This strategy was found to have limited 
value ty  MacDonald who suggested that it might be appropriate to 
restrict surveillance to patients with additional risk factors7*7*85. Rana 
et al.116 reached at the same conclusion in his Scottish study; he 
found that endoscopic surveillance is unlikely to alter overall mortality 
even in certain high risk group of patients such as those with Barrett's 
oesophagus154.
cj Improving healthcare provision - algorithms & services
The Japanese experience with walk-in centres highlighted the 
need to identify services, resources and algorithms which may help 
western clinicians to replicate this model to a certain extent and, what 
is more important, achieve better results in the early diagnosis of 
Gastro-intestinal Cancer. Since mass screening is not yet feasible as 
an option because of the reasons cited earlier, western health care 
providers and clinicians alike have given consideration to alternative 
methods by which they can achieve similar results, but within the
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existent infrastructural and financial constraints; their attention was 
focused on the introduction of mechanisms suitable to speed up the 
management of these patients from the moment they became 
symptomatic to the definitive treatment. One of the first methods to be 
used was the Open Access Endoscopy which initially was employed to 
lower the waiting time in gastroenterological patients at large.
Open Access Endoscopy systems - those in which endoscopy is 
performed without prior gastroenterology consultation - have become 
more common in the cost-conscious healthcare environment, sparing 
doctor-hours of activity and increasing throughput of symptomatic 
patients. It must be mentioned that the open access service had both 
its advocates and opponents. Health care providers, pressurised to 
achieve higher throughput and shorter waiting times, embraced the 
idea as a solution to public discontent in waiting times. The signals 
coming from the opposition side were technical and related not only to 
the financial costs123 - sometimes difficult to assess accurately - and 
time consumed associated with inevitable high ratios of inappropriate 
referrals30:81:87;125, but also related with the diagnostic yield of upper 
gastrointestinal endoscopy5*5*70.
Irrespective of the benefits or the difficulties in introducing 
Open Access Endoscopy systems in the clinical practice for patients at 
large, one benefit seen by many clinicians was that one of speeding up 
the sub-group of patients with symptoms suggestive of malignancy. It 
has been agreed by many gastroenterologists1*146 that Open Access
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Endoscopy is a useful tool in accelerating the diagnosis of gastro­
intestinal cancer by several weeks or even months. Several authors 
reported various results with their experience in delivering Open 
Access Endoscopy services to the Primary Care sector and, besides 
discussing the issue of appropriateness in referral, emphasized the 
benefits in diagnostic yield. However, most of the authors agree with 
the view that Open Access Endoscopy has a self-limiting yield in 
cancer diagnosis. It has been noted that the pickup rate of cancers in 
centres serving a certain catchment's area has not changed with the 
use of these services and remained roughly similar with the pre-Open 
Access Endoscopy era32;53:146.
One question persisted and this was related with the stage of 
the cancers diagnosed within those settings. The Axon group in 
Leeds1*43 reported a favourable change in the proportion of patients 
with early lesions and the authors attributed this to the more frequent 
use of endoscopy, particularly as a result of Open Access Endoscopy. 
There were other authors3*146 who looked to their own practice and 
found no increase in the number of stage 0 and I picked up at Open 
Access Endoscopy. They acknowledged however that certain 
advantages of Open Access service appear to be compromised by 
delayed referral to hospital by the responsible General Practitioner 
and, in some instances, the failure of the endoscopists to recognize 
some lesions with early kariochinetic transformation.
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There are two questions that may arise in relation to the facts 
mentioned above: one refers to the capability of the Open Access 
Endoscopy service to speed up the referral process, the positive 
diagnosis and the treatment of patients with Upper Gastro-intestinal 
Cancer; the second question relates to the benefits induced by the 
increased speed with which cancer patients are seen and examined in 
the Open Access service compared with the traditional referral 
method.
Many papers6*7*13*149 dealt with the answer to the first issue. 
The overall agreement was that the Open Access Endoscopy and 
related clinical services can bring a significant improvement in the 
speed with which patients are being examined, but this is subject to 
certain limitations, such as appropriate referrals, selection of urgency 
criteria based on "alarm symptoms", infrastructure capability, etc. In 
a retrospective study Spurgeon139 found in England significant 
differences between the waiting time for urgent and non-urgent 
referrals. Although the median time to the first appointment seems to 
be acceptable - 10 days for urgent referrals and 27 days for non­
urgent requests -, the time needed to see 90% of all patients is much 
longer - 70 days for the stomach localization and 57 days for 
oesophageal topography of tumours -. These figures may need to be 
discussed in the context of the definition for urgent and non-urgent 
referrals; it is believed that urgent referrals are related to those cases 
that bear the hallmarks of definitive malignancy such as findings at
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clinical examination, association of sinister symptoms or indeed 
epidemiological criteria; as to the non-urgent ones, these cases may 
represent actually the group of patients who may have benefited 
mostly from the offerings of Open Access Services. As to the time 
taken by patients to receive definitive treatment, this is much longer, 
rising to a median figure of 75 days and 65 days respectively.
One issue which attracted much attention was that one of the 
referral criteria. It has been noted that approximately 30% of referrals 
to the Open Access Endoscopy service refers to dyspepsia and, since 
dyspepsia is seen as a symptom in many cases of Upper Gastro­
intestinal Cancer, it was this symptom which was chosen for 
modulation of the referral threshold3*79. Some authors added age 
group as a limiting factor to dyspepsia as a symptom, in an attempt to 
modulate the imbalance between referral volume and diagnostic yield; 
this was based on the observation that less than 3% of gastro­
intestinal cancers are diagnosed below the age of 45. Christie et al.32 
concluded that the age limit for screening patients with uncomplicated 
dyspepsia can be raised even to 55 since only 7.8% of dyspeptic 
patients aged under 55 in their cohort have been diagnosed with 
cancer.
When issues such as referral volume, cost effectiveness of 
endoscopy and diagnostic yield are put together, the need to have 
guidelines for referral of patients to an Open Access Endoscopy service 
becomes stringent36112*136. Most of the UK secondary care centres have
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in a more or less structured form guidelines which assist the primary 
care sector in the task of filtering patients through the correct 
channels. These guidelines are elaborated in conjunction with the 
existence of the so-called "alarm symptoms" - these are symptoms 
recognized by clinicians as being highly associated with Gastro­
intestinal cancer, such as anorexia, weight loss, newly diagnosed 
dyspepsia or anaemia -. Although there is some degree of variation 
between centres, in general there is a common framework within 
which these guidelines operate. The British Society of 
Gastroenterology has already issued guidelines in an attempt to 
improve the functionality of the Open Access Endoscopy service and 
to respond to the variations in service provision seen in many 
units871136:145. It is only fair to briefly mention that there are some 
authors who dispute the effectiveness of channelling patients based 
on guidelines to open access services and consider these guidelines a 
"waste of energy"135.
If the answer to the first question related to the benefits seen in 
the waiting times to diagnosis by using the Direct Referral services 
seems to be more apparent, the answer to the second question as to 
whether Open Access Endoscopy can bring real benefits in the 
diagnosis and management of Upper Gastro-intestinal Cancers as a 
consequence of speeding up the process of examination, diagnosis and 
treatment of these patients is more controversial and is dealt with in 
the next section.
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Chapter III
DELAYS
Summary; This chapter describes the areas where delays can
occur in the management o f the patients diagnosed with Upper Gastro­
intestinal Cancer. B y looking at the medical literature, the first part 
defines issues such as onset delay, delay in referral, or delay in 
treatm ent In the second part reference is made to a fe w  papers that 
seem  to quantify various intervals o f delays. From here it is established 
that the delay the patient face from  the onset o f his symptoms to 
treatment is in the range o f 6 w eeks to 17 weeks. It has been 
established that fo r part o f the length o f delay the patient him self is 
responsible, whilst the health care provider fo r around 70%; other 
authors place more emphasis on pa tien ts related delay. The end o f the 
chapter show s that, whilst the reduction in waiting times started to be 
documented in the literature, there is very little indication as to the 
benefits o f reducing waiting times on patients' outcome; it is explained 
that the role o f this study is to fill up the gap in bringing to light any 
evidence which relates the innovative clinical services and waiting times 
reduction to the effect on outcome and survival o f these patients.
Subheadings in this Chapter:
A. D elays @ th e  onset o f  d isease
B . H ealthcare sector induced  delays
I have looked earlier to the potential measures taken by the 
medical community at large to diagnose the gastrointestinal cancer 
earlier as the only key to better prognosis for these patients. This 
approach to "diagnose early" issue brings us to the concept of delays 
in diagnosis. These delays are important because cancers grow 
continuously, albeit at a variable rate. Decreasing the interval between 
onset of symptoms and treatment should logically result in tumours 
diagnosed at earlier stage and with better potential for cure. It is
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therefore important to pinpoint the time segments where the delay in 
diagnosis and clinical management can occur and examine the 
possibilities and actions available to facilitate early diagnosis of these 
cancers.
A. Delays @ the onset o f disease
There is a general consensus throughout the scientific 
community that, at least at the present time, one way to improve the 
poor prognosis of those patients with Upper Gastro-intestinal Cancers 
is to diagnose these cancers as early as possible. This represents the 
so-called "Japanese Gold Standard" and is an approach much sought 
after both by medical professionals and health providers alike. But 
how to achieve this? How to earmark those future individuals at risk 
of developing cancers with this localization? How to diagnose early 
carcinogenetic changes in the mucosa of upper gastro-intestinal tract 
during the asymptomatic phase in these individuals? What are the 
implications for the health care systems and patients alike the process 
of using various methods of cancer detection currently available? 
Given the natural progression of an Upper Gastro-intestinal Cancer 
and since the majority of well known symptoms appear usually late or 
after the disease became quite advanced, many authors are accepting 
nowadays that a certain degree of diagnostic delay122 might be 
unavoidable. However, what actually would be an "acceptable" time 
interval between onset and treatment is much more difficult to
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answer. Various studies9*9*12*159 tried over the last decade to look to 
the issue of delay in diagnosis and treatment through various clinical 
hypothesis such as: onset symptoms, referral patterns, socio­
economic and environmental issues, staging, treatment modalities 
and outcome.
To answer these questions it is imperative to obviate which are 
the segments where delay may interfere with a speedy diagnosis and 
treatment. Many authors961122:159 agree that based on primary cause, 
delays in diagnosis occur firstly due to late presentation of the patient 
and secondly indeed due to the health care setting. Although the 
literature names these delays or intervals with various terms, a 
common key transpires and is not far from a general consensus that 
the length of the following intervals can induce delays in the patients’ 
management:
1. Onset Delay « Delay induced by the patients because of late 
presentation with their complaints/symptoms;
2. GP Delay * Delay occurring at the level of patients9 local surgery, 
defined by the Interval between patients9 presentation and actual referral 
made by the General Practitioner to the specialist gastroenterologist;
3. Hospital Delay « Delay Induced by the secondary centre or 
specialist service, defined by the Interval between General Practitioners9 
referral and actual clinical examination in the specialist setting;
4. Diagnostic Delay ■ Delay occurred at the level of the specialist 
service, defined by the Interval between specialist examination and 
positive diagnosis of the disease;
5. Treatment Delay ■ Delay Induced at the specialist secondary or 
tertiary centre, defined by the Interval between positive diagnosis and the 
commencement of the actual definitive treatment
U R R G R  GAGW RGtNfrGGltNAG G A N G G R i
G O  Q U R  GGtNiGAG 8G R W G G G  W O R K
1Q W A R G G  TN G  *7W O WGGR RUG G* A N O  N O W ?
- 5 3 -
C h a p te r 121: B ela ys Serban 1* Qheorghiu
Some papers use a cumulative name of NHS Delau or Medical Delau 
for cumulated segments 3 to 5. Although not all the papers at hand 
use the same terminology, the essence is much the same.
The first segment where delay can appear is invariably labelled 
as Onset Delay and essentially refers to the time interval taken by the 
patient to seek advice for his/her symptoms. The only situation where 
this segment is completely eliminated is when an asymptomatic Upper 
Gastro-intestinal Cancer is diagnosed by chance during the 
investigation of other medical conditions, and of course the desired 
situation of active screening. Otherwise, the delay after the clinical 
onset due to the patients' negligence can be variably long, typically 
measured in months rather than weeks; Martin90 found that 29% of 
the time interval Onset of symptoms to Treatment was due to delay 
prior to the first presentation, which represented cca. 5 weeks of the 
median delay figure of 17.1 weeks. Mikulin et al.96 looking to the same 
onset interval found a median delay of four weeks, whilst Rothwell122 
found in his cases a slightly longer median value for onset delay of up 
to 6 weeks. In contrast, Wayman et al. consider that up to four fifths 
of delay can be attributable to the patients and only one fifth to the 
system159.
It is important to emphasize that the papers referred to above 
quantify the delay retrospectively and use the whole interval between 
onset of symptoms and the commencement of treatment. This general 
approach leaves however little room in pointing to various segments
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where the delays can actually occur with a view to find scope for their 
elimination.
At least one question might arise in relation with the delay and 
this is related with the identification of those factors which may 
contribute to the late presentation of patients. During the previous 
pages we have seen that the largest part of the natural histoiy of the 
Upper Gastro-intestinal Cancer evolves silently. However, even after 
the clinical onset, a large number of patients delay to seek medical 
advice and the question arises whether the symptoms and/or signs of 
the underlying condition can be stigmatised as indicators. Looking at 
the causes of the onset delay, Mikulin and Hardcastle96 found that 
these can be attributable to patients’ misinterpretation of overt 
symptoms, dismissal of their importance, self-medication or even 
oncophobia (16%); the authors also found that 81% of the patients 
were aware of their symptoms and discussed them with their close 
family but negligently omitted to seek medical advice. This is a very 
important finding showing the level of public awareness, in contrast 
with Japanese situation96 where patients are using actively the so- 
called "walk-in centres" for gastroenterological diagnosis. Rothwell122, 
Martin90 and Wayman159 found that a significant number of patients, 
sometimes up to 50%, delay their presentation due to symptomatic 
self-medication, namely acid suppressants or indeed, H2 blockers.
Different studies tried to seek an explanation for this onset 
delay by looking at the symptoms presented by the patient. Most of
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the studies6*9*9*159 found that the majority of symptoms were 
regarded by the patients as non-specific or ulcer-like symptoms and 
triggered in more than 50% of cases by self-administered treatment 
with H2 Blockers, proton-pump inhibitors or antacids961159. A notable 
observation was made by Rothwell122 in respect of dysphagia in 
patients with oesophageal carcinoma; he found that dysphagia was 
not triggering a shorter interval of onset and was only the third 
symptom of relevance in patients' symptomatic phase.
In relation to this issue, more recently and with the advent of 
the open access services, a number of authors14516;78;79 raised questions 
about the role of dyspepsia as a symptom in the selection of patients 
for urgent investigation. Without entering the heated debate between 
gastroenterologists, the effectiveness of dyspepsia as an "alarm 
symptom" is not completely clear38. Recent reports suggest that in 
open access systems, dyspepsia may account for at least 30% of 
referral volume and generates only 3% of Upper Gastro-intestinal 
Cancer diagnosis. Recent observations32 show that patients with 
dyspepsia under the threshold of 45 years may elicit only 1.7% to 3% 
of the cancers diagnosed. Although the British Society of 
Gastroenterology, NICE1 and DOH24*105 have issued recently updated 
guidelines with the declared scope of assisting the selection of
1 The National Institute of Clinical Excellence
2 The United Kingdom Department of Health
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referrals, the role of dyspepsia as a triggering factor of suspicion 
seems to be slightly hyper valued.
Another important question to answer in relation to this onset 
delay is whether at this median delay of between four and six weeks 
are there any consequences upon the staging of the tumour or indeed 
upon survival. Given the cancer's doubling rate as seen above, it 
would be logically expected the answer to be yes. However, the 
opinions are quite split amongst researchers. Martin90 failed 
apparently to prove a direct link other than the logical hypothesis and 
Gillison127 showed that his small study can make no link between 
delay and stage at presentation.
It is difficult to suggest a line of action in order to improve the 
patients' onset delay; perhaps the only hope resides in repeated 
actions to increase the public awareness of the non-specificity of the 
symptoms and create the appropriate infrastructure in the community 
to allow easy, unrestricted, free and convenient access of the potential 
patient to the medical consultation. Although there is no convincing 
link between the delay at onset and the advanced stage of the disease, 
rapid presentation to the doctor can only diagnose quicker any 
condition at best and variably increase the activity of medical 
practitioners at worst.
U P P G R  & A 3TR O tN W G 3T tN A L  C A N G G R i
G O  O U R  C U N tC A L . 3 G R Y IG G 3  W O R R
T O W A R G 3  T N G  * 7 * 0  WGGR RUL.G* A N O  N O W ?
- 5 7 *
C hapter U lt Belays Serban 1* Qheorghiu
B. Healthcare sector induced delays
Bearing in mind the Japanese experience and results achieved 
throughout the last three or four decades in the diagnosis and 
management of patients with Upper Gastro-intestinal Cancers, many 
clinicians tried to design various settings in their clinical practice with 
the specific aim to increase as much as possible the ratio of early 
gastro-oesophageal carcinomas diagnosed and consequently to submit 
these patients to the adequate treatment in a stage which may permit 
an improved prognosis.
The previous subheadings dealt with issues such as late 
diagnosis and early cancers; the "diagnose early" approach was 
particularly scrutinized as an attempt to define those actions taken by 
clinicians in order to bring as close as possible the positive diagnosis 
from the advanced stage to the stage of an early cancer. The principles 
of such actions rely upon two major presumptions: one refers to the 
necessity, but not the possibility yet, to diagnose these cancers in the 
asymptomatic phase using methods based on the screening principle; 
the second refers to the presumption that the earlier the diagnosis is 
being established, the greater the chances would be to find a patient 
in an earlier stage and with better chances for long term results90.
It is interesting to start the debate on various causes of delay in 
diagnosis and treatment with two interesting remarks: the medical 
literature as a whole reflects this issue mostly, in relation to the delay
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induced by late presentation of the patients themselves after the onset 
of symptoms, whilst the British and Irish authors905935965122:127 raise also 
questions related with the delay imposed by the health care 
infrastructure. Explicitly, Siewert and Fink90 looking at the results 
published by I.G.Martin90 accept that, in general terms, the German 
hospital setting acts more quicker than in Britain where more than a 
third of the delay in establishing the diagnosis belongs to the NHS 
establishment.
Interestingly, when studying the same paper, Sano et al. noted 
that much of the segments of delay mentioned in Continental Europe 
are completely eliminated in the Japanese system due to different 
approach in healthcare structure and pathways of referral. He 
suggests that the Japanese system is much quicker in delivering the 
gastro-intestinal cancer patient to elective treatment due to both 
increased level of awareness and by eliminating the link of family 
practitioners in the referral process. However, it is omitted from their 
assessment several key factors such as: patients' compliance is 
different, general awareness is increased due to the perceived severity 
of the disease within the patients' mentality and different methodology 
in picking up cancers, although credit is being given to the many 
generous health policies established in Japan in recent decades 
without much consideration to the cost involved.
Based on these observations, as well as on the difference in 
outcome between Europe and Japan on one hand and between Britain
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and Continental Europe on the other hand, many papers emerging 
from British authors tried very hard to answer the questions as to 
whether the delay imposed on patients in general, once they are 
referred, does actually have any importance in the overall outcome 
and how the delay can be modulated, if not abolished altogether. For 
this purpose they looked at various innovative methods of referral and 
services introduced recently, though not particularly with this 
declared goal in mind, and compared the results obtained with the 
European standard.
There are two angles that the current debate on delays is looked 
at in the medical literature. The most important and well researched 
seems to be that of the quantification of the delay in itself. Conscious 
of the importance of reducing to as much as possible the interval to 
treatment, various researchers36:47;65:68;122:139;149:158 have already looked 
to the extent to which the delay intervals are extending and to the 
ways to improve them. It is interesting to mention a few facts related 
to this issue: firstly, the prevalence of the reports coming from the 
British Isles and the second, the scarcity of the reports dealing with 
the Upper Gastro-intestinal Cancers. The fact that the reports are 
coming mostly from Britain is perhaps related to the way the health 
care infrastructure is organized in this country.
Without going into details, the current debate on waiting lists 
and waiting times is an indicator of the importance placed on the 
issue. Whilst the various reports are quantifying the delays variably
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and between different landmarks, everyone agrees that waiting for 
appointments through the traditional pathway of referral to 
Outpatients Department is not an option when dealing with potential 
malignant pathology. Notably, Saunders125 still believes that for 
selected patients this pathway may still be an option. Various 
papers21;41;68;124 started more recently to quantify the length of the 
delays and compare them with the requirements of the "two week 
rule" in cancer services. Notoriously, the majority of papers are 
looking at sub-specialities where the delays were in the "public eyes" 
or where national programmes were in place. For instance, the breast 
cancer and colonic cancer pathologies21;46:47:64:68:91;120 seem to fare better 
in this respect; detailed assessment is already available on the extent 
of the delay for either referring patients or examining them by the 
specialist in the hospital.
However, it seems that, with a few exceptions3*8*9*139, the 
gastrointestinal pathology is less well researched. Available data139 
suggest the median delay for patients referred urgently for gastric 
cancer is 10 days (cohort of 241 cases) and for oesophagus 11 days 
(cohort of 249 cases). Martin90 found that the delay from onset to 
positive diagnosis is in the range of 17 weeks for gastric cancer; he 
calculated that for cca. 71% of the total interval the health care 
provider may be responsible. However, the only correlation he could 
make was related to the oesophageal cancer where he could find a link 
between shorter waiting times and stages II and III of cancer.
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These segmental delays, faced by the patients and generated by 
various factors, also present us with a different and more important 
aspect for which unfortunately very few references are available. It 
relates to the effect of reducing waiting times on the patients' 
outcome. Although, as shown above, there are only a few papers 
referring tangentially to this particular aspect - that of the 
quantification of the segmental delays in Upper Gastro-intestinal 
cancers -, neither of them are looking into the impact that various 
services employed in reducing these delays may have on the outcome 
of those patients. Essentially, data is not available yet in respect of a 
thorough analysis of the outcome improvement in those patients in 
which the various mechanisms and clinical services have reduced the 
waiting time. Again, for other pathologies such as breast21:68:132 or 
colon47;91;158, evidence started to emerge as to the effectiveness of 
reducing these delays on outcome. For instance, Sainsbuiy124 found 
that delays in hospital appointments and diagnosis of 3 months or 
more do not seem to be associated with decreased survival in patients 
presenting with breast cancer. On the same note, Walsh158 found for 
colorectal cancer that the "fourteen-day rule" with respect to colorectal 
cancer has reduced waiting times for a first appointment to see a 
specialist, but he acknowledged that further improvements will 
require additional resources to reduce the delay for investigations 
whilst the effect on long-term survival still remains to be seen.
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Beside monitoring the actual delay in the case of the Upper 
Gastro-intestinal Cancer patients, if the efforts to reduce the waiting 
time to appointments, positive diagnosis and treatment are to be paid 
off, we need to find out if the outcome of these patients has changed 
and how. Unfortunately, the medical literature seems to be looking so 
far only to the actual improvement of the delay intervals, but 
conspicuously missing references to the outcome studies. It is the role 
of the following pages to see not only how innovative services acted 
towards reducing the delays in patients with Upper Gastro-intestinal 
Cancers, but more importantly, if they had any impact on the 
patients' outcome.
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P A R T  II Original R esearch
Chapter IV
A IM S AND O BJECTIVES
Summary: This chapter introduces the reader to the null
hypothesis o f this research, which questions whether the new  clinical 
services and new algorithms o f referral can significantly reduce the 
waiting times o f our patients diagnosed with Upper Gastro-intestinal 
Cancer and i f  consequently, can improve their outcome. The aims o f 
this retrospective study are briefly emphasized together with their 
reasoning. Entities such as waiting times, sinister symptoms, pre­
existent gastroenterological disorders, staging o f the disease, operability 
and survival assessm ent are considered valid criteria to be used in 
assessing the efficiency o f the new innovative services and therefore 
their critical interpretation is considered amongst the declared objectives 
o f this study.
In the previous chapters I have highlighted the interest shown 
by many authors in issues such as waiting times, early diagnosis, 
delays in diagnosis and treatment, as well as methodologies used for 
speeding up the referral process and treatment for gastroenterological 
patients in general. It became obvious to many clinicians and 
healthcare managers involved in the Primary, Secondary and Tertiary 
sector that improvement in the waiting times to examination and 
treatment might represent not only a way to change the public's 
perception of the effectiveness of the healthcare sector in general and 
of the gastroenterological services in particular, but also a tool in 
achieving a more effective management of many gastroenterological 
conditions, with improved outcome and fewer relapses. With the above
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aim in mind, clinicians have devised innovative means of speeding up 
patients' access, consultation, diagnostic and treatment. Thus clinical 
services such as Open Access Endoscopy, One Stop Clinic and Rapid 
Opinion Clinics have been introduced since the late 1980's with the 
specific aim to reduce the waiting time the gastroenterological patients 
in general face between their presentation and definitive treatment.
The clinical need to submit the cancer patients to radical 
therapy during the early stages of their disease in order to maximize 
their treatment possibilities and survival rate is well endorsed at 
present time by many clinicians. Bearing this in mind, it is 
hypothesized that reducing the waiting time intervals patients face 
from their first presentation at the General Practitioner's surgery to 
the definitive treatment may improve the stage of their disease at 
diagnosis and/or treatment time and, ultimately, their survival rate. 
This hypothesis may apply though mostly to those patients in which 
the symptoms appear in the early stages of the disease. However, in 
those patients in whom the onset of the symptomatology is correlated 
with advanced stage of the disease, a quicker diagnosis and definitive 
treatment might improve only certain parameters, such as operability, 
symptomatic relief and quality of life issues without necessarily 
influencing the stage of the disease.
Prior to the commencement of the study, the aims and 
objectives were set and the null hypothesis of the research was 
established. This was set to prove that:
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1. The new modalities of referral and the new clinical services - Open
Access Endoscopy and Rapid Opinion Clinic - have no impact on 
the waiting time to treatment of gastroenterological patients who 
are subsequently diagnosed with Upper Gastro-lntestinal Cancers 
within these settings;
2. Compared with the conventional methods of referral and without
taking into consideration other improvements in patients' 
management such as surgery techniques, palliation, nutrition, 
etc., these new modalities of referral and innovative clinical 
services - designed initially for gastroenterological patients in 
general and based upon the their ability to speed up the patients' 
throughput - can Improve the management stage at diagnosis 
and outcome of those patients subsequently diagnosed with 
cancer.
Since it has already been shown that adopting various algorithms 
of referral and new clinical services might possibly improve the overall 
waiting times to medical care for the patients in general, in this study 
I will research using a retrospective analysis the implications of 
introducing all the above methods and services to the particular group 
of patients with Upper Gastro-lntestinal Cancer. I will also try to 
ascertain whether these services, besides reducing the overall waiting 
times, can confirm the assumptions for this particular group of 
patients alone that the introduction of "novel" clinical services is 
followed by better stage at treatment time and improved treatment 
outcome. In other words, I will try to establish if these new services 
will significantly reduce cancer patients' waiting intervals between 
presentation to the General Practitioner and treatment and whether 
this is followed by a significant improvement in their outcome
V
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parameters compared to the general outcome seen by patients coming 
through the more conventional channels of referral such as outpatient 
referral or indeed acute admission.
The results will inevitably have to be discussed in the context of the 
requirement for the "two week rule" in cancer services and may or may 
not backup the assumption that this rather arbitrarily chosen target 
for dealing with cancer patients can actually deliver improvement in 
their outcome. The NHS Cancer Plan and consequently the NICE 
Guidelines on referral of patients with possible underlying cancer 
pathology801105 have emphasized already the clinical need for the "two 
week rule" to be achieved before the year 2005 as a measure of public 
reassurance in the quality of care offered by the healthcare providers. 
As the British medical literature is scattered with reports suggesting 
various degrees of compliance with this target for different oncological 
sub-specialties but with rare indications of the benefits achieved in 
terms of the outcome parameters and survival figures, the present 
study will aim to complement the debate and underline on a specific 
case mix, the outcomes benefits, if any, of channelling resources for 
various new clinical services.
One of the most obvious objectives to look at in relation to these 
new algorithms and innovative services is that of the waiting time 
these patients face between presentation and definitive treatment.
Since this delay was allegedly linked with late diagnosis and poor
f
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prognosis, it is important to see what will be the benefit of introducing 
new referral algorithms and clinical services upon waiting times in 
general and if one can identify certain intervals where these new 
clinical settings might have a beneficial impact. The issue of patients' 
satisfaction in respect of the speed of their referral and treatment was 
widely looked at both from medical and socio-political standpoints and 
clearly influenced the introduction of the so-called "two week rule" in 
cancer referrals40*211211149. This being only one single side of the 
argument for speeding patients' throughput - already widely 
researched - and because the present study was set as a retrospective 
analysis based on medical records, I have deliberately not included 
patients' satisfaction issues in the current set of analysis criteria for 
patients with Upper Gastro-lntestinal Cancer.
A simple analysis of the waiting times in patients diagnosed with 
Upper Gastro-lntestinal Cancer may not reveal the complete picture 
related to the efficiency of the new services and referral algorithms. 
Beside the inevitable comparison of the waiting times and outcomes of 
these patients diagnosed in either conventional settings or through 
the new referral methods, there are several factors that need taking 
into account as well. For instance the dynamics of the pathology in 
itself, such as variation in overall incidence, or indeed, the 
modification of the prevalence of the anatomical segment involved, 
with certain changes in symptomatology. Since all these factors may
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have a certain influence in the referral patterns, it is sensible to have 
a critical look at their influence upon the waiting times when patients 
are being referred for specialised services.
Referring patients from primary to secondary care must take 
account of the severity of the symptoms these patients present. Whilst 
NICE and The British Society of Gastroenterology have made 
substantial progress in establishing guidelines for referral based on 
sinister symptoms11:19;105, the patients with Upper Gastro-lntestinal 
Cancer may not always present with an obvious combination of 
symptoms suggestive of cancer. On the other hand, taking into 
account a sinister symptom alone as a measure of inclusion criterion 
for referral may not always correctly identify only those patients at 
risk. Some patients will present with apparently benign symptoms and 
there is a balance to be struck between seeing only those who have 
'sinister' symptoms on an urgent basis, and the overwhelming 
numbers that will need to be seen if benign symptoms such as simple 
dyspepsia are included; on the other hand, having a larger spectrum 
of inclusion criteria for initial referral might clutter the infrastructure 
created by the new services with possible knock-on effect upon the 
waiting times in general and ultimately detrimental consequence to 
the efficiency of these services. Beside the non-specificity of the onset 
symptoms, one needs to take account of the limitations imposed by 
the design of the study as a retrospective analysis; this issue is
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playing an important role in establishing the symptoms at onset as 
predictable entities and, more than that, relies on records entries 
which are not always synonymous to the reality, as also noted by 
Malats88.
It is therefore important to look to the population of patients with 
Upper Gastro-lntestinal Cancers that have been diagnosed through 
these services and establish if there is a certain pattern or 
combination of predictive ("sinister") symptoms that may be more 
suggestive of malignant pathology in the upper gastro-intestinal tract. 
This objective may be difficult to achieve and the validity of the data 
may be unreliable in a retrospective analysis based on pre-existent 
clinical records, unless there is adequate provision for adequate data 
recording. Thus, when interpreting the data for this particular subset 
of data certain limitations may apply such as subjectivity in data 
recording, variability of symptomatology thresholds, ability to identify 
specific symptoms, etc. Besides all these, it will be interesting to know 
if the patients with pre-existing digestive conditions might be more 
difficult to be diagnosed and therefore might present with a not so 
favourable stage of the disease.
The interpretation of the possible variation in waiting times needs 
to be looked at from other perspectives too: for instance, what is the 
influence of the new services upon the pre-operative staging of the 
disease or whether they can consequently improve the post-operative
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staging too. Staging of the disease in this group of patients is a well- 
established modality to judge their prognosis and therefore a decrease 
in the waiting time to diagnosis and treatment may appear beneficial 
for better staging and possible better outcome. It is obviously the aim 
to diagnose these patients whilst in an earlier stage, but it is not clear 
yet if the methods of referral and services mentioned above might 
actually improve these patients' staging at diagnosis time or, indeed, 
at the moment of the definitive treatment. Independent of the survival 
study, I will therefore try to establish whether these services can have 
a direct influence on the stage these patients present with, either pre- 
operatively and post-treatment.
Another set of objectives to be followed up during the assessment 
of the potential benefits offered by these new services is related to the 
patients' outcome. Currently there are quite a few criteria established 
which may assist in the quantification of the outcome of cancerous 
patients following diagnosis and treatment. One of the most important 
remains the survival rate of these patients and therefore an analysis of 
the patients' survival data is mandatory if the efficiency of the new 
services is to be critically assessed. I will try to establish whether for 
those patients channelled through the new clinical services there is an 
improvement in the survival figures compared to the patients referred 
through conservative routes or indeed, if there are certain groups of
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patients with this pathology that may have a different benefit from the 
new services.
The survival rate may represent the ultimate criterion for 
assessment of patients' benefit from these new and innovative 
services; however, there may be other outcome criteria to be discussed 
that may enjoy benefits too, such as operability or indeed patients' 
satisfaction with the speed of their treatment or cessation of their 
symptoms.
Introducing these new services may or may not introduce changes 
in the operability of these patients or indeed may or may not bring 
benefits in the adjuvant therapy deployment process. Although the 
relationship between operability, staging and survival is well defined 
in the medical literature, operability alone may remain a favourable 
factor of assessment not only because of the potential marginal 
improvement in life expectancy, but also because of the symptomatic 
relief that it may bring. Regardless of the improvement in the stage of 
the disease, it is therefore beneficial to know whether the new referral 
algorithms and innovative services can introduce any improvement in 
the overall operability figures for those patients channelled through 
the new route. All the afore mentioned factors seem at first glance to 
be influenced by the length of the waiting times between presentation 
and treatment and some of them might indirectly mirror the 
effectiveness of the services in question. Therefore it is only logical to
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quantify the benefits of such services through the critical 
interpretation of these factors.
In spite of all these variables related with the epidemiological 
reality, presentation of the disease and referral pattern, a few 
questions remain clear: to what extent the new methods of referral 
and new innovative secondary care services can decrease the waiting 
times specifically for patients with Upper Gastrointestinal Cancers 
and whether reducing these waiting times - particularly to the target 
imposed by the so-called "two week rule" - can actually make a 
significant difference in patients presentation, TNM stage, operability 
and treatment outcome. The following pages will try to identify 
answers to these questions through critical assessment of the above 
mentioned variables and establish whether these new algorithms of 
referral and innovative services can make a difference in the early 
diagnosis and management of patients with diagnosed Upper Gastro­
intestinal Cancer.
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SETTIN G . M ATERIAL AND METHOD
Summary: The setting fo r the study presents the two general
hospitals and em phasizes their clinical services such as Open Access 
Endoscopy and Rapid Opinion Clinic in parallel with the conventional 
services such as Acute Admission and Outpatient Clinics. The material 
fo r the study is presented after the criteria o f inclusion and exclusion are 
exposed. Based on these criteria, it is retained that a case mix o f 440 
patients are identified together with their complete data s e t The sources 
fo r case identification are described and the assumptions used to isolate 
the relevant cases are enumerated. The mechanisms o f data extraction, 
validation and analysis are also explained together.
Subheadings in this Chapter:
A. N eath  - M orriston S e ttin g
B. M aterial
a) Inclusion  & E xclusion  Criteria
b) A ssum ptions
c) Cancer Case Mix
C. M ethod
a) Case Iden tifica tion
b) D ata E xtraction , V alidation & A na lysis  Tools
Having established the aims and objectives of this study and 
bearing in mind its potential epidemiological and infrastructural 
implications for the structure and design of future medical services, it 
was paramount to choose an adequate model of study; this model had 
to reflect a populational area sufficiently representative for the 
objective chosen and comprehensive enough in respect of services and 
methods of referral offered to the patients eventually diagnosed with 
Upper Gastro-lntestinal Cancers. By the same token, this model had 
to feature several other important elements such as: reproducibility,
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design based upon inclusion of all categories of gastroenterological 
patients, homogeneity of populational case mix, infrastructural 
similarities between sites as well as facilities for identification and 
follow-up of those patients who are diagnosed and treated within the 
same clinical setting.
A. Neath - Morriston Setting
In order to research the implications of various modalities of 
referral and clinical services offered to patients with potential Upper 
Gastro-lntestinal Cancer, as well as the consequences of these clinical 
services in respect of the speed of diagnosis, treatment and fined 
outcome for these patients, I have chosen the case mix offered by 
Neath Genered Hospital and Morriston University Hospital in South 
Wales; these are two district general hospitals situated edong the M4 
Motorway corridor and on the outskirts of the City of Swansea, the 
second largest City in Wales in terms of population size and economic 
development. The area covered by the two hospitals offers an 
interesting socio-economic structure, containing pockets of favourable 
socio-economic deprivation index as well as areas of high 
unemployment and high morbidity, more recently associated 
significantly with the declining opportunities offered by the local 
British Steel industry.
Historically, the two hospitals were individual secondary care 
entities serving two different catchment areas, each having distinct
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and specific primary care sector and featuring direct referral patterns 
to the allocated hospital. This feature was consistent throughout the 
period of the case identification exercise in respect of primary-to- 
secondaiy care sector referral pathways and medical investigation 
infrastructure, both for elective and non-elective referrals. During the 
period of time when the case identification process took place, each of 
the two hospitals belonged to the same Iiechid Morgannwg Health 
Authority as health care provider. Each was allocated to serve a 
population of an approximately similar structure and volume - cca. 
130000 people -. It must be noted though that shortly after the 
commencement of the case identification period - i.e. 1994 - Neath 
General Hospital lost its acute surgical services in favour of Morriston 
University Hospital, thus unifying under one roof all surgical services 
for gastroenterological malignancies. Also, in 1999 a major 
reconfiguration of clinical services has taken place in South Wales 
when Neath General Hospital lost its status as an independent NHS 
Trust. These changes did not affect significantly the provision of 
service in the catchment area for upper gastro-intestinal patients as 
explained later in Chapter VIII.
Both hospitals offered the corresponding primary care sector all 
of the referral facilities and services that are under scrutiny in the 
present study. Beside the usual and traditional forms of referral - i.e. 
elective referrals to a consultant firm for Outpatient clinical 
appointments as well as emergency referrals to the Acute Inpatients
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service both of the hospitals offered, in one form or another, new 
and innovative services designed to speed up the throughput of the 
gastroenterological patients in general; in spite of using various 
names, such as Fast Track Endoscopy, One Stop Endoscopy, etc., 
these new services were essentially represented by two different and 
specific modalities of medical appointments: Open Access Endoscopy 
and Rapid Opinion Clinic. Therefore, during the period of the case 
identification process, in both hospitals I have identified the following 
structured clinical services which were offered both to General 
Practitioners and in-house medical teams:
1. Acute Emergency Admission
2. Elective Outpatients Clinic Appointment
3. Open Access Endoscopy
4. Rapid Opinion Clinic
The clinical services number 1 and number 2 above represent the 
traditional services whereby the patients were referred by the primary 
care sector either to the outpatients department - in this case patients 
were seen electively after having an appointment scheduled on a "first 
come, first served" basis - or referred as acute inpatients - and seen 
immediately within the bedded area of the hospital -. The clinical 
services number 3 and number 4 were the new innovative services 
where patients were referred through a new route: in these cases the 
patients were seen either directly in the Endoscopy Suite where they 
were called readily prepared for an upper gastro-intestinal endoscopy, 
or were seen with priority in the case of the Rapid Opinion Clinic,
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normally within an interval of a few days from referral date and 
benefited from a direct consultation with the gastroenterologist.
Both hospitals presented fully functional gastroenterological 
departments featuring designated endoscopic facilities and assisted by 
specific and dedicated supportive diagnostic departments such as 
Radiology, Histopathology, Immunohistochemistiy and GI Surgery. 
Following the positive diagnosis of Upper Gastro-lntestinal Cancer, for 
each patient the pathway taken for treatment and palliative care in 
the secondary and tertiary care sector converged on the same point in 
both settings. The principal setting was Morriston University Hospital 
for patients’ surgical management, Singleton Centre for Oncology for 
patients' adjuvant therapy and Ty Olwen Hospice for palliative and 
terminal care respectively. In other words, both gastroenterological 
settings used the same Upper Gastro-lntestinal surgical service and 
oncological tertiary centre for adjuvant therapy, even though the two 
sites were acting as independent entities of referral for diagnostic 
facility. Therefore, in these settings a particular diagnostic-therapeutic 
model has been observed, whereby there were two diagnostic units 
which converged towards one multi-disciplinary pathway for 
therapeutic, adjuvant and palliative care for upper gastro-intestinal 
cancer patients.
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B. Material
Both hospitals offered an impressive case mix due to their 
position as secondary health care entities. Their case mix was 
generated by the referral process of gastroenterological cases at large 
and included both malignant and non-malignant conditions. For the 
purpose of this retrospective study and based on this large number of 
referrals, it was decided to take into consideration a period of time of 
six calendar years, from l 1* J u ly  1993 to  30 th Ju n e  1999 . To this 
decision contributed various factors, including the need for a 
sufficiently large case mix, possibility to cover various changes in the 
local healthcare infrastructure that may occur from time to time and 
last but not least, the necessity to allow time for the relevant referral 
algorithms and pathways of referral to be fully implemented within the 
primary and secondary care practice. To assist in the process of 
identification of suitable patients for the present study, it was 
mandatory to establish the patients' criteria of inclusion and exclusion 
as well as some assumptions since the research is a retrospective one 
based on past medical records.
a) Inclusion & Exclusion Criteria
The case identification process involved the scrutiny of all 
referrals for gastroenterological complaints followed by the isolation of 
only those patients with upper gastrointestinal cancers diagnosed and 
treated during the interval of time to be agreed to cover the study.
U R R G R  GLASTRatNTGSTtHAL. G A N G G R i
G O  O U R  GHN4GAL. G G R W G G 3 W O R tt
TO W A R G O  T N G  T W O  W GGtt R U IG *  A N O  N O W ?
*79*
C hapter V: Setting* M aterial & M ethod Serban L Qheovghiu
Soon it became obvious that some criteria for inclusion could be 
observed both in respect of the definition of histological malignancy as 
well as in respect of the anatomical topography of the gastro-intestinal 
segment involved. Also, due to the timing feature of the referral event, 
diagnosis through investigations, staging and actual treatment, the 
criterion of time was to be observed when deciding to include any 
patient in the study’s time frame or not.
Although the definition of malignancy is not clearly defined on 
clinical grounds but perhaps more precisely defined in a histological 
context and, taking into consideration what various conceptual 
medical schools might include under the term of "malignancy", it was 
important to establish the boundary of what one may consider 
"malignant" in respect of the Upper Gastro-lntestinal Tract. First of 
all, the provisions of the International Classifications of Diseases ICD- 
101 were taken into consideration; secondly, the conceptual difference 
between primary and secondary malignancies was observed. Finally, 
consideration was given to both epithelial and non-epithelial 
originating tumours arising from the Upper Gastro-lntestinal Tract 
wall.
Therefore, from inception I have considered and observed 
throughout the following criteria for inclusion:
1 ICD-10 codes used: Oesophagus -  C15.9 & C78.8; Stomach -  C16.9 & C78.8 
Duodenum ■ C l7.0 & C78.4
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1. histological confirmation of malignancy; this confirmation had to be
provided on a  histo-pathological specimen - gained either by 
direct biopsy, brushing cytology or a resection specimen - and 
then validated by a  histo-pathologist with interest in 
gastroenterological pathology;
2. the final diagnosis in the patient's clinical record consistent with
malignancy in spite of histological uncertainty; such cases were 
only considered where the histo-pathological report was 
inconclusive and the clinical multidisciplinary consensus based 
upon clinical signs and progression of the disease was 
consistent with "malignancy" of the upper gastro-intestinal tract; 
the record's coding was therefore in accordance with the 
provisions of ICD-10 classification of diseases(254) and 
consistent with malignancy;
3. the malignant tumour must arise and involve a s  a primary tumour
the wall of any of the segm ents of the gastro-intestinal tract; this 
criterion also includes the possibility of synchronous and 
metachronous primary tumours in the gastro-intestinal tract, a s  
well a s  some m etastasis from other cancers had not been 
diagnosed at the time of patient's initial referral for upper gastro­
intestinal symptoms;
4. the malignant lesion must have originated in any structural
component of the gastro-intestinal tract wall: epithelial, stromal, 
vascular neural, lymphatic, etc.; therefore both epithelial and 
non-epithelial cancers were included;
5. the segm ents of the gastro-intestinal tract taken into consideration
were oesophagus, stomach and duodenum; adjacent or 
associated anatomical structures to these segments, such as  
papilla, head of pancreas, elements of porta hepatis or splenic 
hilum were excluded on anatomical grounds a s  not part of the 
upper gastro-intestinal tract;
6. any patient diagnosed as  above was included in the study if either
the positive diagnosis was established - i.e. histologically
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reported - within the interval of time chosen or if the referral date 
or diagnostic episode occurred within the interval of the study;
7. all patients included must have been either positively diagnosed or 
submitted to treatment at either of the two sites chosen, 
irrespective of being referred from within or out with of the 
catchment area of the two hospitals.
In the context of inclusion criteria it is worth mentioning the 
following changes in the provision of services for the Neath General 
Hospital site:
1. between 1st July 1993 and 30th June 1994 the name used fo r
Open Access Endoscopy service was One-Stop Endoscopy; 
the Open Access Endoscopy name was used only after 1st 
July 1994;
2. the Rapid Opinion Clinic w as formally introduced under this
name on the 1st October 1995; previously, relevant 
referrals were channelled as in Morriston University 
Hospital setting;
3. the acute surgical services were moved to Morriston University
Hospital on the 1st October 1995. These services related 
only to the admission facility fo r acute surgical intake and 
not elective and /  or semi-elective work.
There were a number of cases of Upper Gastro-lntestinal Cancer
that were not seen fit for the purpose of this research; if included, they
might have introduced a certain degree of bias and skewed the results
and findings. It was therefore necessary to establish the exclusion
criteria to be employed when identifying the unsuitable cases. The
observed exclusion criteria were the following:
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1. cancers arising from a nearby viscus - such as pancreas, papilla, porta
hepatis, bronchial system, lungs, colon, etc - and only secondarily 
invading any segment of the gastro-intestinal tract;
2. the small gut, based upon its anatomical, histological and clinical features
w as excluded;
3. the histology reports on patients showing various degrees of dysplastic
lesions of the gastro-intestinal tract; these patients were excluded 
based upon the use of the western definition of malignancy rather than 
the Far-Eastern one - e.g Japanese definition of cancer includes also 
severely dysplastic lesions such as  polyps, ulcers, etc. -;
4. the absence of a confirmed histological feature of malignancy on either
bioptic specimens or operative samples, as  well a s  border-line cases 
where multidisciplinary consensus of malignancy was not achieved;
5. m etastasis in the Gastro-lntestinal Tract arising from known primary
cancers in other abdominal or non-abdominal viscuses; unless these 
patients were not observed or followed up during the usual process of 
clinical scrutiny for their original cancer, for the purpose of the current 
objectives of study these patients were not included in the case  mix, 
even if they later presented with new symptoms or were referred as 
new clinical episodes;
6. those patients referred solely for the purpose of a  second opinion but not
treated within the sites mentioned earlier; although these patients were 
referred through with potentially positive diagnosis of malignancy and 
were subsequently submitted to the positive diagnosis algorithm, their 
staging and treatment was not accomplished within the originating 
setting; therefore, insufficient data for appraising the outcome of the 
services was achievable and they were excluded;
7. patients with incomplete data available; this could be due to lost, destroyed
records or insufficient data available; however, patients with complete 
records available but who were geographically transferred to other 
sites during the follow up period were included in the study.
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b) Assumptions
During the data extraction process it was apparent that there 
were several cases where the route taken by the patients was 
different; some referrals were addressed in the first instance to the 
Radiology Department or to various specialities like ENT, 
Rheumatology, etc. Also, although some patients were sometimes 
routed to one department or the other, the modality of referral was 
subject to the doctor's ability to recognize featured symptoms or even 
a possible diagnosis of malignancy. As these two conditions may 
influence the speed of referral and specialist care appointment the 
patients received, several assumptions were made a priori. In 
addition, the need to simplify the process of analysis of a quite 
heterogeneous collection of clinical data meant that, when data was 
introduced into the database, the following assumptions were used:
1. the initial diagnosis was considered to be negative at the moment of
the first hospital appointment if there was no hint in the 
consultation letter/record or indeed, during the first Outpatients 
consultation, that a  malignancy might explain the presentation 
symptom(s); if this assumption was correct, the medical 
practitioner failed to initiate the specific investigations and the 
patient had to be referred for the second time based on the sam e 
clinical picture; som e delay in the referral process can occur on 
these grounds;
2. the diagnosis in respect of the Acute Admission modality was
considered to be negative if no specific investigations were 
organised during that period of admission, even if these might 
have been organised after discharge from hospital; if this
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assumption was correct, som e delay in the diagnostic process 
might have occurred;
3. the diagnosis was also considered to be negative at the first hospital
examination if the biopsy failed to positively diagnose cancer and 
another endoscopy was warranted; if this assumption was correct, 
then some delay could be explained during the diagnosis phase;
4. the modality of referral was considered to be Open Access Endoscopy
when the patient's first contact with the hospital setting was at the 
endoscopy, irrespective of the referral's modality. This was 
particularly true in the case  of Morriston University Hospital's site, 
a s  well a s  in the situation of re-routing in both sites of som e 
referrals considered to be wrongly issued;
5. when Barium Meal was the first line of investigation, this situation was
considered to be a  referral to the Medical Department as an 
Outpatient modality; if this assumption was correct, a  delay in the 
referral process can be explained in respect of these settings, due 
to the subsequent necessity for endoscopic confirmation;
6. cancer localisations at the interface between the oesophagus and
stomach posed an important challenge in respect of topography; it 
was arbitrarily considered that cases involving the cardia do 
belong to the oesophagus - i.e. the bulk of the tumour situated in 
this area rather than eccentrically at the fundus of the stomach -; 
the reasons to do so  are based on histological, anatomical and 
surgical criteria;
7. for a  short period of time the modalities of referral directly to the
endoscopy service were recorded with a different name, such as  
Fast-Track Endoscopy or One-Stop Endoscope; therefore these 
modalities of referral were grouped under the generic name of 
Open Access Endoscopy, a  term which was used since mid 1994 
for all these type of referrals;
8. it has been assum ed that, irrespective of the four main modalities of
referral - i.e. Acute Admission, Outpatients Clinic, Open Access 
Endoscopy or Rapid Opinion Clinic -, each referral w as addressed
upesft gangcr?
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to the following grouped clinical services: gastroenterology, (other) 
medical specialties, (other) surgical services; grouping the 
targeted clinical services in this way makes sense  based upon the 
internal collaborative features and differential diagnoses issues;
9. arbitrarily, patients' past co-morbidities were classed abdominal and
gastroenterological; some patients might have had co-morbidities 
that may have altered their perceived symptomatology and a s  a 
consequence might have delayed their presentation or indeed the 
diagnostic algorithm; therefore, past medical or surgical co- 
morbidities may represent delaying factors of positive diagnosis 
and need to be observed when analysing the speed of diagnosis 
in Gastro-lntestinal malignancies;
10. recording the main presentation symptoms at GP level and / or main
hospital consultation's symptoms is retrospectively unreliable; 
based on the assumption that each medical practitioner would 
describe in the clinical records the most significant symptoms in 
their respective order of magnitude, the sam e order of importance 
was preserved when introducing the symptoms into the database;
11. it has been assum ed that several interval segm ents (see Appendix
A01: Natural History & Delay Intervals) observed during the clinical 
progression of the disease are potential sources of delaying the 
management of these patients and they were a priori named 
herewith as "delay intervals". The assum ed potential delay 
intervals and their substance were a s  follows:
- “Onset Delay” ■ from the occurrence of the first symptom to
the I^GP examination
. “GP Delay” ■ from the 1st GP examination to the GP referral
r “Hospital Delay” ■ from the GP referral to the 1st Hospital
appointment
r “Diagnosis Deiav” ■ from the 1st Hospital appointment to the
positive diagnosis moment
•: *
- “Treatment Delay” * from the positive diagnosis moment to
the s |u t  of treatment
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12. the presentation delay is extremely difficult to quantify both during the 
direct history taking process and retrospectively in the clinical 
records assessm ent; therefore, the following ranges of delay in 
presentation were chosen to be more useful for the purpose of 
quantification:
- less than 24 hours;
- less than 1 week but more than 24 hours;
j- less than 1 month but more than 1 week;
- less than 3 months but more than 1 month;
- less than 6 months but more than 3 months;
- less than 12 months but more than 6 months;
- more than 1 year;
c) Cancer Cose Mix
Based on the inclusion criteria mentioned above, a total number 
of 462 cases of patients diagnosed with various forms of Upper 
Gastro-lntestinal Cancer have been identified in the two settings for 
the period of 6 calendar years, i.e. between 01 July 1993 and 30 June 
1999. This represents approx. 2.36% of the total number of patients 
endoscoped for gastrointestinal symptoms or one case of cancer 
diagnosed for every 42.35 endoscopies performed.
However, 22 cases were excluded from the study based on the 
following reasoning:
- Incomplete data in clinical notes and/or electronic records = 15
cases;
- Destroyed primary and/or secondary medical records on several
deceased patients = 6 cases;
- Diagnosis on Barium Meal alone without histological confirmation = 1
case;
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A total number of 440 cases of Upper Gastro-lntestinal Cancer 
were therefore finally entered into the study after having fulfilled all 
the inclusion and exclusion criteria mentioned earlier. All these cases 
offered essentially complete clinical data sets and had positive 
diagnosis made by endoscopic and histological means.
C. M eth o d
Bearing in mind that the period covering the study was 
significantly long and because the study covered essentially two 
different hospital sites, the following approach was used as a method 
of identifying the relevant cases and collecting the data:
cQ Case Identification
The interval of time covering the case identification was chosen 
to extend between 1st July 1993 to 30th June 1999 inclusive and 
comprised of 6 calendar years. During this interval, the infrastructure 
of health care delivery in the two chosen settings for 
gastroenterological patients was stable and all the services were in 
place in one form or another. For the purpose of establishing the 
patients' outcome, the clinical results for these patients were 
monitored for a further 5 calendar years until 30th June 2004.
The case mix available was identified at the inception of the 
research from different sources, within or with direct connection to 
the two established sites. These sources were chosen in such a 
manner that they could offer:
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1. speediness in the identification of each diagnosed Upper 
Gastrointestinal Cancer case;
2. thorough filtration of all gastroenterological malignancies within 
the two settings;
3. guarantee for accuracy and exhaustiveness of the clinical details 
to be collected.
The sources of data collection offered the facility for a thorough 
filtration of all cases of upper gastro-intestinal malignancy positively 
diagnosed within the two hospitals. These sources were:
1. The computerised records of the Histopathology 
Department; the identification of cases was based upon the coding system 
used by that department for various clinical entities compatible with the 
definition of malignancy and referring to the anatomical segm ents of the 
upper gastro-intestinal tract;
2. The Endoscopy Suite1 records in both hospitals; the 
identification of cases was based upon a code-searching exercise against 
the macroscopic diagnosis registered by the examining endoscopist at the 
end of the examination;
3. The Electronic Patients Records ePR in both hospitals; a 
cross-reference process was employed based upon patients' demographic 
data;
4. The Coding Department; the identification process involved 
a  code-searching exercise based on the International Classification of 
D iseases - ICD-102 - code of malignancy for the anatomical segm ents of 
the upper gastro-intestinal tract;
5. The Radiology Department; a search of all reports issued 
was carried out in order to identify potential cases which were missed from 
previous searches or perhaps not subjected to tissue diagnosis;
1 GeneCIS™ - Generic Clinical In form ation  System , Authors: Hayley Dickinson, 
Jayne Morgan, University of Wales Swansea, United Kingdom
2 ICD-10 codes used: Oesophagus » C15.9 & C78.8; Stomach -  C16.9 & C78.8 
Duodenum -  C17.0 & C78.4
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6. The Singleton Centre for Oncology; the records of patients 
treated for upper gastrointestinal malignancy in this centre were 
scrutinised and cross-referenced to previous findings;
7. CANTORIS1 - the Cancer Registry Database for South 
W ales; this service had their records filtered for cases coded a s  upper 
^astro-intestinal malignancy as  per reports received at their end;
8. The liechid Morgannwg NHS Authority2; the information 
department of this health care provider was also queried for reported 
case s  of upper gastrointestinal malignancy coming from local General 
Practitioners;
9. All Wales Cancer Registry Cardiff; this registry was queried 
to obtain reported cases based on ICD-10 coding system and cases 
reported to the National Statistics Office.
Whenever necessary and possible, the data was cross- 
referenced with the computerized clinical system of various 
institutions and organisations involved in the respective patient's care, 
such as patient's general practice, local hospice, cancer registry, etc. 
There was no correspondence involved however with any of the 
patients or their families, nor any direct contact by phone or other 
means to obtain further clinical data other than that recorded in 
patients' clinical notes or in the electronic sources. On occasions the 
data extracted was completed with clinical details from the family 
practitioner's records or from nurses' records.
1 CANTORIS Cancer Treatment & Outcome Registry, Singleton Hospital, Sketty 
Lane, SWANSEA, SA2 8QA;
2 IMH Iechyd Morgannwg Health Authority, IT Department, 41 High Street, 
SWANSEA, SA1 1LT;
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b) Data Extraction, Validation da Analysis Tools
To answer to the objectives previously established, a list of 
required data was compiled between the main researcher, the 
gastroenterologist and the statistician. It was decided that the set of 
information required needed to be structured in the following way:
i  Patients' Demographic details;
2. Personal & Family History of gastro-intestinal malignancies;
3. Chronic use of gastroenterological-related medicines;
4. Presenting main symptom and other symptoms as they are specified, 
the order of recording as well as the estimate delay in presentation;
5 .1st Examination details (primary care sector);
6 .1st Hospital Examination (secondary care sector);
7. Positive Diagnosis and staging examinations;
8. Treatment instituted - both surgical and adjuvant;
9. Recurrence of disease (when present);
10. Death and cause of death (where applicable);
As an intermediate tool in the data collection process, a 
proforma in paper format was designed (see Appendix A03-A05: Data 
Collection Form) and data was collected onto it from the clinical 
records. The data extraction process was carried out by the main 
researcher who accessed the medical records at source for each 
identified patient and also cross-matched the references in the clinical 
notes with other sources. To structure better the collected data and 
for manipulation and house-keeping purposes, the data was 
transferred onto a database using Microsoft Access1 software. This
1 Microsoft ACCESS 2000 in Microsoft OFFICE 2000 Premium®, Seattle, USA, 1999
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was specifically in-house designed for this purpose (see Appendix A06: 
Database Interface in Access 2000 format). The accuracy of data 
collection and recording was validated with the assistance of an 
independent validator through a process of independent selection of 
12% of the initially identified cases followed by scrutiny against the 
original recorded proformas.
Subsequently, the final data was imported into a statistical 
package (SPSS for Windows1) for statistical analysis. Data analysis 
and interpretation was assisted by a professional statistician. The 
statistical methods aimed to clarify the difference or relationship 
between the variables considered. These variables were established at 
the beginning of the statistical analysis process. They include 
demographic variables - such as age group, gender, hospital of 
referral, etc. -, referral variables - such as referral modality, clinical 
service -, pathological data - such as topography of tumour, tumour T 
stage, clinical TNM stage, histology, differentiation, etc. -, clinical 
variables - such as personal medical history, familial history, 
main/presentation symptoms, dates of presentation and diagnosis, 
staging procedures and treatment, etc. -, as well as outcome variables 
- such as recurrence episodes and individual survival -.
For the purpose of investigating the null hypothesis, the 
statistical analysis employed both parametric and non-parametric
1 SPSS for Windows ver. 10, release 10.0.7, 1 June 2000, Copyright© SPSS Inc. 
1989-1999, USA
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tests; the scope was a) to investigate the differences between the 
various groups of data considered as confounding factors, b) to 
research fully the relationships between various factors and c) to draw  
sound conclusions which could be used to ascertain whether the 
method of referral had any consequence upon the waiting times and 
upon the principal outcome characteristics of the case mix. In most 
instances the re ferra l m ethod  and the d ep a rtm en t o f  re ferra l were 
considered as independent factors because the chosen results aimed 
for were the waiting times as well as the various outcome factors 
resulted from the change in referral pattern. The other factors - such 
as demographic details, clinical data, histology, stage and other 
tumour related data, treatment variables and outcome data mentioned 
above - were introduced in the analysis in most of the cases as 
independent variables.
With the number of variables considered, a multivariate 
analysis was initially employed but this was abandoned soon after it 
was found that findings derived from this analysis were offering 
unstable results. This was due to the presence in many cells of low 
counts, for instance the case of the Rapid Opinion Clinic group of 
referrals where the overall method was used in only 12 patients.
I decided therefore to observe the relationship between the 
independent factors and the variables collected using a bivariate 
analysis where, in most instances, * the method of referral was the 
independent factor. The results aimed to show the way in which the
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waiting times and the patients' outcome were influenced by the 
method of referral. The frequencies and the instances of various 
factors such as age groups, gender, tumour size, TMN stage, etc., were 
analyzed in most instances using the cross-tabulation method - I have 
tried this way to summarize the intersections of independent and 
dependent variables and understand the relationship (if any) between 
those variables; by applying this method of analysis I have controlled 
the independent variable considered to be the method of referral (and 
as much else as possible and natural) and measure the dependent 
variables to test my hypothesis that there is some relationship 
between them. To test the nominal data a Chi squared test (x2)1 was 
employed in most of the situations. The statistical level o f significance 
was interpreted based on the p-value with a threshold of 0.5. The non- 
parametric Spearman's Rank Order Correlation test was also used. I 
have considered this approach because most of the data looked at was 
not categorical in nature.
To investigate the survival probability at the end of the study, 
the test of choice used was Kaplan-Maier te s t The calculation of the 
survival proportion was observed deliberately at 1 year and 5 years as 
per current standard of reporting survival either following definitive 
treatment for treated patients or similarly after positive diagnosis only 
for non-treated patients respectively; the basis of the statistical
1 Chi square or (x2) is a non-parametric test of statistical significance for bivariate
tabular analysis
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computation was the Log Rank and the Breslow method; the survival 
probability graphs were constructed based on this computations using 
the 95% Confidence Intervals.
Once the aims, material and variables were established, a risk 
management and costing exercise have been carried out. It was found 
that - at the material time when the study was designed - there were 
no conflicts of interest or hazards envisaged, both for the patients and 
for the researchers alike. Also, no breach was noted with respect to 
the Data Protection Act1 in force at the time and no other Disclosure 
of Information issues were to be observed. The research had no direct 
or indirect funding or grants either at the beginning or during the 
process of data collection and interpretation; no conflict of interests 
were known. The case identification and data collection exercises were 
carried out within the infrastructure already existent within the two 
chosen sites and not shared directly or indirectly with third parties. 
Approval from the regional Ethics Committee was sought and duly 
obtained.
This research was designed as a retrospective study based upon 
the auditing methodology. Making use of the algorithms, guidelines 
and new clinical services implemented at the beginning of the 1990's 
at Neath General Hospital, as well as the corresponding approach to 
the gastroenterological referral pathway in Morriston University
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Hospital, the patients diagnosed with Upper Gastro-Intestinal Cancers 
in both settings were identified and their medical appointments, 
diagnostic pathway, therapeutic management and clinical outcome 
was scrutinised. The case mix required was not subjected to any 
selection process and all complete and validated records within the 
study interval were used for the analysis of data.
For all 462 upper gastro-intestinal cancer patients identified the 
clinical data set was obtained from their medical records and entered 
into the database. Each record consisted not only of demographic 
data, but also comprehensive clinical details of their first presentation 
at general practice level, including symptomatology and first line 
treatment, if any. Also, each record provided detailed referral pathway 
to the secondary care sector with positive diagnosis and staging 
events, treatment and outcome features. The data collected was 
analysed using the method described above and offered the results 
mentioned in the following two chapters. Subsequently, and in 
keeping with the auditing methodology, the results and conclusions 
which resulted following the analysis of the data were used to fine- 
tune the disseminated guidelines, criteria of referral and pathways of 
care for those gastroenterological patients presenting with symptoms 
suspicious of upper gastro-intestinal malignancy.
1 Data Protection Act 1984, © Crown Copyright 1984, HMSO The Queen's Printer of 
Acts of Parliament, The Stationery Office Ltd.
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Due to the complexity of data analysis, I considered it beneficial 
to look at the results in two separate parts: first approach refers to the 
speed of diagnosis alone in conjunction with a few variables seen to 
play an important role in the pre-treatment phase for these patients, 
such as demographic factors, anatomical organ, service and method of 
referral used, etc. The second approach looks to the results from the 
outcome and survival benefits standpoint, if any, resulting from the 
introduction of the referral algorithms and novel clinical services.
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Chapter V!
R E SU LTS: IN TERVALS  & D ELAYS
S u m m ary : This chapter presents the results o f the study looked
at from  the perspective o f the newly introduced clinical services and 
methods o f referral. A fter briefly showing the possible confounding 
factors across the four methods identified as referral modality and 
presenting the distribution o f the 440 cases from  an epidemiological 
point o f view - e.g. gender, age group, hospital setting, anatomical 
gastrointestinal segment involved and histological diagnosis -, the bulk 
o f the chapter is dedicated to the quantification o f the delay intervals 
established under the method o f study. It is retained that the cohort 
includes 278 gastric cancers and 160 oesophageal lesions. The median 
age o f the cohort is 73 years. Only 24 cases o f non-carcinomas have 
been isolated compared to 416 carcinomas. The most frequent symptoms 
at presentation were dysphagia and weight loss. It was found that 42% 
o f patients were initially referred to the Outpatients Clinic and only 
21.4% to Open Access Endoscopy. Most patients have delayed their 
presentation with a minimum o f 3 months; they faced a median delay o f 
11 days (mean delay -  15.96 days) before were examined in the 
hospital setting. The overall mean NHS Delay in this cohort is 117.88 
days.
Subheadings in  th is  Chapter:
A . C ase  m ix  p r e s e n ta t io n
B . D is tr ib u tio n  o f  C a n cer  P a th o lo g y
C. D is tr ib u tio n  o f  S e rv ic e s  &  M e th o d  o f  R e fe r ra l
D. S p e e d  o f  R e fe r ra l, D ia g n o s is  &  S u b m is s io n  to  T r e a tm e n t
a) O n se t D e la y
b) GP D e la y
c) H o sp ita l  D e la y
d) D ia g n o s is  D e la y
e) T r e a tm e n t D e la y
f )  N H S D e la y
The case identification exercise and data collection process 
offered a huge array of variables that may allow for an exhaustive 
scrutiny of the presentation, referral, diagnosis, treatment and 
outcome of those patients with Upper Gastro-intestinal Cancer
uprzr eA&rRQtNrrearwtAL. canccri 
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diagnosed over a period of 6 calendar years. When looking at the raw 
results of this uncensored cohort from the perspective of the newly 
introduced clinical services and referral algorithms, there are 
essentially two areas of interest to be scrutinized: a) one refers to the 
speed of referral, diagnosis and in-hospital management of these 
patients and b) the second observes the consequences that the new 
services produced on the patients' outcome.
Due to the wide spectrum of the null hypothesis to be 
investigated as well as the complexity of data analysis, in this chapter 
I will only present those results with emphasis on the speed of 
patients' referral, positive diagnosis, staging and submission to 
treatment.
A. Case mix presentation
For the interval of 6 calendar years - i.e. 01 July 1993 to 30 
June 1999 - a number of 440 cases of Upper Gastro-intestinal Cancer 
have been entered into the database having fulfilled the inclusion- 
exclusion criteria established from the start under Method and having 
offered complete recorded clinical details. These cancers were 
diagnosed following an impressive number of referrals - more than 
16000 - coming from the General Practitioners who were serving at 
the time a population in excess of 320,000 people. The distribution of 
cases positively diagnosed as upper gastro-intestinal cancers and 
picked up at the two sites was similar:
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- Morriston University Hospital “ 224 cases (50.9%)
- Neath General Hospital ■ 208 cases (47.3%)
- Other referring Hospitals « 8 cases (1.8%)
The cases originated from other units had the suspicion of cancer 
raised there, but positive investigations, staging procedures and 
clinical management still carried out in the two hospitals mentioned 
above.
Overall, there were 278 cases (63.1%) of gastric cancer, 160 
cases (36.3%) of oesophageal cancer and only 2 cases (0.5%) of 
primary duodenal malignancy. All these cancers were primary 
malignancies arising from various structures of the Upper Gastro­
intestinal Tract wall (but excluding biliary/pancreatic structures), 
with four notable exceptions: these were the cases of primary tumours 
arising in other remote organs (lung, colon, kidney and melanoma 
respectively), but the patients were referred from primary care sector 
for upper gastro-intestinal symptomatology without prior knowledge of 
the primary tumour at referral time; as a consequence, from the 
beginning these patients were classed as upper gastro-intestinal 
patients until that moment in time when the primary tumour was 
identified.
B. Distribution o f Cancer Pathology
Examining each suspected cancer patient, the general 
practitioner has chosen a method of referral or another based on 
his/her judgment and balance of probability between the patient's
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symptomatology and several other elements with various degree of
prediction for malignancy.
Parameter Admi­ssion O A E OPD RO Total Significance
Age Mean Age 75.30
n=149,
68.62
n-94
71.76
n=185
72.50
n=12
72.31
n=440
G
en
de
r Male 89
(59.7%)
63
(67.0%)
114
(61.6%)
7
(58.3%)
273
(62.0%) 5 s
■ 1N nFemale 60
(40.3%)
31
(33.0%)
71
(38.4%)
5
(41.7%)
167
(38.0%)
S
a
8z
Morriston (6Z4%)
43
(45.7%) (47 6^%)
224
(50.95)
X2 
= 2
4.
20
2 
P 
< 0
.0
01
Neath 54(36.2%)
50
(53.2%)
92
(49.7%)
12
(100%)
208
(47.3%)
Other Hosp 2(1.3%)
1
(1.1%)
5
(2.7%)
8
(1.8%)
An
ato
m
ica
l
Se
gm
en
t Oesophagus (242%)
38
(40.4%)
80
(43.2%)
6
(50%)
160
(36.4%)
X2 
= 1
5.5
47
 
P 
= 0
.01
6
Stomach 112(75.2%)
56
(59.6%)
104
(56.2%)
6
(50.0)
278
(63.2)
Duodenum 1(0.7%)
1
(0.5%)
2
(0.4%)
Cl
in
ic
al
D
ep
ar
t
Gastroen­
terology
5
(3.4%)
88
(93.6%)
18
(9.7%)
12
(100%)
123
(28.0%)
X2 
= 3
32
.73
 
P <
 0
.00
1
Medical 117(78.5%)
5
(5.3%)
97
(52.4%)
219
(49.8%)
Surgical 2718.1%)
1
(1.1%1
70
(37.8%)
98
(22.3%)
| 
Ag
e 
G
ro
up
<34
X2 
= 3
4.3
00
 
P 
< 0
.00
1
35-44 1(0.7%)
2
(2.1%)
6
(3.2%)
9
(2.0%)
45-54 9(6.0%)
6
(6.4%)
8
(4.3%)
2
(16.7%)
25
(5.7%)
55-64 10(6.7%)
22
(23.4%)
28
(15.1%)
60
(13.6%)
65-74 41(27.5%)
36
(38.3%)
66
(35.7%)
4
(33.3%)
147
(33.4%)
>*75 88(59.1%)
28
(29.8%)
77
(41.6%)
6
(50.0%)
199
(45.2%)
Total 149
(100%)
94
(100%)
185
(100%)
12
(100%)
440
(100%)
Fig. 6 .0 1  -  S y n o p s is  o f  C o n fo u n d in g  fa c to r s
These factors - namely the age group, gender, main symptom, anato­
mical segment and department of referral - are confounding factors
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that might influence the adopted method of referral. There are other 
factors that will be discussed later -  such as stage of the disease, 
suitability for adjuvant therapy, etc. - but this may not be 
confounding factors; they are not known at the time of initial referral 
and as a consequence they may not influence the practitioner's 
decision to adopt a route or another for referral. For this case mix a 
synopsis of the confounding factors for each separate method of 
referral is presented on the previous page (Fig. 6.01). When choosing 
the model of study to assess the null hypothesis it is essential that the 
groups of factors representing method of referral are comparable and 
well defined. The groups considered in these study present certain 
differences which are depicted in the synoptic table above and need 
due interpretation later in chapter VIII.
The predominance of male gender in this case mix was obvious - 
273 cases (62.04%) males against 167 cases (37.95%) females -, giving 
an overa ll m a le/fem a le ra tio  of 1.63 in favour of males. Yet, the 
same ratio appears to be smaller in the Morriston setting - 1.48 - than 
in the Neath setting - 1.73 signalling that female gender was less 
often diagnosed positively with cancer in Neath than in Morriston 
Hospital (x2 88 25.536, p<0.001). The overall median age for all cancer 
patients was 73 years, whilst the overall mean age was 72.31 years 
(range 37 to 96). The distribution of cases in decades of age is shown 
in Fig. 6.02 below, according to the current pattern of reporting 
cancers based on risk prevalence.
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• overall eases •
31 to 44 years
9.00 I 2.0% 
41 to S4 years 
25.00 I 5.7% 
t f  to 44 years
40.00 I 13.6%
t f  to T4 years
147.00 I 33.4%
Fig. 6 .0 2  -  C ase Mix D is tr ib u tio n  p e r  Age D eca d es  
In this case mix the female gender seems to be diagnosed with
Upper Gastro-intestinal Cancer at an older age (females: mean age = 
76.44 years, median age = 77, Std.Dev. = 10.94) than the male gender 
(males: mean age = 69.78 years, median age = 71, Std.Dev. = 10.55). 
However, there was no significant difference in respect of the patients' 
age between the two settings (mean age at diagnosis: Morriston = 
73.72 vs. Neath = 71.40), nor between cancer localizations (mean age 
at diagnosis: Oesophagus = 71.21 vs. Stomach = 73.08 years).
As far as the anatomical segment is concerned, 160 cases 
(36.6%) were of oesophageal localization and 280 (63.63%) of gastro­
duodenal topography - that is an oesophageal/gastric ratio = 0.571 
-. Tumours localized a t cardia level - 147 cases (33.40%) - were 
considered, as per initial established assumptions, of either
tv w  ?S y u r t
199.00 I 45.2%
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oesophageal (93 cases a t cardia/lower 1/3 oesophagus) or gastric- 
fundus origin (54 cases at cardia/gastric fundus), depending upon the 
localization of the bulk of the tum our on the endoscopic / 
laparoscopic /  CT scan basis.
Fig. 6.03 below presents the distribution of histological types of 
cancers encountered:
Histological type of cancers
■ Intestinal Type■
□ Diffuse Type □ Mixed Type
■ Non-Carcinomas
N on-C arcinom m s,
2 4
In te s tin a l T ypa% 
2 9 0
S q u a m o u s C ait9 9 6
Fig. 6 .0 3  - H is to lo g ic a l T yp es  o f  C an cers  
Amongst the identified 440 cases, only 24 cases (5.50%) were
non-epithelial tum ours (i.e. 16 lymphomas /  4 carcinoid / 2
melanomas /  1 sarcoma /  1 myeloma) and 416 cases (94.50%) were
carcinomas of various forms and differentiations. Amongst
carcinomas, there were 3 cases of metastasis originating in other
primary tum ours which were unknown and /o r asymptomatic at the
OPPGP OA37PatM7C37tMAL GAMC.EP:
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time of referral. Amongst the 24 non-epithelial cancers, 23 cases were 
localized in the stomach and only 1 case originated at oesophageal 
level (oesophageal/gastric ratio = 0.043).
Overall, 23 patients (5.3%) had a strong family history of 
malignancies, with 6 of them having more than one member of their 
family demised due digestive cancer; 17 patients had ancestors or 
siblings with gastro-oesophageal cancers and two of them had both 
parents demised with gastric carcinoma.
In 165 patients (37.5%) some form of past personal medical 
history -  i.e. abdominal, gynaecological, metabolic, etc. - has been 
noted. These past conditions were multiple and various and can be 
grouped in:
- Previous Digestive Pathologies -134 cases (30.5%)
- Previous Surgical Abdominal conditions - 7 cases (1.6%)
- Other medical or surgical conditions - 24 cases (5.5%)
Out of the total cohort of 440 cases, 157 patients (35.68%) 
presented previous digestive conditions that might have interfered 
with their presentation to the family doctor. These past medical 
conditions were as follows:
- In 7 cases other previous carcinomas and /  or lymphomas
- In 4 cases various previous abdominal surgical procedures
- In 146 cases previous diagnosis and/or treatment for gastroenterological
benign conditions (these Include diagnosed conditions such as: Hiatus 
Hernia (20 cases), Gastro-Duodenal Ulcer Disease or Non-ulcer 
Dyspepsia (OB cases), GORD & Oesophagitis (13 cases), Chololithiasis 
(12 cases), Hepatic Cirrhosis (3 cases), vaifous colon disorders 
excluding cancers (28 cases).
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All these patients had previous interactions with the health care 
system in one form or another, some of them being actually on regular 
follow-up lists for their medical problem. In 275 patients (62.5%) no 
past medical conditions were identified in their medical records.
The patients’ records showed both at general practitioner’s level 
and at hospital level a large array of symptomatology. A retrospective 
analysis of the symptomatology must take consideration of the 
limitations imposed by the current method of collecting data; this 
analysis is quite difficult because it relies on unstructured criteria for 
the recording of the patient's main symptom and/or associated 
symptom(s) at the time of their presentation.
1st Referral Symptom Frequency %
weight loss 219 16.6
dysphagia 148 11.2
abdominal pain 130 9.8
dyspepsia 96 7.3
anorexia 79 6.0
vomiting 74 5.6
lethargy 62 4.7
anaemia 59 4.5
chest pain 40 3.0
regurgitation 47 3.6
bleeding 41 3.1
other symptoms 85 6.4
t
No symptom 2 or symptom 3 240 18.2
Fig. 6.04 - Frequency of Symptoms at Presentation to GP
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However, if recording of the first three symptoms took place in 
accordance with the magnitude of the sufferance each patient 
requested consultation for with his/her general practitioner, then the 
prevalence of symptoms that have been isolated are show the 
frequency seen in table Fig. 6.04 on the previous page. In 240 cases 
the patients complained of only one single symptom - at least as 
portrayed on the medical record -. Surely this must be dependent to 
many factors, including patient's threshold to discomfort, anatomical 
segment involved, previous gastroenterological history, etc.
Perceived Mqjor Symptom Frequency %
dysphagia 103 23.4
weight loss 73 16.6
abdominal pain 73 16.6
dyspepsia 55 12.5
lethargy 35 8.0
chest pain 16 3.6
vomiting 14 3.2
anorexia 12 2.7
anaemia 12 2.7
bleeding 12 2.7
regurgitation 3 0.7
other symptoms 73 7.3
total 440 100
Fig. 6.05 - Perceived Major Symptom at Presentation to GP 
When taking account of the assumptions made at the beginning
that the first recorded symptom is also the most prevalent one, a list
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of symptoms may emerge in which one can find a few symptoms 
recognized as indicators of malignancy; the frequency of the major 
symptom at presentation emerged from this analysis is seen in Fig.
6.05 on the previous page. Dysphagia and Weight Loss appear to be 
the most important causes of worry for the patient and they appear as 
the recorded dominant symptom in 40% of the cases, whilst dyspepsia 
concerns these patients in only 12.5% of the cases.
Perceived Major Symptom Frequency %
dysphagia 116 26.4
weight loss 29 6.6
abdominal pain 84 19.1
dyspepsia 31 7.0
lethargy 21 4.8
chest pain 23 5.2
vomiting 32 7.3
anorexia 3 0.7
anaemia 28 6.4
bleeding 29 6.6
regurgitation 2 0.5
other symptoms 42 9.5
total 440 100
Fig. 6.06 - Perceived Major Symptom o f Presentation to Hospital
If we look to the symptom recorded as the most worrying for the
patient at the time of his/her consultation in the hospital setting (see
Fig. 6.06 on the previous page), dysphagia seems to be on the first
position (in 116 cases - 26.4%) followed by Abdominal (Epigastric)
Pain (in 84 cases - 19.1%). Other acute symptoms that might
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precipitate patient's attendance at the specialist level - such as 
vomiting and bleeding - 61 cases, 13.6% - are completing the shift in 
symptomatology compared with the GP setting:.
1 s t  E xam ination  a t  th a  H ospital
■ Barium Enema B Barium Meal □ Clinical Exam Only
□ Endoscopy A Biopsy B Laparotomy □ Abdominal U/S
Morriston Hospital Neath Hospital Other Hospitals
H ospitals
Fig. 6 .0 7  -  1st E x a m in a tio n  o ffe red  a t  th e  H o sp ita l  
The graph seen above (Fig 6.07) shows comparatively the first
investigation undertaken at the both hospital sites; the majority of 
patients were channelled towards Endoscopy with biopsy; yet, approx. 
3.4% were examined only by clinical means without any specific 
investigations arranged and, more disturbing, 107 patients (24.3%) 
were offered only a Barium Meal as a first line investigation. The 
implications of this approach to the investigation of the Upper Gastro­
intestinal Tract in this day and age merit some attention later The 
suspicion of malignancy with subsequent urgent scheduled 
investigations was obvious at the first examination in the hospital 
setting in only 310 cases (70.46%) whilst in other 130 (29.54%) the
a<Pi our ezLMtcAt ssrviccs womic 7oidw«e» rkte wee* rulg* a/ho how?
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required investigations were triggered without the expected degree of
urgency.
All of the patients had Upper Gastro-intestinal Endoscopy and 
multiple biopsies as a means of positive diagnosis. In 4 cases the 
positive diagnosis was made after the surgical treatment was 
performed as an emergency operation for various complications of the 
cancer itself - i.e. bleeding tumours, perforated tumours, etc. -. There 
were 8 other cases, emergencies as well, where the positive diagnosis 
was made during the laparotomy itself, either by frozen section 
histology or definitive histology on the operative specimen. In 2 
patients the positive diagnosis has been reached only at necropsy. 
Various other investigations (e.g. CXR /  U/S scan /  CT scan / 
endoscopic U/S /  laparoscopy /  etc.) were undertaken for staging 
purposes as below:
undertaken inBarium Meal 
Endoscopic U/S Scan 
CT Scanning 
Laparoscopic U/S Scan 
Laparoscopy 
Laparotomy 
Ba Enema 
Necroptic
139 patients (31.6%) 
280 patients (63.6%) 
225 patients (51.1%) 
98 patients (22.3%) 
98 patients (22.3%) 
10 patients (2.3%) 
10 patients (2.3%)
2 patients (0.5%)
After positive diagnosis and staging investigations, the pre­
operative T-stage distribution of the epithelial tumours is as shown in 
Fig. 6.08 on the following page; it refers at the “T* component of the 
TNM stage.
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When taking into consideration the other elements of the
clinical TNM stage, i.e. N = Nodes and M = Metastasis, the pre­
operative distribution in clinical TNM stage of this case mix is 
presented in figure 6.09 below:
Pro-Oporatlve TNM Distribution
Not Staged
□ nib
Esophagus n ■ 160 Gastro-Duodenal n ■ 280 TOTAL n ■ 440
A natom ica l S eg m en t
Fig. 6 .0 9  -  O vera ll C lin ica l TNM S ta g e  D is tr ib u tio n
u p r g r  O A a rp a tn rrea T tH A L  c a n c e l  
g o  a u p  G U H tcA t. a e R v t c e s  w o r k :
VOWARG& THff “TWO Wffff*? RULG* AHO HOW?
' I l l -
C hapter VI: R esults: In terva ls & B elays Serhcm L Qheorghiu
The overall pre-operative early/advanced cancer ratio for this 
uncensored case mix was 36/376 * 0.095 and the
differentiated/undifferentiated ratio was 170/218  * 0.779.
C. Distribution o f Services & Method of Referral
The two hospital settings made use of the various modalities of 
referral slightly differently, although the distribution of cases between 
the settings was approximately similar. The 440 patients have been 
referred initially to one of the following group of specialties / 
departments, as a referral from their General Practitioner to the 
secondary healthcare provider:
- surgical (incl. General/ENT/Orthopaedic/etc.) 98 cases (22.3%);
- medical (incl. Cardiology/Geriatrics/etc.) 219 cases (49.8%);
- gastroenterology alone 123 cases (28.0%);
The modality of primary referral included the following services, 
available to both hospitals:
- Acute Admission 149 cases (33.9%);
- Elective Outpatients 185 cases (42.0%);
- Open Access endoscope 94 cases (21.4%);
 ^ Rapid Opinion Clinic (Neath setting alone) 12 cases ( 2.7%).
The two hospitals made use differently of the new clinical services 
created to serve the gastroenterological referrals - Neath Hospital = 62 
cases, vs. Morriston Hospital * 43 cases (x2 * 7.050, p -  0.008). The 
Appendix A 07  shows the distribution of cases between the two 
settings based on the modalities of referral and clinical services used. 
It appears that for the Neath General Hospital setting a larger
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proportion of cancer patients - 77 (37.0%) and 72 (34.6%) patients 
respectively - were referred almost equally to the medical and 
gastroenterological services, whilst for Morriston Hospital a larger 
proportion of referrals were channelled to medical services alone, 
nearly equally distributed between the Admission and Outpatient 
Clinic modality of referral - 142 (61.2%) patients (x2 ■ 25.727, p < 
0.001). It also appears (see Appendix AOS) that the overall preferred 
department for referral was the medical department, particularly for 
the age group of above 75 years of age (113 patients out of 199), whilst 
for the modality of referral the preferred one was admission for the 
older patients (above 75 years 44.22%) and Outpatients Clinic for 
younger ones (55 to 64 years of age 46.66%).
D. Speed o f Referral, Diagnosis & Submission to Treatment
Both of the hospitals made use of the new modalities of referral 
to channel the patients for a speedy resolution of their symptoms and 
to establish as urgently as possible the correct diagnosis and 
treatment. Since the interval of time taken by the patient to come 
forward for a consultation as well as the time spent for him /  her to be 
examined and staged within the secondary care sector are potential 
sources for delay in the management of these patients, I have next 
looked at what has been named as "delay intervals" (see Chapter V - 
Assumptions).
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a) Onset Delay
A certain am ount of time elapses until the patient, already 
symptomatic, makes his way to the general practitioner or family 
doctor. This longer or shorter interval of time, which extends up to the 
day of the first GP Examination, is defining the "Onset Delay" in 
Appendix A01. This interval is the most difficult period to be 
quantified in a retrospective analysis and therefore the assum ptions 
introduced in Chapter V apply very heavily here. Based on these 
assum ptions, the data collected from patients' records shows for the 
overall case mix a net prevalence of a 3 months onset delay; in other 
words the majority of patients have waited on average up to 3 m onths 
before seeking medical advice (Fig. 6.10 below).
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There was no difference in the Onset Delay between the patients 
diagnosed with involvement of different anatomical segments of the 
upper gastro-intestinal Tract: in the stomach group 64.0% of patients 
requested medical advice within 3 months of becoming symptomatic 
vs. 60.7% of patients in the oesophageal group (x2 = 0.463, p ** 0.490). 
Similarly, other variables such as: gender - 59.5% of females 
requested examination in the first three months against 64.0% of 
males (x2® 2.837, p -  0.829) -, age group (x2* 17.828, p * 0.811) and 
hospital setting, appear not to introduce any longer period of delay in 
seeking medical consultation with the general practitioner, although 
of note is the observation that the confounding groups are not 
comparable.
The relationship between the Onset Delay as an interval of 
delaying the presentation and the perceived prevalent symptom at 
presentation is difficult to assess due to the limitations of data 
collection imposed by the retrospective character of the study. In this 
case mix the first 5 major symptoms noted at presentation (see Fig.
6.05 above) - i.e. Dysphagia, Weight Loss, Abdominal Pain, Dyspepsia 
and Lethargy - were related to an Onset Delay of a minimum of three 
months in 42.04% of patients compared to an overall Onset Delay of a 
minimum three months in 62.95% of all patients (Pearson correlation 
= 0.309, p<0.001).
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b) OP Delay
This interval equates with the time past between patient's first 
presentation to the general practitioner and the actual referral made 
for further investigation. This is related with the capacity of the 
general practitioner to assess the severity of a patient's symptoms and 
decide the appropriate modality of referral. The overall mean GP Delay 
interval was 17.09 days with a median delay of 0 days (Std.Dev. = 
46.23). The age decade the patient belongs to is obviously a  significant 
diagnostic aid which should trigger a certain degree of diagnostic 
suspicion within the clinical context.
Age Group n Mean(days)
Median
(days) Std. Dev.
35 -44 9 40.88 8 71.27
4 5 -5 4 25 8.40 0 14.25
5 5 -6 4 60 29.68 0 66.49
6 5 -7 4 147 19.81 0 52.89
>75 199 11.31 0 31.71
Fig. 6.11 - "GP Delay" at various Age Decades 
The age group, together with other confounding factors shown earlier,
represent the only elements for guidance available to the general
practitioner when he/she may decide to adopt a route or the other for
referral purpose. Based on the combination of these factors the
clinical judgement will dictate the practitioner to adopt an emergency
route for referral or to adopt a more standard approach. Although the
majority of cases were referred straight to the secondary care sector
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for further investigation - median delay 0 days -, there is still a certain 
degree of delay in referral seen in certain age groups (Fig. 6.11 above).
Obviously, the general practitioner, based on his/her 
assessment of the case, may decide to issue the referral to one clinical 
service or another, using one method of referral or another. The table 
in Fig. 6.12 below shows the mean and median figures for the GP 
Delay interval relative to the various clinical services used and the 
modalities of referral employed to send patients to the secondary 
sector:
Clinical Service n Mean(days)
Median
(days) Std. Dev.
Surgical Dept. 98 15.44 0 38.83
Medical Dept. 219 17.17 0 51.68
Gastroenterology 123 18.26 0 41.40
Acute Admission 149 6.14 0 17.14
Outpatients Dept. 185 24.92 0 59.96
O AB 94 19.94 0 46.19
ROC 12 10.08 0 19.29
Fig, 6 ,12  - Mean & M edian “GP Delay*9 a n d  C linical Sendees
The GP Delay interval seems to be slightly longer for the oesophageal 
patients - in days: mean = 18.46, median * 0, Std.Dev. * 45.90 - 
compared with the gastro-duodenal localizations - in days: mean = 
16.43, median * 0, Std.Dev. -  46.62 -.
c) Hospital Delay
This is the time which spans between the dates of the general 
practitioner's referral letter to the first appointment the patient
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attends at specialist level. The "Hospital Delay" is actually the interval 
targeted by the "two week rule" in cancer services and reflects 
primarily the ability of the system to provide for the patient; also, in 
some cases at least, this may be influenced by the patient's incapacity 
to take up the first appointment offered. The overall mean Hospital 
Delay was 15.96 days and the median value was 11 days (Std.Dev. = 
18.68).
Variable n Mean(days)
Median
(days) Std. Dev.
Neath Hospital 208 16.73 13 17.91
Morriston Hospital 224 14.94 7 18.89
Other Hospital 8 24.62 16.50 29.81
Surgical Dept. 98 17.87 16 17.96
Medical Dept. 219 11.87 1 18.82
Gastroenterology 123 21.79 18 17.30
Acute Admission 149 1.44 0 6.57
Outpatient Clinic 185 24.37 20 19.81
OAE 94 23.17 18 16.26
ROC 12 10.25 9 4.99
Fig. 6.13 - Synopsis of the "Hospital Delay"
The table above (see Fig. 6.13) presents comparatively the mean
and median figures for the Hospital Delay interval with respect to the
hospital setting, clinical services and modalities used to refer patients.
The demographic variables did not introduce any significant changes
in the respective figures for the mean and median delay on this
segment. However, it appears that the elderly group of patients above
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75 years of age enjoyed the shortest Hospital Delay interval - mean = 
12.67 days, median * 6 days (Std.Dev. -  16.13) - when compared with 
younger patients of 55 to 64 years of age where this interval was 
nearly double - mean = 24.13 days, median * 17 days, (Std.Dev. = 
26.60) -.
It appears that the patients had their first appointment quicker 
at Morriston University Hospital and using the medical department. In 
respect of the method of referral used, the shortest Hospital Delay was 
accomplished by using Acute Admission and the Rapid Opinion Clinic 
respectively. As expected, the longest wait occurred for patients 
referred via an Outpatient Clinic appointment.
d) Diagnosis Delay
This interval mirrors the time required by the hospital to 
confirm endoscopically and histologically the positive diagnosis of 
Upper Gastro-Intestinal Cancer. Usually it is accomplished when the 
histopathological result is reported back by the pathologist. It follows 
that a number of days are automatically introduced for processing 
purposes. The overall "Diagnosis Delay" interval was surprisingly 
longer than expected - mean = 38.95 days, median * 10 days, 
Std.Dev. * 87.98.
Looking at each of the hospital settings, a quicker positive 
confirmation appeared to happen in other referring hospitals followed 
by Morriston and Neath settings; it also appears that a positive
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diagnosis was reached quicker in the gastroenterology department 
and using the Open Access Endoscopy method of referral. As 
expected, the delay to positive diagnosis was longer if the patient was 
referred via the Outpatients Clinic as a method of referral (Fig. 6.14 
below).
Variable n Mean(days)
Median
(days) Std. Dev.
Morriston Hospital 224 30.62 9.50 64.59
Neath Hospital 208 48.64 11.50 108.19
Other Hospital 8 20.12 0 31.28
Surgical Dept. 98 50.06 15.50 79.97
Medical Dept. 219 40.81 13.00 85.70
Gastroenterology 123 26.78 0 96.91
Acute Admission 149 26.18 8 60.41
Outpatients Dept. 185 63.29 22 116.20
OAB 94 13.34 0 38.92
ROC 12 22.83 0 55.61
Fig. 6 .14  - Synopsis o f  the  "Diagnosis D elay"
The Diagnosis Delay in conjunction with the demographic
variables showed that in the elderly group of above 75 years of age the
Diagnosis Delay was longer - mean -  42.78 days, median * 10 days,
Std.Dev. * 106.37 - than for the younger patients - mean -  19.66
days, median * 8 days, Std.Dev. -  29.44 In respect of the
anatomical segment involved in the malignancy process, oesophageal
tumours seem to be positively diagnosed quicker - mean * 31.21 days,
U P P E R  © A S7«04N TC 3744stA t C A N C E R i
O O  O U R  C U N 4C A L  3 G R W C C 3  W O R tt
7 Q W A R G 9  7 R S  *7W O WGGt? RULjG* A N O  H O W ?
*120*
Chapt& rVt: R esults: In terva ls da Itetays Serhan L Qh&orghiu
median -  8 days, Std.Dev. = 90.89 - than the gastroduodenal 
tumours - mean = 43.34 days, median = 13.0 days, Std.Dev. =86.37 -.
Based on the Lauren classification of carcinomas, it appears 
that the intestinal type of cancer took longer to be positively diagnosed 
- mean = 36.29 days, median =11 days, Std.Dev. = 73.69 - than the 
diffuse type - mean = 19.76 days, median = 7 days, Std.Dev. = 55.23 -. 
This appears to be linked more significantly to the gastric localization 
than to the oesophageal one (x2as 32.727, p<0.001).
e) Treatment Delay
This is the interval of time elapsed between the moment of 
established positive diagnosis of malignancy and the beginning of 
definitive treatment. It normally incorporates both the time taken for 
staging procedures and the delay in actually commencing the 
treatment itself.
Not all 440 cases were submitted to some form of treatment: 
140 cases (31.84%) were not given any form of treatment based on 
both their overall clinical picture and evidence-based appraisal of the 
stage of their disease and/or the patient's refusal of treatment, whilst 
222 patients (50.45%) were subjected to one form of surgical 
procedure or another. In two cases the positive diagnosis was 
established after definitive treatment provided in emergency 
conditions. The overall Treatment Delay for those patients treated in 
one form or another - 300 patients (68.16%) - as well as its synopsis
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for anatomical involvement as a variable is shown in table below (see 
Fig. 6.15 below):
Variable n Mean(days)
Median
(days) Std. Dev.
Overall Treated Cases 300 44.43 33.50 46.20
Surgical Cases 222 39.24 29 41.25
Chemo ± RxTh 78 55.50 49 37.88
Oesophagus 84 54.36 41 52.72
Gastro-Duodenal 188 38.97 28 41.50
Fig. 6.15 - Synopsis of the "Treatment Delay" (treated patients)
There was no significant difference (x2 ■ 25.536, p * 0.001) in the 
delay to treatment for both genders - mean -  38.42 days (Std.Dev. = 
50.29) for males and mean -  42.56 days (Std.Dev. -  52.35) for females 
respectively, but it seems that the younger group of patients were 
submitted to treatment much quicker:
Age Group n Mean(days)
Median
(days) Std. Dev.
3 5 -4 4 9 26.11 17 24.25
4 5 -5 4 25 41.90 34 32.53
5 5 -6 4 60 39.90 31.50 36.98
6 5 -7 4 147 49.66 38.50 52.86
>75 199 42.99 28 46.17
Fig. 6 .16-  “Treatment Delay99 and Age Decades (treated patients) 
Using the clinical services and the method of referral as
variables, it appears that the Treatment Delay was shorter when
patients were referred as a  targeted department of referral to the
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surgical department using an Acute Admission modality. However, 
there was no significant difference between hospital settings:
Variable n Mean(days)
Median
(days) Std. Dev.
Morriston Hospital 224 43.11 31 47.47
Neath Hospital 208 45.95 36 45.55
Surgical Dept. 98 37.38 26 36.43
Medical Dept. 219 42.20 28 54.03
Gastroenterology 123 52.03 42 39.24
Acute Admission 149 35.20 21 55.91
Outpatients Dept. 185 43.89 32 44.46
OAE 94 55.03 42 38.09
ROC 12 54.88 44 31.89
Fig. 6 .17  • "T rea tm en t D elay" and  C linical Services
The clinical stage of the disease -  that is the stage of the T after 
quantification of the Tumour at the staging procedures - was 
significantly linked with a longer treatment delay (Pearson %2 *
589.535, p -  0.001). It appears that advanced cancers waited longer 
for the treatment than early cancers - T4 tumours mean = 53.47 days 
- than early cancers - T0 tumours mean = 23.66 days.
f) NHS Delay
Some authors use, as a measure of NHS efficiency, the interval 
from the first GP examination to the moment the treatment has 
commenced; this is variably named in the medical literature but most 
authors agree with the term NHS Delay; indirectly, it may signify the 
delay introduced at NHS infrastructure level in submitting the patient
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to diagnosis and treatment. When taking into consideration the whole 
case mix, I found this global interval rather long - mean delay = 
117.88 days, median -  82 days, Std.Dev. -  115.34 -.
The overall NHS Delay interval for the 300 cases treated in a 
form or another was significantly longer for early cancers than for 
advanced ones - in the sample of 280 cases of carcinomas, 20 cases of 
non-carcinomas treated with surgery or /  and adjuvant therapy 
produced a mean NHS Delay of 191.60 days - although other forms of 
gastro-intestinal cancers had longer delays too it seems that the 
gastric localization required a longer mean NHS Delay interval (see 
Fig.6.18 below):
Variable n Mean(days)
Median
(days) Std. Dev.
Gastric Cancer 201 120.59 80 126.27
Oesophageal Cancer 97 113.27 91 93.41
Duodenal Cancer 2 101.50 101.50 109.60
Advanced Cancer 240 108.31 77 94.72
Early Cancer 36 144.81 95 163.66
Other Cancer 24 191.60 149 149.76
Fig. 6 .1 8  - S y n o p s is  o f  th e  "NHS D elay"
There was no significant difference between genders - mean 
delay * 117.13 days for males vs. mean delay -  119.31 days for 
females -, although again for Morriston University Hospital site the 
mean NHS Delay interval was significantly shorter (mean = 108.73 
days), than for the Neath site (mean * 127.79 days).
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Looking at the clinical services that the patients were 
channelled to, as well as to the methods of referral, it appears that 
referral to Gastroenterology as a service offered a shorter NHS Delay 
(mean delay * 110.88 days) than to the other clinical services; it was 
obvious that Admission as a method of referral offered patients the 
shortest route to treatment (see Fig. 6.19 below).
Variable n Mean(days)
Median
(days) Std. Dev.
Surgical Dept. 98 119.35 88 108.54
Medical Dept. 219 122.95 66 142.95
Gastroenterology 123 110.88 89 69.32
Acute Admission 149 66.67 33 98.72
Outpatients Dept. 185 155.47 109 136.41
O AE 94 109.37 86.50 67.50
ROC 12 101.88 52 78.12
Fig. 6 .19  -  “NHS Delayn com piled fo r  Services & R eferral M ethod
Before discussing the results mentioned above in the wider 
context of speed of referral and early diagnosis of upper gastro­
intestinal cancer, the data collected permits a general look to the 
issues of clinical outcome and survival for these patients.
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Chapter VII
R E SU LTS: OUTCOME &  SURVIVAL
Summary: Changes in the outcome are scrutinized in respect of
a few  variables such as staging of the disease, operability, recurrence 
and survival rates. Staging of the disease is looked at both from a pre­
opera angle, where only 36 cases are noted to be in the early stages, as 
well as from a post-operative perspective where in the carcinoma group 
only 21% of patients appear to have early cancers. It is noted that only 
222 patients were submitted to some form of surgical treatment, raising 
the crude operability rate in this series to 50.40%. Only 139 (31.59%) 
cases had radical surgery, whilst 168 patients (38.18%) were beyond 
any treatment means. Clinical records show only 92 patients (41.44%) 
with dear evidence of recurrence of the disease, although it is 
speculated that in many others the pattern of post-operative progression 
might also be suggestive of a recurrence. In this series the patients' 
survival, as a true measure of the implementation of clinical algorithms 
and services, is monitored as per current medical literature at 1 year 
and 5 years. It is noted that the overall 5 year survival rate is 15.06% 
and the mean survival is 472.87 days. Those patients who were 
referred to the gastroenterology department and had only surgical 
treatment as a method of definitive treatment yield the largest number of 
patients Hiring for more than 1 year and 5 years respectively.
Subheadings in this Chapter:
A. Staging & Treatment
B. Recurrence of Disease
C. Survival
It is expected that the innovative clinical services and the 
implemented methods of referral would have a certain impact upon 
the whole management of our patients diagnosed positively with 
Upper Gastro-Intestinal Cancer. The speed with which the patients 
have been eventually submitted to the referral process and open 
services appointments system may also have a certain impact in 
relation with their clinical outcome following investigation and
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treatment. When judging these outcome results, it is paramount to 
look at several factors that might define in a quantifiable manner the 
potential benefit triggered by the implemented services and referral 
methods; variables such as staging of the disease, operability, 
adjuvant therapy, recurrence and not least survival parameters may 
be considered quantifiable variables suitable for this purpose.
A. S taging  & T reatm ent
In this series of 440 patients, 416 cases (94.54%) presented 
with various forms of carcinomas; they were staged immediately after 
positive diagnosis according to the revised (1997) TNM1 classification 
of cancers adopted by the UICC. The pre-operative TNM staging of 
these 416 cases is shown in Fig. 7.01 on next page. In four cases the 
minimum set of staging investigations needed to determine the pre­
treatment values of T, N and M has not been achieved - therefore their 
stages were shown as stage X - all four cases belonging to the gastro­
duodenal group -.312 patients (75.0% in the carcinoma group) were 
noted to be diagnosed in stages not suitable for curative treatment; 
only 36 cases (8.65% of patients with carcinomas) could be labelled 
under the current standard as early cancers. Also, there were 24 
cases (5.45%) of non-epithelial cancers - 16 lymphomas, 4 carcinoid
1 TNM Classification of Malignant Tumours Sixth Edition, Union Internationale 
Centre Cancer (UICC), Geneve, Switzerland, Sobin,LH, Wittekind,CH, ISBN 0-471- 
22288-7
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tum ours, 2 melanomas, 1 sarcoma and 1 myeloma - and these cases 
cannot be staged under the TNM classification.
Pi
■ Not Staged
Esophagus Gastro-Ouodsnal TOTAL
Anatomical Segment
Fig. 7 .01  -  C arcin om as  -  P re-o p era tive  TNM S ta g e  D is tr ib u tio n  
In this series I found only 12 cases where the Multidisciplinary
Team (MDT) Meeting has agreed that pre-operative down-staging
adjuvant chemo-radiation therapy might be beneficial - 8 cases of
oesophageal tumours and 4 cases of gastric cancers -. In the
oesophageal group, 7 cases presented with the bulk of the tumour
within the lower third of the oesophagus and only one case within the
mid third. 11 cases were adenocarcinoma and only one down-staged
case was a squamous carcinoma of the mid-third of the oesophagus.
The following graph (see Fig. 7.02 on the next page) presents the
modality of treatment the patients were submitted to; in 222 patients
the surgical management of the disease was the chosen method of
treatment, giving a crude operability rate of 50.45%. Following
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surgery, 59 of these patients (26.57%) were submitted to further 
chemo + /- radiotherapy as adjuvant treatment.
Type of Treatment
■  No Treatm ent ■  Surgical only
□  Chemo ♦/- RadioTherapy □  Surgery * Adjuvant
Chemo +/- 
RadioTherapy;
50; 11.36%
Surgical only) No Tr. a tm . Bt|
163; 37.05% 168; 38.18%
Fig. 7 .0 2  -  O vera ll T rea tm en t M o d a litie s  
However, 168 patients (38.18%) were not deemed either fit for
any sort of treatm ent (48 patients - 10.90%) or not envisaged to have
gained any benefit other than symptomatic relief. In 50 patients
(11.36%) chemo +/- radiotherapy was the only method of treatment.
The treatm ent modalities applied to each anatomical localization
are shown in Fig. 7.03 on the next page. The localization of the
neoplasm at gastro-duodenal level made the patient more susceptible
to some form of surgery - 160 patients (57.85%) out of 280 cases had
surgery - compared with the oesophageal localization - 60 patients
(37.5%) out of 160 cases had surgery (Pearson x2 = 20.697, p = 0.002)
-. A larger proportion of the patients from the oesophageal group - 76
Surgery ♦ 
Adjuvant; 59; 
13.41%
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cases (47.50%) out of 160 - had no form of treatm ent compared to the 
gastric group - 92 cases (32.85%) out of 280 - This is largely due to 
the stage a t presentation and the age group association (%2 = 132.49,
p<0.001) .
Type of Treatment
• am to w i i l  iM a liza tiM  •
I
m&Bk
!■■■■■■
!■■■■■■!■■■■■■
TyfM «f Treatment 
^jSw §#ry* Adjuvant 
B oAeme RxTh 
S jjsu n p try  enly 
E S n* Treatment
Fig. 7 .0 3  -  T rea tm en t f o r  A n a to m ic a l lo c a liza tio n s
If we are matching the treatm ent method used for each of the 
anatomical parts of the oesophagus and stomach respectively (see Fig. 
7.04 below), a  pattern is noted by which the more the proximal the 
tum our is, the less likely would be the patient would be subjected to 
surgical + /- adjuvant treatm ent (Pearson x2 = 52.76, p<0.001):
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Fig. 7 .0 4  -  O eso p h a g ea l &  G a str ic  - S e g m e n t-re la te d  T re a tm e n t  
The distribution of patients who were subjected to surgical
treatm ent relative to their stage of the disease is shown in Fig. 7.05
(for the oesophageal group) and Fig. 7.06 for the gastro-duodenal
group.
Surgery
Per­
formed
0 I ila lib Ilia lllb IV X Total
no 2(2.0%)
35
(35.0%)
2
(2.0%)
11
(11.0%)
18
(18.0%)
32
(32.0%)
100
(100.0%)
yes 1(1.7%)
5
(8.5%)
29
(49.2%)
1
(1.7%)
10
(16.9%)
9
(15.3%)
4
(6.8%)
59
(100.0%)
Total 1(0.6%)
7
(4.4%)
64
(40.3%)
3
(1.9%)
21
(13.2%)
27
(17.0%)
36
(22.6%)
159
(100.0%)
(Pearson %2 =  18.67, p  = 0.005)
Fig. 7 .0 5  *  O eso p h a g ea l C a n cers &  th e ir  p re -o p e ra tiv e  TNM s ta g e  
74 patients (34.4%) of the 21§ non-surgical ones were in TNM
stages I and II of the disease or were non-carcinomas (7 cases). In the 
surgical group of 222 patients, 74 of them (33.40%) belonged to TNM
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stage III and IV as advanced cancers where curative therapy is not 
expected.
Surgery
Per­
formed
0 la lb II Ilia lllb IV X Total
no 2(1.8%)
13
(11.7%)
20
(18.0%)
17
(15.3%)
1
(0.9%)
57
(51.4%)
1
(0.9%)
111
(100.0%)
yes 3(2.1%)
20
(13.7%)
49
(33.6%)
38
(26.0%)
19
(13.0%)
14
(9.6%)
3
(2.1%)
146
(100.0%)
Total 3(1.2%)
22
(8.6%)
62
(24.1%)
58
(22.6%)
36
(14.0%)
1
(0.4%)
71
(27.6%)
4
(1.6%)
159
(100.0%)
(Pearson X2 = 68.88, p<0.001)
Fig. 7.06 - Gastro-Duodenal Cancers & their pre-operative TNM stage 
However, it appears that the elderly group of 74 years of age and
above was subjected to no treatment what-so-ever in 57,8% of the
cases, whilst the younger patients belonging to the decades of 55 to
74 years of age were subjected to some form of surgery in the
proportions of 75.0% and 55.1% respectively (x2 * 99.047, p<0.001).
From a gender standpoint, 77 patients (46.1%) from the female group
had no treatment against 91 patients (33.3%) in the male group. It
also appears that male patients - 140 patients (51.3%) - were
subjected more often to some form of surgery compared with the
female group where only 82 cases (49.1%) had surgery(x2 ■* 17.012, p
-  0 .001).
Chemo +/- radiotherapy as a form of palliation was given more 
often to male patients - 42 males (15.4%) - than to female patients - 8 
females (4.8%) -. In those 222 cases where surgical management was
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deemed beneficial, the following types of surgical procedures were 
deployed (Pearson x2 -  61.65, p<0.001):
Surgical T raa tm an t Typa
S egm en ta l Localization
No Surgery Palliative Non-Radical Radical TOTAL Surgery 
n«21S Surgery n«31 Surgery n*62 Surgery n>139 Performed
n«222
□ Duodenum
I Gaatrlc Antrum
I Gaatrlc Body
□ Gaatrlc Fundus
□ Total Stomach
□ Lower 1/3
□ Mid 1/3
I Upper 1/3
Fig. 7 .0 7  - T ype o f  S u rg ic a l P rocedu res P erform ed  
Mean corrected age for surgical patients was 68.80 and median
age was 69.50 (Std.Dev = 10.73). The procedures addressed gastro­
duodenal cancers in 162 cases (72.97% of the overall surgical 
episodes) and oesophageal localizations in 60 cases (27.02%). As 
expected, the operability was higher at younger decades - 77.8% and 
64.0% at the decades of 35 to 44 and 45 to 54 years respectively - 
rather than in the elderly people - 36.7% operability beyond 74 years 
of age -. The graph below (Fig. 7.08) shows the type of surgery 
undertaken with respect to the pre-operative assessm ent of the 
clinical TNM stage; it emphasizes the relationship between equivalent 
TNM stages in both oesophageal and gastric localizations ( 2 = 32.07, 
p = 0.022) and treatm ent strategy adopted. As expected, the more
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advanced the stage of the disease, the less radical the surgical 
treatm ent is.
Type off Surgory Performed  
TNM Stage Correspondence
iO
%
100%-r
80%
60%
40%
m  i MH
20%
Fig. 7 .0 8  -  TNM S ta g e s  &  T yp es  o f  S u rg ic a l P ro ced u res  
The postoperative pathological pTNM staging - i.e. the T, N and
M stage based on clinical "T", "N" and "M" grouping and concluded 
after definitive surgical treatm ent - is shown in the graph (see Fig. 
7.09 on the next page). Among the surgical cases, 17 (7.7%) were non­
carcinomas and they were not staged. Within the carcinoma group, 
the majority of cases - 145 cases out of 222 (65.30%) - were found in 
stages III and IV beyond potential curativity and only 21 patients 
(9.50%) were found with early cancers.
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Surgical C asas Only
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□ 0
Esophagus n«67 Qastro-Duodtnal n«14» TOTAL n-203 
A natom ical Sagm ant
Fig. 7 .0 9  - P o st-o p era tive  pTNM  S ta g e s  
In 66 cases (15.0%) included in the study some form of
palliation was used, other than surgical palliative resection or
adjuvant therapy. These forms of palliation were:
- Gastric by-pass - 1 case (0.2%)
- Gastrotomy 2 cases (0.5%)
- Dilatation 9 cases (2.0%)
- Stenting 54 cases (12.3%)
There were only 2 complications of oesophageal rupture with 
demise following stent insertion. Overall postoperative mortality - i.e. 
mortality occurring within 30 days following surgery - was 13.51% (30 
cases). For each anatomical localization of cancer the mortality was:
- operated oesophageal cancer - 10 cases (4.5%)
- operated gastro-duodenal cancer - 20 cases (9.0%)
Mortality in these cases was due to several pathological entities, some 
of them being a mirror of the background co-morbidities:
100%
90%
80%
70%
60%
50%
40%
30%
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0%
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- anastomotic leak 7 cases
- bleeding complications 5 cases
- cardio-vascular cases 13 cases
- pulmonary embolism 1 case
- infective causes 4 cases
Severe postoperative morbidity was noted in another 7 cases and was 
represented by:
- anastomotic leaks 
>  bleeding
- ischemic complications
- cardio-vascular complications -
B. R ecurrence o f  D isease
Recurrence of the disease is usually an indicator for the efficacy 
of the treatment received by patients in the appropriate stage of their 
disease, rather than a measure of how speedy the patient was passed 
through the healthcare infrastructure. However, due to the 
particularities of the neoplastic spread, often impossible to obviate, 
recurrence may sometimes represent an indicator of the early 
diagnosis and management of cancer; therefore, one could argue that 
recurrence may also represent an indirect mirror of the patient's 
speedy management when looked at in association with other more 
quantifiable variables, such as staging and operability. In this series 
only the surgical group of patients - i.e. 222 patients - in which a 
more or less radical exeresis of the cancer took place can offer 
quantifiable results related to the recurrence of the disease as an 
outcome factor.
3 cases 
1 case
1 case
2 cases
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Out of the 222 patients submitted to some form of surgery, in 
92 patients (41.44%) recurrence of the disease was eventually 
diagnosed a t some point in time during their follow up; their clinical 
records showed clear evidence of this fact based on various 
examinations and investigations. The mean interval between surgery 
and diagnosis of recurrence in these patients was 459.66 days 
(median = 318,50 days, Std.Dev.= 411.22). The rest of 130 patients 
subjected to surgery had no recorded evidence of recurrence 
diagnosed by clinical or para-clinical means, although some of them 
passed away peacefully in a m anner which was highly suspicious of 
recurrent disease.
R ecurrence Distribution - Histology
□ Other Types
■ Sarcoma
■ Lymphoma
□ Mixed Type
□ Duff use 
Type
■ Squamous 
Cell
■ Intestinal 
Type
No R scu rrsn cs R ecu rren ce
Fig. 7 .1 0  -  R ecu rren ce  D is tr ib u tio n  &  H is to lo g ica l T ypes  
It seems that for the follow up interval of time of 5 years that we
monitored the clinical records, the younger group of patients -
decades 35 to 44 and 45 to 54 years of age - presented with a lesser
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susceptibility of developing recurrence of the disease (14.3% and 
37.5% respectively) compared with the elderly group (41.1% of over 75 
years of age). The graph in Fig. 7.10 above presents the distribution of 
recurrence related to the histological type of cancer. In a bivariate 
analysis between the recurrence occurrence in the treatment group 
and various other factors, I have found no significant correlation 
between recurrence after treatment and the pTNM stage of the disease 
(Spearman's rho * 0.205, p<0.001), or chemotherapy alone as method 
of treatment (Spearman's rho -  0.178, p<0.001). It appears that the 
highest incidence of recurrence was observed in the cases of 
squamous cell carcinomas - 11 patients out of 15 or 73.3% - and the 
lowest for lymphomas - 3 patients out of 13 or 23.1% -.
Type of Treatment Total
Surgery only Surgery + ChemoTh.
No Recurrence 102(62.6%)
28
(47.5%)
130
(58.6%)
Recurrence 61(37.4%)
31
(52.5%)
92
(41.4%)
Total (ioo6o%)
59
(100.0%)
222
(100.0%)
Fig. 7.11 - Recurrences & Treatment Modalities
When looking at the recurrence rates within 5 years after 
treatment from the perspective of the main method of treatment (Fig. 
7.11 above), the cases treated only by surgical means recurred in 
proportion of 37.40% of cases compared with those who had chemo 
+/- radiotherapy associated to the clinical management, which 
recurred in proportion of 52.50% of cases.
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When the recurrence was suspected, the diagnosis of recurrence 
has been established using the following investigations:
Fig. 7.12 - Investigations for Recurrence Diagnosis 
The following table (Fig. 7.13) shows the treatment decided for
in these 92 cases where the recurrence of the disease has been noted:
Either the treated and non-treated groups of patients had their 
survival quantified both at 1 year and 5 years. The findings are 
presented below.
C. Survival
When introducing new clinical services or referral pathways for 
potential cancerous patients, the ultimate aim is to improve their life 
span. Survival length after early diagnosis and adequate treatment is 
therefore recognized as one of the most accepted tools for assessing 
oncological measures of diagnosis, treatment and palliative care. All 
patients introduced in the study were followed up as per current 
standard for 5 years. The follow-up period was closed for calculation
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Clinical exam 89 cases out of 92
Ultrasound 32 cases out of 92
Biopsy / Tissue Dg. 31 cases out of 92 
Endoscopy 27 cases out of 92
CT Scanning 21 cases out of 92
Barium Meal 4 cases out of 92
No treatment 
Palliative Treatment 
Surgical palliation
59 cases out of 92 
24 cases out of 92 
8 cases out of 92
Fig. 7.13 - Treatment of Recurrences
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purposes at 30th June 2004, or for earlier patients still alive, at five 
years from the date of treatment date which must have been 
coincidental with an Outpatients Clinic follow-up episode.
Two cases would have been introduced with negative values in 
the survival study - these cases refer to patients who were dealt with 
as emergencies and the positive diagnosis was established after the 
surgical event or necropsy respectively; for the purpose of breaking 
down the figures, although with little influence on the end result, 
these two cases were excluded and the total number of patients 
discussed for survival assessment was kept at 438. Since the patients 
in this case mix were followed up for 5 calendar years, the results 
concerning the patients’ survival will be presented for both 1 year and 
5 years, consistent with the current accepted pattern of reporting 
clinical oncological outcome.
In this series of 440 patients, there were 62 patients still 
alive (14.09%) at the end of the interval allocated for follow up - i.e. 5 
calendar years -. However, 66 patients survived a minimum of 5 years 
following treatment, making up a 5-year survival rate of 15.06%. At 1 
year following the treatment date there were alive 151 patients 
(34.30%) from all recorded cases) or 121 cases (54.50%) from the 222 
cases surgically treated. Following the null hypothesis of this study, it 
is noted that the mean survival figures for the uncensored case mix is 
varying with the method of referral used (see Fig. 7.14 below):
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M ethod o f 
R eferral n M ean Survival
M edian
Survival S td . Dev.
Admission 148 379.34 101.50 598.28
O utpatients
Referral
184 436.75 199.00 564.25
Open Access 
Endoscope
94 622.30 336.50 619.33
Rapid Poi- 
nion Clinic
12 743.91 711.50 616.18
Total 438 465.59 204.00 595.98
Fig. 7.14 - Mean Survival & Method of Referral
It is also noted, as per our expectations, that younger group of 
patients had presented longer survived intervals (see fig. 7.15 below): 
and the survival data were far better for the gastro-duodenal group of 
patients compared to the oesophageal group (see Fig. 7.16 next page):
age group at diagnosis mean(days)
median
(days) Std. Dev.
35 to 44 599.66 257.00 940.39
45 to 54 779.00 459.00 711.90
55 to 64 702.78 310.50 721.07
65 to 74 468.77 265.00 568.34
>*75 361.26 127.00 540.07
Overall 472.87 204.00 609.53
Fig. 7.15 - Mean & Median Survival for Age Decades
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O esophagus Gasitro-Duod<;nal
pTNM
Stage M ean M edian Std.D ev Mean M edian S td . Dev.
0 1189.00 1189.00 214.68 1584.66 1552.00 286.40
la 51.50 51.50 9.19 1193.61 1300.00 883.16
lb 1049.15 1016.00 721.25
Ha 932.29 1047.00 630.77 880.86 679.50 709.85
lib 460.20 199.00 481.11
Ilia 518.17 350.00 489.11 540.58 302.00 552.85
M b 228.80 181.00 231.44
IV 321.11 201.00 336.70 302.44 210.00 461.22
T otal 600 .87 350.00 554 .84 709.02 436 .00 702.96
Fig. 7.16 - Mean Survival @ pTNM stages
The overall mean value for survival following positive diagnosis 
of cancer was 472.87 days with a median of 204.00 days (Std.Dev. = 
609.53). The table in Fig. 7.15 above details the mean and median 
survival figures for various decades of age. It appears that the decade 
of 45 to 54 years of age enjoyed the longest survival, whilst the elderly 
over 75 years of age did not live much longer than a year, on average.
The overall survival figures at 1 year and 5 years following 
presentation or definitive treatment respectively are seen below:
interval n % of 438 cases
12 months survival from 1st GP examination 186 42.46
12 months survival from positive diagnosis 151 34.47
5 years survival from treatment 66 15.06
Fig. 7.17 - Crude Survival Rates at 1 year & 5 years
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A breakdown of survival figures at 1 year and 5 years for 
patients undergoing various forms of treatment is presented in the 
table below (Fig. 7.18).
Interval n
Survived days after:
No
treatm ent
Surgery
alone
Surgery
+
Adjuvant
Chem o +/- 
Radiotherapy
12 months 
survival from 
1st GP 
Examination
186 30 89 44 23
12 months 
survival from 
positive 
diagnosis
151 16 83 38 14
5 years 
survival from 
treatment
66 2 48 13 3
Fig. 7.18 - Treatment modalities & their Survival Ratio 
Surgical treatment and surgical treatment + chemotherapy yielded the
largest number of patients surviving beyond 1 year or 5 years from the
definitive treatment, respectively.
n
Age Group
3 5 - 4 4
(9
cases)
4 5 - 5 4
(25
cases)
5 5 - 6 4
(60
cases)
6 5 - 7 4
(147
cases)
>75
(197
cases)
12 months 
survival from 1st 
GP Examination
186 3 16 31 69 67
12 months 
survival from 
positive 
diagnosis
151 2 14 28 55 52
5 years survival 
from treatment 66 2 9 15 21 19
Fig. 7.19 - Survival Breakdown for Age Decades
There was however no significant difference in the numbers of patients 
surviving 1 year or 5 years respectively in relation to gender or 
hospital of origin. Patients belonging to the decade of 45 to 54 years of
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age seem to survive in larger number than the other decades for the 
same period of time (Fig. 7.19 on the previous page). The number of 
patients surviving at 1 year and 5 years respectively varies largely
subject to the method of referral used:
Survival n
Method of Referral
Adm ission
(148 cases)
O P D
(184 cases)
0  A E
(94 cases)
R O C
(12 cases)
12 months 
from 1“ GP 
Examination
186 43 86 50 7
12 months 
from positive 
diagnosis
151 41 60 43 7
5 years from 
treatment 66 17 23 22 4
Fig. 7,20 - Method of Referral & Survival
It appears that a larger number of patients survived at 1 year and 5 
years respectively when the referral was addressed to the Gastro 
Department - 68 cases out of 123 at 1 year after presentation to the
GP and 29 cases out of 123 at 5 years following treatment (Fig. 7.21):
Departm ent of Referral
Survival n Surgical
(98 cases)
Medical
(217 cases)
G astroenterology
(123 cases)
12 months from 1st 
GP Examination 186 39 79 68
12 months from 
positive diagnosis 151 31 61 59
5 years from 
treatment 66 13 24 29
Fig. 7,21 - Department of Referral & Survival
These are the overall (crude) figures and not corrected in any 
way for various confounding factors such as age, gender, anatomical 
segment, clinical department of referral, etc. Although the survival raw 
figures mentioned above are obviously influenced by other factors as
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well, such as stage of the disease, co-morbidities of the patients, 
treatment instituted, etc., they are not directly linked to the method of 
referral and speed of diagnosis which represent the hypothesis of this 
study. The survival ratios can however be corrected in the light of the 
above entities should one wish to quantify every aspect of the survival 
ratio. From the study standpoint though, the confounding factors 
were considered only those which influenced in a form or another the 
decision to refer the patient using one of the methods of referral and 
subject to the initial assessment made by the referent General 
Practitioner. As a matter of interest though, it appears that the 
survival at 12 months following the initial referral is not influenced by 
the site of the malignancy (Pearson x2 ■ 6.170, p ■ 0.046, Spearman's 
Coefficient = 0.048) or by the clinical pTNM stage (Pearson x2 = 8.770, 
p -  0.119, Spearman's Coefficient -  0.129). In case of the stomach 
localization, the clinical pTNM stage can influence the survival ratio at 
12 months (Pearson x2 “ 26.885, p<0.001) but the correlation is poor 
(Spearman's Coefficient * 0.070).
In the next chapter I will discuss the implications of these 
results and how they have been influenced by the clinical services or 
referral algorithms introduced specifically to improve these figures. It 
would also be interesting to see if the current model described in 
previous pages, with a dichotomy in diagnostic vs. therapeutic 
services can improve outcomes and whether it can be replicated to 
other healthcare providers.
3 R R G R  OASTRC H M JCSTtN AL GANCGR?
G O  G U R  C U N  t GAL 3 G R V tC G 3  WORK'
7 Q W A R G 3  7H G  *7W O WCCK R ltL C *  A H G  H O W ?
*145*
Chapter VU!
D ISCU SSIO N &  INTERPRETATIO N
Sum m ary: In this chapter I  am discussing the implications o f the
results found earlier. Firstly, the strength and w eakness o f the method 
and chosen model is scrutinized, the pros and the cons fo r adopting 
such a model o f inter-specialty collaboration are discussed and the 
validity fo r other health providers is favourably argued. Using this model 
reveals a continuous trend in the volume o f endoscopies performed 
without being followed by a similar trend in the rate o f cancers 
diagnosed. The interval o f delays are scrutinized and is found that their 
median figures are compliant with the "two w eek rule" in cancer services, 
but mean values suggest a number o f cases delayed due to 
unrecognized clinical presentation. The statistical analysis o f the 
presentation symptoms confirms the presence o f "alarm sym ptom s", but 
fa il to stigmatize any combination o f them as prevalent fo r cancer 
suspicion. There is certain benefit in using open access services as 
clinical setting which is demonstrated by slight benefit in operability 
ratios and probability o f survival. The open access services did not pick 
up either significantly more early cancers or improved better TNM ratios.
Subheadings in this Chapter:
A. Internal Validity
a. Neath - Morriston Model of Study
1) Epidemiological benefits
2) Structured healthcare benefits
3) Specialized staffing benefits
b. Overall Trends in Referrals
1. Gastroenterological referrals
2. Cancer cases
B. External Validity
C. Delays in presentation, referral, diagnosis and 
treatment
a) Traditional vs. Rapid Referral Pathway
b) Presentation - still the key to late diagnosis
c) Specialist care related delays
D. Outcome & Survival
Irrespective of their clinico-pathological particularities, Upper 
Gastro-Intestinal Cancers represent a significant pathological entity
U P P Z R  O A S T R a tH re s r tH A L . g a n g e r ;-
a a  G U R  G U N tG A L  3 G R W G G 3  W O R tt
7 Q W A R G 3  TNG  *7WO WEEK R U L G * A N G  H O W ?
*146*
Chapter VIU: Discussion & Interpretation Serhan L Gheorghiu
which is present with variable incidence and prevalence throughout 
the world and affecting generally people from all ethnic 
origins22;23;67:79:148. It is of undisputed notoriety that the incidence is 
higher in the Eastern hemisphere and somewhat smaller in the 
Western World, whilst in the African continent the incidence is quite 
low79.
Japan has overtaken the rest of the world in the rapid diagnosis 
of early stages of these cancers, as well as in respect of multi­
disciplinary management and survival rates for their patients. It 
appears that the secret for these survival rates, in excess of 90% at 5 
years in some specialised centres, is the diagnosis of early Upper 
Gastro-Intestinal Cancer, which in Japan exceeds 50% for TNM stages 
0 and I 18:43 in the majority of reports during 1990's. It is mentioned 
earlier that one of the ways by which the Japanese have achieved 
these results in the early 1990's was broadening patients' access to 
imaging and diagnostic facilities - i.e. one-stop centres, expansion of 
radiological, and more recently endoscopic services, with direct 
"access from the street", etc. -.
As a direct consequence of this early diagnosis, the 5-year 
survival rate in Japan can exceed 45%1S;79 for patients with early 
Upper Gastro-Intestinal Cancer; papers from some specialised centres 
- for instance Axon and Lambert cite in 1999 the Tokyo Cancer 
Institute reports - quote ratios close to 86% for T0 and Ti gastric 
cancers. In America the survival rates at 5 years varies between 7%
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and 22%35:79;112, whilst in the European Union these rates are between 
9% and 27% depending on the report and case mix2^ 7211011102; some 
other authors1011111 may even give figures of up to 54% for selected 
cases, depending whether the case mix refers to a hospital-based 
study or epidemiological population-based research. In a population- 
based statistic, the average European Union 5-year survival rate is 
13% in the EUROCARE I Study2*79, with a poorer figure of 5% for the 
oesophagus and 19% for the stomach. In the UK1;3;79 the relative 5- 
year survival rate is around the figure of 9% again with poorer values 
of 7% for the oesophagus and significantly better values for the 
stomach at 19%27. It appears clear that the survival expectancy in 
Japan is twice than the average Western world rate; this is mainly due 
to early detection of these cancers, although some other factors can 
contribute as well, such as: different biology of tumours, gender and 
age group distribution, more aggressive standardized care, etc. At the 
same time, Britain's survival figure at 5 years is lower than the 
average for the whole of Europe; however, patients in the UK with 
gastric cancer appear to have "a better deal" than their European 
counterparts.
Having said that, due to increased collaboration and 
standardization of care, almost all Western and Japanese authors are 
now reporting 5-year survival rates of over 90% for early gastric
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cancer - stages 0 and la under the TNM classification1 - if relative 
survival for these cases are considered alone43. Experience (backed up 
with research) shows that early cancer detection represents the key to 
better results. It has been reported that when the Japanese 
community-based system of identifying these patients and the 
subsequent Japanese surgical technique is applied to Western 
patients diagnosed with early gastro-intestinal cancer, the results 
appear to be similar in terms of outcome and survival90. It appeared 
logical under these circumstances to try to copy - or apply - the 
Japanese methodology in diagnosing gastro-intestinal cancer to the 
Western population, as a vector for diagnosing these cancers at an 
early stage. It is hypothesized that early diagnosis associated with 
oncological standardized care can identify patients in the early stages 
of their disease and therefore much fitter from a surgical standpoint 
and with higher chances of sustaining aggressive multifactorial 
treatment.
In the United Kingdom these cancers are considered a real 
problem for health care providers and medical professionals alike due 
to their late diagnosis, poor survival rates and financial implications 
for early diagnosis and comprehensive management. In a recent 
document issued by the Department of Health ^  the incidence of
1 TNM Classification of Malignant Tumours Sixth Edition, Union 
Internationale Contre Cancer (UICC), Geneve, Switzerland, Sobin,LH, 
Wittekind,CH, ISBN 0-471-22288-7
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these cancers in England and Wales is assessed as in the table below 
(Fig. 8.01). In Wales alone the total number of patients affected by the 
upper gastro-intestinal malignancy was in decrease during the 
previous decade, i.e. from 16259 cases to 15816 cases registered in 
1992114. According to the figures released by the Office of National 
Statistics in London, there appears to be a slight increase in the 
incidence of oesophageal carcinoma over the previous 10 year-period -
i.e. 1981 to 1990 - (from 9.8 to 13.8 per 100000 population) and a 
slight decrease in the incidence of gastric cancer (from 29.8 to 24.9 
per 100000 population)1:2:114.
L ocalization New cases P-a. No. p .a. /  100 000  popu lation
Oesophagus 5736 13.8(<J) /  9.0(9)
Stomach 10227 24.9(<?) /  14.7(9)
F ig , 8 ,0 1  - In c id e n c e  o f  U pper g a s tr o - in te s t in a l  c a n c e r s  (a d u lts  1 5  
years+  in  E n g la n d  &  W ales)40
This high incidence is associated with a high prevalence of the disease 
in the community, followed by significant economic costs, 
psychological implications for the patient and the family and 
pressures at every level of the NHS upon the medical staff responsible 
for the care of these patients.
Numerous attempts have been made, not least at political80 and 
professional5 level, to find ways to improve the speed of diagnosis and 
treatment for these cancers, as well as the outcome of the patients 
treated for these conditions. Observing the recommendations from 
NICE, many trusts have embarked on a relatively costly exercise to
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provide the adequate infrastructure to ensure compliance with the 
"two week rule" requirement for referral resolution and 62 days cancer 
waiting times from presentation to treatment of all referrals1 .
Observing the experience of these hospitals trusts in which 
clinical services were able to make use of general endoscopic direct 
access pathway and referral algorithms that were functional from the 
beginning of 1990's, the aim of this retrospective analysis was firstly 
to establish whether these services can achieve the target of the "two 
week rule" in Upper Gastro-intestinal Cancer and secondly if there are 
any clinical benefits for the patients' outcome that would follow the 
implementation of these services. To answer these questions it would 
be essential to find a model for the study that:
1. features all of the services and referral algorithms In question;
and
2. subject to clear benefits being noted, the infrastructure allocated
for these services could be replicated to other settings.
A. Internal Validity
Based on the established objectives set aside for this research 
and bearing in mind the potential epidemiological and infrastructural 
implications for the structure and design of future medical services, 
the chosen model had to reflect a populational area sufficiently 
representative and comprehensive enough in respect of services and 
methods of referral offered to the patients eventually diagnosed with
1 DoH 2001 - Cancer waiting times. Maintaining the "two week target", DoH, London
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Upper Gastro-intestinal Cancers. Such a setting must offer the 
general practitioners good guidance on patients' pre-selection for 
referral pathway, all the possible options for getting the patient 
investigated at the right speed in the secondary care sector, as well as 
supported services by all specialties that may influence the outcome 
study. By the same token, this model had to feature several other 
important elements such as: reproducibility, design based upon 
inclusion of all categories of gastroenterological patients, homogeneity 
of populational case mix, infrastructural similarities between sites as 
well as facilities for identification and follow-up of those patients who 
are diagnosed and treated within the same clinical setting.
a, Neath - Morriston Model of Study
In order to research the implications of the various modalities of 
referral upon the waiting times and their consequences upon the 
outcome of the patients with Upper Gastro-intestinal Cancer, I have 
chosen the case mix offered by Neath General Hospital and Morriston 
University Hospital; these are two District General Hospitals situated 
in South Wales (United Kingdom), along the M4 Motorway corridor 
and on the outskirts of the City of Swansea, which is the second 
major city in Wales. The area covered by the two hospitals offers an 
interesting socio-economic structure, containing pockets of favourable 
socio-economic deprivation index around the City of Swansea, as well 
as areas of high unemployment and poor income translated by a low
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depravation index around the towns of Neath and Port Talbot and 
associated with the declining opportunities offered by the scaling 
down of the local British Steel Industry.
At the time of the end of the study, i.e. 1999, both hospitals 
were part of the same Iechyd Morgannwg Health Authority1 as 
individual NHS Trusts and each one was serving a population of an 
approximately similar structure and volume; the NHS reconfiguration 
process beginning in April 1999, which changed the structure of 
trusts in Wales, did not affect the patients' flow and therefore did not 
influence the validity of the data collected within the study. In fact, 
the re-organisation of trusts in South Wales made the provision of 
gastroenterological services even more inter-twined than before: the 
acute surgical services were already established for years in Morriston 
University Hospital and the flow of the patients for out-of-hours 
service was known to everybody within the health establishment. As a 
bonus, even before the re-configuration of services and continued 
afterwards, the endoscopic team at Neath General Hospital was 
attending on a regular basis the Multi-Disciplinary Team meetings in 
Morriston Hospital where cases were debated and direct referrals to 
the Upper Gastro-intestinal surgical team were made.
The use of the Neath-Port Talbot and Morriston model presented 
me with several benefits which contributed to the homogeneity of the
1 IMH Iechyd Morgannwg Health Authority, 41 High Street, SWANSEA, SA1 1LT;
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dataset and as such, to the scientific validity of the collected data. 
Briefly these benefits are:
1) Epidemiological benefits
Both hospitals are situated in close proximity to each other; this 
means that the population within their catchment areas will tend to 
be homogeneous, based on cultural background, ethnicity and 
geographical access to health services; this setting allowed a thorough 
monitoring of the case mix, based not only on the Secondary Care 
sector access to medical records, but also the possibility to engage 
some population-based research methods through the use of the 
medical records from the local health care provider and the regional 
cancer registries. Some inevitable socio-economical differences can be 
perceived between the two settings at populational level, translated in 
different rates of the socio-economic depravation indexes6.
2) Structured healthcare benefits
Both hospitals had similarly organized services. During the 
interval of the study both units were running Acute Medical Services 
in General Medicine (i.e. medical & surgical emergency admissions) 
plus the usual Outpatients Clinics, based on the standard referral 
request open to practitioners from the primary care sector; also, both 
of the hospitals each had a dedicated gastroenterological team 
interested in Endoscopy and gastrointestinal malignancies, as well as
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a dedicated up-to-date Endoscopy Suite for diagnostic and therapeutic 
procedures.
Most importantly for the purpose of this study, both hospitals 
and both gastroenterological teams had from the early 1990's put in 
place, in a more or less formed manner, various modedities for 
patients' access to the diagnostic facilities; these modalities were open 
to all primary care practitioners to facilitate direct referral of their 
patients with gastroenterological symptoms in general and were 
assisted by algorithms for easy guidance. Essentially, these modalities 
were: One-Stop Clinics, Open Access Endoscopy and Rapid Opinion 
Clinics, although for some short interval some of them carried 
different names, such as Fast Track Endoscopy or One-Stop 
Endoscopy Clinic.
Since the beginning of the 1990's the setting in Neath General 
Hospital was one of the fewest in the country to establish in a more 
formal way both new clinical services as well as more structured 
clinical recommendations for the referral pathway of 
gastroenterological patients; these were in the form of guidelines to 
the primary care sector associated with proformas for structured 
reasoning of the referral (see Appendix No. A03 to A05 - Referral 
Proforma). As in many other UK hospitals, these guidelines, and 
particularly the proformas for referral, were designed to serve the 
population of gastroenterological patients in general and not the 
potential cancer patients in particular. Whilst Neath General Hospital
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employed these specific proformas in the process of accepting 
referrals, based upon guidelines and algorithms which were 
distributed in advance to local General Practitioners, Morriston 
University Hospital achieved, in essence, the same end-result for 
channelling its patients to the appropriate service, with the difference 
that the interpretation of the severity or association of symptoms was 
done at the hospital level rather than by the referring doctor. Also, the 
Neath General Hospital setting enjoyed a more formal infrastructure 
dedicated to these new services, in the form of support staff and IT 
infrastructure. Instead of this, Morriston University Hospital used a 
system of triage for channelling referrals based upon the perceived 
clinical severity of the described symptoms in the practitioner's 
referral letter.
It is also worthwhile to note that in both hospitals there were 
radiological services with similar technical facilities, staffing levels and 
direct access by means of referral from both the primary and 
secondary care sector, as well as a single Pathology Department which 
served both units.
And finally, to complete the similarities, it should be noted that 
during the time of this study both settings were linked with the same 
tertiary Centre for Oncology1 situated in close proximity and accepting 
all patients for assessment and necessary adjuvant therapy. The units
1 Cancer Treatment Centre, Singleton Hospital, Sketty Lane, SWANSEA, SA2 8QA;
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also shared the same network of voluntary services for palliative and 
terminal care: e.g. the Macmillan Nurses Service and The Hospice for 
the Care of Terminally ill patients.
However, there were some structural differences between the 
two settings, the main one being the loss of Acute Surgical Services at 
Neath General Hospital during the first part of the study, with the 
immediate transfer of all acute surgical intake to Morriston University 
Hospital; this change happened relatively soon after the starting point 
of the study - 1st October 1995 - and hypothetically was possible to 
affect a certain proportion of the patients' flow. The change in services 
provisioning did not negatively affect the inclusion-exclusion criteria 
issues, nor did it introduce further delays due to referral patterns.
The NHS re-configuration of services and health care providers 
in Wales, which began in the autumn of 1999 and changed the 
structure of the NHS Trusts in Wales, also had no effect upon the case 
identification criteria; logically however, the consequences of this 
change were probably diminished by the fact that the surgical team 
involved in the management of the patients with Upper Gastro­
intestinal Cancer was essentially based at Morriston University 
Hospital anyway and all multi-disciplinary conferences, other 
diagnostic facilities and inter-specialty consultations took place in 
Morriston University Hospital as well. The provision of all multi­
disciplinary oncological collaborative activities on one site had 
significant implications for the quality of care for cancer patients; this
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was beneficial not only in respect of the speediness of the decision­
making process, but also in respect of standardized care, adoption of 
algorithms for practice and educational purposes.
Another important difference between the two settings is related 
to the logistical organization of certain services, such as Open Access 
Endoscopy service and Rapid Opinion Clinic service in respect of the 
modalities of referral from the primary care sector and from within the 
hospital itself. Whilst Neath General Hospital had started a clearly 
structured Open Access Endoscopy referral service at the beginning of 
the 1990's and Rapid Opinion Clinic at a defined point in time during 
the study -  1st October 1995 -, with a dedicated, in-house produced, 
electronic patient record software1 and specifically designed referral 
algorithms for patients with sinister symptoms, Morriston University 
Hospital in contrast used a less structured approach but with much 
similar effects: the elective referrals were vetted by the
gastroenterological team and fast-tracked straight to the Outpatients 
Department or to the Endoscopy Suite, as necessary; this created in 
effect an Open Access Endoscopy service, but with the absence of 
dedicated referral algorithms and pathway of referral. There was 
however no Rapid Opinion Clinic service formally organised in the 
Morriston Hospital setting and the software to record the endoscopic
1 GeneCIS™ - Generic Clinical Information System, Authors: Hayley Dickinson, 
Jayne Morgan, University of Wales Swansea, United Kingdom
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episode was less clinically centred at the beginning, but adequate for 
timing purposes and diagnostic criteria.
3) Specialized staffing benefits
Patients attending, diagnosed and treated for Upper Gastro­
intestinal Cancer in both Neath General Hospital and Morriston 
University Hospital in broad terms had been assisted throughout the 
study period by the same surgical and oncological teams of 
specialists. This feature conferred uniformity to the dataset in terms 
of: algorithms of treatment, approach, criteria applied for selection of 
patients, expertise in staging and surgical management. As such, with 
only minor exceptions, all patients were dealt with by the same team 
in a Multi-Disciplinary Team type of approach:
- in more than 95% of cases the positive diagnosis and final histology result,
irrespective of the endoscopist concerned, was dealt with by the same 
pathologist who specialized in gastro-intestinal pathology; all of the 
specimens and reports were again reviewed by the same pathologist in a 
Multi-Disciplinary-Team (MDT) meeting together with the upper gastro­
intestinal surgeon, gastroenterologist and oncologist throughout the 
progress of the study;
- radiological support was provided by a radiologist with special interest in
Digestive Radiology, including radiological staging procedures such as CT 
scanning and Endoscopic Ultrasound;
- surgical assessment, surgical treatment and follow-up in more than 85% of the
cases was the responsibility of two teams of upper gastro-intestinal 
surgeons who performed nearly all the elective procedures; only in less than 
15% of patients the surgical team was different due to emergency work and 
work undertaken in Neath General Hospital before moving the Acute 
Surgical Services to Morriston University Hospital;
- the adjuvant therapy was decided, administered and assessed by the same
oncological team at the Swansea Oncological Centre in Singleton and
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closely linked with the surgical team through the collective Multi-Disciplinary- 
Meeting (MDT) and medical correspondence;
- supportive specialised medical, nursing and technical staff were used in all
settings and these were briefed whenever necessary about changes 
occurring in the algorithms and protocols;
- for the patients being in the terminal phase, palliative care was ensured by a
Hospice in close proximity to Morriston University Hospital and adequately 
staffed with support nurses and palliative care physicians;
- finally, the clinicians involved in the patients' assessment and care -
gastroenterologists, surgeons and oncologists - did maintain constant 
correspondence during follow-up with the patient's general practitioner 
responsible for each individual patient's care in the community.
However, there were several notable differences between the two
sites and these were related to the staffing level and expertise of the 
two gastroenterological departments: the Endoscopy lists in Neath 
General Hospital, including the referrals for Open Access Endoscopy 
and Rapid Opinion Clinic, were manned by two experienced 
endoscopists - one physician and one Fellow Research Registrar with 
interest in Endoscopy -, although the department as a whole and the 
outpatient clinics were conducted and monitored by a Consultant 
Gastroenterologist with concomitant Academic involvement. In 
contrast, the Endoscopy lists in Morriston University Hospital were 
provided by a Consultant Gastroenterologist and a middle grade 
endoscopist and, with rare input, by the Specialist Registrars in 
training in General Medicine allocated to the firm and constantly 
supervised throughout. The medical staff in both units were assisted 
by dedicated nursing staff with extensive training in running 
Endoscopy procedures. All these, together with regular circulation of,
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and easy access to algorithms and advice, made the differences 
between the settings minimal, whilst ensuring a constant increase in 
throughput of patients and maintaining appropriate safeguards for 
rapid diagnosis and staging protocol.
Based on the above observations, one can conclude that the model 
of two adjacent hospitals comprising two different teams of physicians 
endoscopists who can triage and process the referrals for primary 
diagnosis and with one single team of specialists responsible for the 
staging, therapeutic, follow-up and palliative care process may 
represent a homogeneous model; this model may be extremely 
beneficial not only in respect of understanding epidemiological issues, 
uniformity in management of patients and pathways of care, but also 
for retrieval and analysis of evidence-based data.
b. Overall Trends in Referrals
The possibilities for investigation of the upper gastro-intestinal 
tract have evolved over the years. These possibilities, generally 
speaking, address two large areas of upper gastrointestinal pathology: 
morphologic changes and functional disorders, with some degree of 
commonality between the two in a few of the clinical entities. In 
general it is accepted through consensus that any gastrointestinal 
diagnostic algorithm should always investigate firstly the potential 
morphological changes in the upper gastrointestinal tract; therefore, 
the Upper Gastro-intestinal Endoscopy has made recently significant
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in-roads in any algorithm of investigation. It is no surprise that the 
use of Gastro-intestinal Endoscopy has therefore extended in recent 
years, becoming the gold standard for starting the investigations in 
any patient with upper gastroenterological symptoms. It follows that 
any medical service in receipt of referrals of such patients would 
normally rely on this particular investigation to start off the diagnostic 
algorithm.
1. Gastroenterological referrals
For the period of time considered in this study - i.e. 01 July 
1993 - 30 June 1999 - both of the two hospitals offered an impressive 
case mix of patients with gastroenterological symptoms referred to 
their medical and surgical services. Although the referral reason was 
not always deemed to be related to an upper gastro-intestinal 
pathology, in the majority of cases the clinicians at the receiving end 
of the referral algorithm were convinced that some form of gastro­
intestinal investigation might be necessary. These hospitals made no 
exception to the general rule of investigating patients with upper 
gastrointestinal symptoms referred to their services and a huge 
number of upper gastro-intestinal endoscopies were performed in the 
two settings, as shown in Fig. 8.02 on the next page. Obviously, the 
procedures outlined below were required based on a very large range 
of indications, from simple dyspepsia to cases where the possibility of 
a gastro-oesophageal malignancy was strikingly obvious; these figures
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also include endoscopies as therapeutic indications for other 
pathologies, remotely related with the upper gastro-intestinal tract, 
such as insertion of Percutaneous Endoscopic Gastro-Enterostomy 
feeding devices or even endoscopic echographic investigations 
employed in the diagnosis of extra-gastroenterological pathologies.
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However, even under these circumstances, the concomitant potential
diagnostic yield for upper gastro-intestinal malignancy was significant
and these procedures may be included in the general pool of
endoscopic examinations for the purpose of cancer detection.
Obviously a number of endoscopies were repeat procedures in aid of
the initial diagnosis or follow-up and staging.
These procedures are, however, not symmetrically distributed in
time and locality between the two settings. The variable distribution is
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related not only with the provision of endoscopic services in the two 
hospitals, but also with the differences between the sites in respect of 
acute admissions, variability in disseminated guidelines to the 
primary and secondary care sector, as well as other infrastructural 
capabilities.
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For both hospitals, and particularly for Neath General Hospital,
several moments can be identified in respect of the introduction of
new services or reconfiguration of the current ones, as described
above. Considering the above events and matching the number of
endoscopies performed for each interval, there was an obvious
ascending trend in the overall num ber of examinations performed (Fig.
8.03). The graph on the previous page shows this trend in time; the X
axis refers to certain events, such as reconfiguration of acute clinical
services or introduction of new services.
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It becomes obvious that there is a progressive increase in the 
number of procedures performed in the two settings which equally 
mirrors the trend in referral pattern. This result was contributed to 
not only by epidemiological factors, such as ageing of population, 
increased local population or increased awareness elicited by the 
socio-mediatic factors, but also the disseminated algorithms of referral 
which guided general practitioners in deciding who should get referred 
for further investigations. It must be noted though that the increase in 
the number of procedures is not associated with any change in the 
infrastructure allocated for running these services.
The question arises whether the increase in the number of 
requested procedures would have any detrimental effect upon the 
overall speed of patients’ throughput; this may affect not only the 
Endoscopy service per se, but also related services such as radiology, 
histopathology, etc. The consequences of progressive surge in referrals 
based upon certain guidelines and the capacity of the infrastructure 
to absorb these referrals is not yet fully explored and only anecdotal 
evidence exists in this respect. Although this issue is outside the remit 
of this study, it is obvious that the relation between the 
infrastructural provisions offered by the health care provider and the 
volume of referrals needs to be explored further.
It seems at first sight that the increase in the number of 
endoscopies performed may offer a chance to pick-up more cancers; 
and not only that, these cancers may have the chance to be picked up
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at earlier stages than before. It follows that the trend seen in the two 
settings - see Fig. 8.03 on page 164 - might be followed by a similar 
trend in the number of cancer cases diagnosed, or indeed, a 
progressive lowering of the advanced cancers in favour of the early 
ones. Therefore I will be looking below at the cancer case mix alone 
offered by the two settings.
2. Cancer cases
During the exercise of identification and collection of data, a 
number of 440 cases have been isolated and their clinical details 
introduced in the database. The study was designed to collect data for 
an uncensored case mix during a six year period and, as a 
consequence, the cases were not filtered in respect of any variable. 
Observing the objectives and declared aims of the study, it was 
paramount to establish the independent factors to be monitored, as 
well as the confounding factors which would permit the correct 
interpretation of the results.
Since the objective of the study was the impact of the newly 
implemented methods of referral used in the referral pathway of those 
patients subsequently diagnosed with upper gastrointestinal cancer, it 
followed that the main independent factor would be the method of 
referral - i.e. Admission, Outpatients, Open Access and Rapid Opinion -. 
This would also mirror the real life environment whereby the General 
Practitioner would end up sending the patient to one of the hospital
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departments using one or another of the methods of referral described 
earlier, subject to his assessment of the patient’s case. Therefore, 
according to the design of the study, the results will need to prove or 
disprove the benefits of using the newly introduced methods of referral 
compared to the traditional ones.
However, from the General Practitioner's standpoint, the 
decision to refer patients suspected of cancer involves a process of 
taking account of several factors which, individually or in association, 
may raise the suspicion of malignancy. Since these factors represent 
the main instruments the practitioners have to hand during their 
decision process, it is worthwhile to consider these ones as 
confounding factors in establishing the homogeneity of my case mix. 
Thus, the main confounding factors are in my opinion the age of the 
patient and his/her dependence to an age group of recognized risk of 
malignancy, the gender of the patient, the anatomical segment of the 
upper gastro-intestinal tract involved - which is sometimes indirectly 
mirrored by the onset symptom(s) -, as well as a few other factors 
which could also influence the decision of the General Practitioner to 
use any method of referral, such as the hospital where the patient 
would be referred or the department o f referral.
Examining the cohort from the perspective of the confounding 
factors, it appears that there are significant differences between the 
allocated groups matching the referral methods. This is surely the 
consequence of using a case mix which, consequent to the method
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described in an earlier chapter, is not filtered in any form or shape. 
The question which arises is whether this lack of consistency of some 
of the confounding factors would alter the results and compromise the 
validity of my conclusions.
There are confounding factors such as mean age at presentation 
which are clearly limiting the consistency of the 4 referral method 
groups; it follows that I cannot draw any conclusions in which the 
factor age group might have significance for the speed of referral or 
outcome measures relative to the referral pathway. However, if the 
mean age at presentation is looked at from the perspective of a 
broader approach, such as the inclusion into age groups o f increased 
risk o f malignancy, it appears that this confounding factor is actually 
bracketed within the same age decade of 65 to 74 years of age, with 
the notable exception of the Admission group (mean age = 75.30 
years). Based on this cohort and from statistical standpoint, any 
conclusion which associates the age at presentation to a specific 
method of referral may need to be interpreted in relation with the age 
group the patient belongs to rather than the age of the patient itself. 
This does however have a connotation of practicality since, within the 
algorithm of referral, the age group the patient belongs to may be 
considered a confounding factor; in this cohort, the association 
between the age groups of malignant risk and the four methods of 
referral was consistent (x2 = 34.30, p<0.001).
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There are other confounding factors noted in this study which 
return consistent association with the four groups of referral methods. 
Both the hospital site where the 1st referral was made (x2 = 24.20, 
p<0.001) and the anatomical segment of the upper gastro-intestinal 
tract (x2 = 15.54, p = 0.016) appear to show only limited differences 
across the four referral groups. Since the hospital site as a 
confounding factor tests the healthcare provision in an area with 
direct implication to the referral pathway to be chosen by the medical 
practitioners and since the anatomical segment involved may 
indirectly test the patient’s clinical presentation, consistency of the 
association with the referral groups is paramount for the validity of 
my conclusions. A particular note must be added later in relation to 
the effect these confounding factors and their differences may place 
upon the outcome results, such as stage of the disease, associated 
treatment or survival.
One mention needs to be made in respect of the Rapid Opinion 
method; although the number of cases grouped under this method is 
quite small and suggest disparity, the statistical analysis would gain 
even more significance when the Rapid Opinion Clinic and Open 
Access Endoscopy groups are considered under a single spine as One- 
Stop method of referral.
The differences between the four referral groups are clearly 
obvious and have been highlighted above. In answer to the question 
as to whether these inconsistencies across the four groups of referral
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would compromise the study, one may need to take account of the 
fact that the study was designed from the start as a longitudinal 
observational study based on an uncensored case mix and the 
limitations of the data collection and interpretation process was set 
from the beginning. As such, there are set of results and areas of 
interpretation which may not be duly influenced by the inconsistency 
of the factors observed; I am thinking here at the global delay intervals 
and the stage of the disease at presentation and positive diagnosis. 
There are however other areas -  such as mean survival or even 
survival probability - which would be clearly influenced by the lack of 
comparable distribution of the case mix.
The cases of Upper Gastro-Intestinal Cancer diagnosed in the 
two settings during the six calendar years the study refers to did not 
follow the dynamics of referral pattern described above. In other 
words, there was no notable dynamic increase in the overall number 
of cancer cases picked up that parallels the increase in the number of 
referrals /  endoscopies performed. For example, for the Neath General 
Hospital site, with its more structured approach to referral pathway 
and clinical services offered, the number of cases diagnosed have not 
increased from period to period, as the graph below (see Fig. 8.04) is 
showing based on 6-monthly interval pick-up rate:
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However, the progressive increase in the total number of cancer
cases diagnosed subsequent to the increase in the referrals number
represents only one face of the coin; the other aspect, which is
extremely relevant to the substance of the present study, refers to the
possibility to diagnose a progressively increased ratio of "early"
cancers, i.e. more and more stage 0 and stage I cancers compared to
stage II to IV cancers as classified by the TNM system.
The case mix material highlighted above in brief offers a large 
pool of quantifiable data in respect of the number of patients, their 
clinical presentation, as well as the clinical services and referral 
methods used to diagnose their cancers. Because the main purpose of 
the current study is to assess the implications of new services and 
referral algorithms upon the speed of diagnosis and outcome of these
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patients, I will discuss next these implications in relation to the 
introduction of these services.
B. E xternal V alidity
There are however certain views that need to be aired in this 
context. There are advocates for this type of approach, based on the 
need to increase the input of skills and expertise in the management 
of these patients. It is easy to understand the need of a unified 
approach, in a multi-disciplinary manner, since the standardized care 
of these patients is far from being achieved and plenty of scope is still 
left for refining the management of the individual patient. Also, the 
management of these patients require certain specialized facilities, 
such as endoscopic and anaesthetic-surgical; the provision of these 
facilities is not always a ’’one-way street", but also requires the 
collaboration of the clinicians involved in the care of these patients. 
Finally, from a surgical perspective, it is much easier and beneficial at 
the same time to have all the specialists involved in the critical phase 
of patients' care on the same site.
There are however people who found certain disadvantages to 
this approach. One of these is of socio-political connotation, involving 
the decision to agglutinate many clinical services on one site; the 
consequences are that, in contrast with the expectations of population 
at large, some medical local infrastructural facilities would have to be 
slimmed down in favour of expansion of the main centre ones; this
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issue attracts criticism from those who advocate "a hospital on the 
doorstep", since the patients and their relatives would have to travel 
more to benefit from specialist services. Another criticism is the 
financial burden induced by the reconfiguration of services, with all 
that this expenditure entails: staff re-training and re-deployment, 
financial investment in infrastructure, change in communication and 
collaboration patterns between the primary and secondary care sector, 
expansion of local services to enable them to deal with increased need 
and/or magnitude of after care issues, etc.
The question arises whether this model is viable. Before seeing 
the evidence, it appears that many Health Authorities have already 
embarked on this direction27, based on financial and staffing 
constraints. Throughout the UK many acute services have 
agglutinated their work under the term "special interest" and therefore 
the patients' stream started to be guided towards larger centres. This 
way, specialist upper gastro-intestinal teams have been formed and 
the management of upper gastrointestinal patients started to become 
more structured and standardized43.
The qualitative and economical benefits of such a model for 
distributed specialised work are still to be seen; however, the situation 
is slightly different when scrutinizing its interaction with the 
diagnostic facilities and referral pathways. Here, the evidence started 
to trickle slowly into the medical press and seems to be related with 
the influx of patients towards the endoscopic services205119;136;159. The
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experience encountered at our two settings in South Wales showed 
without doubt a clear trend in increasing the number of referrals (Fig. 
6.02). Beside the issue of costs - although not within the scope of this 
study, I am aware of Delaney's findings39 that endoscopy is a cost 
effective method of intervention even for the management of dyspepsia 
in patients over 50 years of age the ever increasing trend in referral 
pattern may have a rebound effect on the speed with which the service 
is delivered and therefore negating the specific reason for which the 
open access services have been introduced; Jones et al.65 already 
found that, in general, urgent referrals treated under the "two week 
rule" have led to a doubling of the waiting time for routine cases.
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By the same token, Thomas149 argued that transferring
resources from routine cases to fast-track urgent referrals would be 
followed by ever increasing waiting times. When looking to the benefits
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of the new services for rapid diagnosis of gastro-oesophageal 
malignancies it is therefore important to take account of this reality as 
well. Based on the cohort of cases presented here, it appears difficult 
to endorse the above view. In an analysis of the mean intervals of 
delay encountered for all cancer patienls, the 6 monthly trend in delay 
increase is not immediately obvious. The graph (see Fig. 8.05 on the 
previous page) shows the variation and linear trend of the mean delay 
for the Hospital Delay, Diagnosis Delay and overall NHS Delay.
There was no evidence that the Hospital Delay encountered an 
ascending trend; this would normally be the interval which is facing 
firstly the effects of increased referral rates and the first to 
progressively change. Since the referrals sent to the open access 
service are not filtered and potential cancer cases are not clearly 
earmarked - although referrals are based on algorithms that suggest 
selection of "sinister" cases -, and because the incidence of cancer 
cases within the catchment area is not fluctuating largely for a given 
period, it was expected that the mean Hospital Delay would parallel 
the increase of the referral numbers. The cohort in this study does not 
support therefore the view that increased referral numbers associated 
with the "two week rule" for suspected cancer may be followed by a 
progressively increased delay to the first appointment at open access 
services.
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The same does not appear to be true for the Hospital Delay and 
the overall NHS delay to treatment inter-'J.s; here, there is an evident 
linear ascending trend, suggesting the increase in mean delay figures. 
Since these delay intervals refer only to the timing when the patient 
was fast-tracked within the specialist setting, this trend may not be 
explained by the increased throughput of patients in open access 
services; the patients suspected of cancer at hospital appointments 
were fast-tracked as per previous arrangements and there was no 
evidence that diversion of Programmed Activities took place in the 
timetable of the medical staff in order to support increased activity 
within the open access services. It is difficult to explain the basis of 
this progressive increase in mean hospital-based delays other than 
agreeing with Thomas and Burnet149 that diverting resources from 
routine activity might produce a discrepancy between demand and 
capacity offer with ever increasing waiting times. However, it is not 
less true that certain measures need be contemplated to deal with the 
eventual increase in demand on the open access services generated by 
other factors, such as population-based changes, dynamic changes in 
pathology, etc.
Based on the observations above I can conclude that the model 
chosen to investigate the waiting times, referral pattern, trends and 
outcomes in the management of the upper gastrointestinal cancer 
patients has sufficient strengths to be representative for the purpose
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and is robust enough to be able to replicate in other hospital settings 
in order to obtain the same results.
C. Delays in presentation, referral, diagnosis & treatment
Conscious of the discrepancies between Britain and the rest of 
the European countries in relation to the waiting times and post­
treatment outcome for some of the cancer localizations, the British 
government has promised a change in the approach to this issue. The 
targets set out in The NHS Cancer Plan 200080 for dealing with cancer 
pathology in general and waiting times in particular, introduced time 
constraints on the referral process and on the period taken for each 
patient to be submitted to definitive treatment. The NHS Cancer Plan80 
states in its preamble that "the ultimate goal is that no one should 
wait longer than one month from an urgent referral for suspected 
cancer to the beginning of treatment except for a good clinical reason 
or through patient choice"; also, The Governments White Paper40 
entitled "The new NHS - Modem, Dependable" guaranteed that 
everyone with suspected cancer will be able to see a specialist within 
two weeks of their GP deciding that they need to be seen urgently and 
requesting an appointment. In 2004, The National Institute for 
Clinical Excellence NICE recommended that all NHS cancer services 
should urgently consider the endoscopic services they provide as a 
tool in speeding up the cancer diagnosis sequence and expand them 
wherever necessary11.
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Therefore, the importance placed by various political and non­
governmental bod'ec on the waiting d  ^ :rsue becomes evident for 
every clinician, although there is only anecdotal evidence in the 
medical literature that reducing waiting times to the current target of 
the "two week rule' may bring any palpable benefit in staging and 
outcome for these patients.
Beside a huge number of medical reports concerning various 
methods of treatment and staging of the disease, the medical 
literature is quite scarce in evidential papers looking at ways to 
improve the early detection and speed of diagnosis for this particular 
group of patients, i.e. Upper Gastro-Intestinal Cancer patients. This 
fact is more evident in the United Kingdom where, due to historical 
reasons, the health care system seems to take more time in referring 
and submitting patients to the appropriate treatment. A quick browse 
of the work published in the last 10 years alone shows a net 
prevalence of papers 41;47;65;68;91;n?;124;149’158 dealing with the rapid 
diagnosis issues, early diagnosis or indeed the issue of the "two week 
rule" in cancer referral for many of the cancer localizations, such as 
breast, colorectal, etc., but with the notable exception of the gastro­
intestinal cancer. Based on the experience of the these two 
neighbouring NHS trusts described above, the following pages are 
designed to fill the gap noted in the lb/nature by referring to the 
gastro-intestinal cancer localization in particular and by assessing the
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efforts and results in these two trusts in complying with the "two week 
rule" in cancer services in South Wales.
The open access services described earlier were not initially 
designed to "filter" referrals for potential cancer cases, but this started 
to change once the available algorithms of referral were adapted to 
serve the more sinister pathology. Progressively, the concept of 
reducing the waiting time to conventional clinical services for 
gastroenterological cases at large has been overtaken by the need to 
speed up the referral process for potentially malignant cases. The 
trend we have noticed in these two hospitals was not singular in the 
UK; it was noted in approx. half of the hospitals by mid 1990's and 
some of them even started to use open access services offered to the 
general practitioners for identifying e a r l y  gastric cancer as Hallisey 
and Heatley59 wrote in 1993. Therefore, with the advent of the "two 
week rule" in cancer services, the two hospitals like many others in 
the UK, were ready to implement and at the same time monitor the 
implications of the required changes. It would be interesting to 
scrutinize how the two hospitals used the implemented services to 
address the ever rising needs of appointments for those patients with 
gastrointestinal malignant disease alone; the results shown earlier in 
chapters VI and VII will need to be interpreted according to the new 
requirements addressed to cancer sendees and establish whether 
these services can improve cancer detection without delay and if this 
is followed by improvement in outcome.
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a) Traditional vs. Rapid Referral Pathway
It is already known that the patients with upper gastro­
intestinal carcinomas are experiencing the progression of their disease 
in several phases, two of which are quite well demarcated: pre- 
symptomatic and symptomatic phases. Whilst it is agreed that the 
pre- symptomatic phase is longer, measured in years and difficult to 
obviate, unless targeted screening is employed, the symptomatic 
period appears much shorter in time and, more importantly, easier to 
highlight in a retrospective history-taking exercise. What is more 
obvious is that, once the symptoms appear, the patient becomes the 
main focus of the diagnostic algorithm; as a consequence, clinical 
records may be able to obviate, with more or less accuracy, certain 
events that mark the progression of the disease on one hand and 
diagnostic, staging, and treatment processes, where appropriate, on 
the other hand.
Certain landmarks in time are therefore present in the clinical 
history of each patient and may mirror various events such as: onset 
of symptoms, first presentation to the family doctor, referral to 
secondary care sector, first examination by the clinician, positive 
diagnosis, staging episodes, treatment and occasionally outcome 
related events. Placed on a timescale bar as in Appendix A01t these 
landmarks may identify several time intervals; they can be longer or 
shorter and in conjunction with the natural history of cancer
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progression could represent a potential delay in the patients' diagnosis 
and clinical management; it is on this basis that they were named 
"Delay Intervals". As a consequence they may be used to indirectly 
quantify the effect of the referral methods and clinical services 
introduced in the clinical practice to manage these patients. The 
definition and substance of these intervals is shown below (see Fig.
8.06) and graphically emphasized in Appendix AO 1:
Appendix AOl 
Mapping
Interval
Name Significance
1 Onset Delay
Time elapsed between occurrence 
of 1st symptom AND Presentation 
to the General Practitioner
2 GP Delay
Time elapsed between 
Presentation to the General Prac­
titioner AND Referral made by 
the General Practitioner
3 HospitalDelay
Time elapsed between Referral 
made by the General Practitioner 
AND 1st Hospital Examination
4 DiagnosisDelay
Time elapsed between l 8t 
Hospital Examination AND 
Positive Diagnosis
5 TreatmentDelay
Time elapsed between Positive 
Diagnosis AND Beginning of 
Main Treatment (where 
appropriate)
Fig. 8 ,06  - D efinition o f  Delay In terva ls
It is worth mentioning in the above context the following:
-  the "Onset Delay" mirrors the speed with which the patient comes forward to
seek medical advice;
-  depending upon the GP practice involved, the "Onset Delay" as an interval
may incorporate not only the delay related to the patient himself/herself, 
but also a longer or shorter period of time required for offering an elective 
appointment to the patient;
- on a retrospective basis it is quite difficult in the vast majority of cases to
isolate the precise moment in time when the first symptom occurred;
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therefore, it is more common to establish the length of this "onset delay" 
interval arbitrarily as blocks of time which may be more transparent to the 
patient when taking history and more certain to be found highlighted in the 
patient’s medical records;
- the "GP Delay" interval is larger than 0 days only when the general
practitioner did not refer the patient at the first encounter and recalled the 
patient after instituting some form of treatment;
- the "Hospital Delay" interval is always 0 days when the patient was referred
as an Acute In-Patient Admission;
- the "Diagnosis Delay" is always incorporating the necessary time to process
the histo-pathological diagnosis of the bioptic /  operative specimen; it can 
be 0 days only in emergency situations where a frozen section examination 
is employed;
- the "Treatment Delay" interval refers only to patients who were submitted to
some form of treatment such as surgical, chemotherapy, radiotherapy, 
stenting, etc.; it is always 0 days when patient had his /  her treatment 
administered as an emergency procedure;
- the "Treatment Delay" interval must incorporate the time elapsed after the
positive diagnosis which is used for staging procedures and examinations.
Before discussing the practical results of the introduction of referral 
algorithms and new clinical services in the two hospital settings, it is 
important to note that:
-  based upon the patients’ interaction with the healthcare infrastructure, the
above intervals can be consolidated in two global intervals that have been 
used by several authors90 to explain better the reasoning behind delays in 
presentation and clinical management of these cancers: Presentation 
Delay - attributable essentially to the patient - and NHS Delay - for which 
the health care infrastructure is assuming responsibility - (Fig. 8.07 on the 
next page);
- the referral algorithm which was disseminated to the general practitioners
and other hospital doctors aimed to guide the appropriate channelling of 
the patients to the most efficient service; it may influence the length of the 
interval 2 -i.e. GP Delay interval -;
- the new clinical services implemented at the two hospital sites may influence
interval 3 - i.e. Hospital Delay - by eliminating the potential extra time
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required by the patients to pass through the conventional clinical services 
such as Outpatients clinics;
Appendix A01 
Mapping Name Significance
1 Patient’s Delay
Time elapsed between the 
occurrence of 1st symptom 
AND Presentation to the 
General Practitioner
2 + 3 + 4 + 5 NHS Delay
Time elapsed between 
Presentation to the General 
Practitioner AND beginning of 
the definitive Treatment
F ig . 8 .0 7  - D e fin itio n  o f  G lobal D elay  In te r v a ls
-  irrespective of the method of referral used and the clinical services 
introduced', the time elapsed after the implementation of the main 
treatment defines the outcome period which historically is equated for 
these patients with survival interval; it is agreed by consensus in the 
medical literature to discuss survival at 1 year, 5 years and 10 years 
respectively. Sadly, this survival interval may end abruptly at any time with 
the demise of the patient due to recurrence of the disease or, in some 
occasions, due to other medical conditions. Only for statistical and 
calculation purposes I extended this inten/al to the end of the follow up 
date only for the patients still alive at that particular date.
I found the overall picture of these delay intervals as shown in table 
at Fig.8.08 on the next page. It is evident that neither the overall mean 
Hospital Delay nor the mean Diagnosis and Treatment Delay intervals 
complied in retrospect with the requirements of the "two week rule" or 
the requirements for commencement of treatment of a malignant case 
within 30 days from the initial referral. However, their respective 
median delay figures show that the majority of these patients were 
seen, diagnosed or treated respectively within the timescale imposed 
by the current required standards.
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In terval Mean(days)
Median
(days) Std. Dev.
“GP Delay” 17.09 0 46.23
“H ospital Delay” 15.96 11 18.68
“Diagnosis Delay” 38.95 10 87.98
“T reatm en t
Delay” 44.43 33.50 46.20
“NHS Delay” 117.88 82 115.34
Fig. 8,08 - Overall Mean & Median Delays
Out of the 440 patients with cancer I found, only 245 patients
(55.68%) were seen at the hospital level within two weeks from referral 
date; as a matter of fact, this figure includes 139 patients who were 
seen on the same day of referral made by the General Practitioner 
which implies that they were referred as inpatient emergencies.
On the same note, it must be added that, despite of distributed 
algorithms and availability of open access services, still a large 
number of patients were diagnosed using the outpatients referral 
modality: 42.0% of diagnosed cancers were referred initially to the 
Outpatients Clinic and only 21.4% were initially channelled to the 
Open Access Endoscopy. These figures may explain the length of the 
Hospital Delay interval as well as the differences in mean Delay 
figures between the various modalities of referral. The figures are 
reproduced in a statistical analysis for individual hospitals and 
various delay intervals; the results show that the Hospital Delay is 
longer than 14 days in Morriston University Hospital in 40% to 45% of 
cases and in Neath General Hospital in 45% to 50% of cases. It
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appears that the "two week rule" for referrals works slightly better in 
the Morriston University Hospital than in the Neath General Hospital.
I have also calculated for each method of referral the outliers to the 
"two week rule"; in a %2 test, the breakdown for cases seen beyond the 
14 days target interval is as follows:
-  for Acute Admission 6 patients out of 149 or (4.02%) seen after 2 weeks
-  for Outpatients Clinic 94 patients out of 121 or(77.68%) seen after 2 weeks
-  for Open Access Endoscopy 66 patients out of 185 (35.67%) seen after 2
weeks
-  for Rapid Opinion Clinic 3 patients out of 12 or(25%) seen after 2 weeks
In Fig. 8.09 below a comparative look to the mean and median 
values of Hospital Delay for various methods of referral reveals little 
difference between the Open Access Endoscopy and the Outpatients 
Clinic method of referral - mean delay = 23.17 days compared to 
24.37 days respectively -.
M ethod o f Referral n Mean(days)
Median
(days) Std. Dev.
Admission 149 1.44 0 6.57
O utpatien ts 185 24.37 20 19.81
Open Access Endoscopy 94 23.17 18 16.26
Rapid Opinion Clinic 12 10.25 9 4.99
T otal 440 15.96 11 18.68
Fig. 8.09 -  *Hospital Delay99 & Methods of Referral
Not all of the patients referred to the Open Access Endoscopy
were seen within the "two week rule" timescale and in fact the 
improvement comparative with the conventional method of referral to
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Outpatients Clinic was minimal. However, the median delay figure is 
11 days and this is below the required threshold for the two-week 
standard. However, if we associate the figures from the %2 test with the 
slightly lower value for mean Hospital Delay in the Open Access 
Endoscopy group compared with the Outpatients Clinic group, we 
may conclude that the cases seen after the two weeks deadline in the 
Open Access Endoscopy group had a shorter wait compared with the 
patients from the Outpatients Clinic group. This may signify that the 
Open Access Endoscopy, although not always complying with the "two 
weeks rule", may offer shorter delays for these patients compared to 
the more traditional referral method.
When taking account of the fact that the two sites had a slightly 
different mechanism of accepting referrals and Neath General Hospital 
had algorithms distributed locally to General Practitioners empha­
sizing the need for urgent referral, the figures above seem to be at 
least disappointing. The reasons behind the increased delay are 
difficult to identify. This picture may be explained by a number of 
factors, including patients' decision to attend appointments according 
to a timing suitable to them - for instance Flashman47 in 2003 quoted 
in his series a compliance for colorectal appointments to urgent 
referrals of only 91.68% for the "two week standard" -; another factor 
that might have prolonged the interval could indeed be the large 
throughput induced by the referral pattern which may clog up the
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service to certain extent with non-cancerous cases. Ultimately, this 
situation relates to the impossibility of distinguishing either an 
obvious sinister symptom and/or a combination of symptoms highly 
suggestive of malignant pathology which may ultimately guide the 
decision to refer to the appropriate service. There was no mechanism 
in place to verify whether the date given for an appointment was 
chosen by the individual patient or the appointment was scheduled 
based on filling up free examination slots within the session's 
timetable.
The Acute Admission method of referral was the second most 
used amongst the four methods (149 patients out of 440 or 33.86% 
and after Outpatients referrals for 185 patients or 42.0%) and offered 
the lowest mean Hospital Delay as per our expectations. It is expected 
that this method should be used for acute emergencies, even though 
in the case of the surgical department as a recipient for referral this 
may not mean automatic surgical management of the patient's 
condition. It is difficult to scrutinize the reasons behind an urgent 
referral or indeed to correlate the need for emergency admission with 
the recorded symptoms. This interval certainly correlates better with 
the Diagnosis Delay as it is expected that the patients using this 
referral method will be examined quicker - sometimes this is what is 
expected at local surgeries - and will have a positive diagnosis quickly 
established. Unfortunately this is not the case in this cohort of
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patients where the Diagnosis delay was longer for the Admission 
method (mean Diagnosis Delay = 26.18 days, median = 8 days) 
compared with Open Access Endoscopy (mean Diagnosis Delay = 
13.34 days, median = 0 days). This way I may explain what all medical 
practitioners may have previously thought: some patients are 
admitted and only their acute symptoms are dealt with, whilst 
investigation to reach a positive diagnosis may on many occasion take 
the conventional route through the Outpatients Clinic system.
It is only the Rapid Opinion Clinic method that complied with 
the required rule; this may be an endorsement of the need to have 
more precise referral criteria29;149, since patients were referred to this 
clinic with quite serious symptoms or complaints. When a balance is 
struck between the provision of service and correct interpretation of 
patients' symptoms based on accurate and updated guidelines and 
algorithms, the Rapid Opinion Clinic may be the example to follow in 
dealing with potential Upper Gastro-intestinal Cancer patients. High 
attendance rates associated with provision of service for "on the spot" 
upper gastrointestinal investigation may be the answer in reducing 
both the Hospital Delay interval and the Diagnosis Delay interval as 
well.
One can also question the benefit of the Open Access 
Endoscopy pathway, since the mean Hospital Delay difference is not 
so much reduced compared with the Outpatients Clinic pathway; in
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fact, the two hospitals were already operating in one way or another 
some form of Open Access Endoscopy at the time the study was 
commenced and local practitioners were already used to channelling 
patients via this quicker route of access to specialist care. This way 
the traditional long waiting time for outpatients appointments is not 
negated and the benefit of an open access service is re-endorsed. 
However, considering the report given by Spurgeon139 for the waiting 
times of gastric and oesophageal patients in a national retrospective 
survey, our figures are encouraging; for both stomach and oesophagus 
the urgent referrals were seen after a median delay of 9 days in our 
case mix comparative with a median of 10/11 days shown in the 
national survey. The non-urgent referrals are more difficult to assess, 
since the majority of the papers139 class them as outpatient clinic 
appointments and data for Open Access Endoscopy waiting time in 
the Upper Gastro-intestinal Cancer group of patients is difficult to 
identify; even so, our figure of median delay at first appointment of 18 
to 20 days is lower than the national average - median 24 and 27 days 
respectively -.
Another interesting aspect is related to the level of interaction in 
the grey areas between specialties. It is obvious from day-to-day 
practice that patients with certain suspicious symptoms are referred 
by their practitioner to various specialties or departments without a 
certain guidance being available. In this case mix there was a
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significant shift in referrals towards the medical referrals at the 
Morriston University Hospital site and approximately equal 
distribution at the Neath site between surgical, gastroenterology and 
medical departments respectively. I believe that this is a direct 
consequence of the profile held by each hospital and their recognized 
status for acute admissions. Since the Open Access Endoscopy lists 
were manned in the Neath General Hospital by gastroenterologists, 
the majority of referrals for the Neath site were addressed in this 
direction; in Morriston University Hospital the situation was different 
and the bulk of referrals were addressed to the medical department, 
most likely due to acute symptoms.
In fact the Hospital Delay was the shortest for Medical 
Department - mean = 11.87 days, median = 1 day - and the longest for 
Gastroenterology - mean delay = 21.79 days, median = 18 days this 
result is contributed to by the large number of emergency admissions 
that used this route for the first referral. Paradoxically, these figures 
appear to negate the benefit of introducing Open Access Endoscopy 
and Rapid Opinion Clinic services which traditionally are functioning 
under the umbrella of the Gastroenterology Department. However, I 
believe that this result is in fact related to the surge in acute 
admissions that the medical practitioners saw fit to request, which 
shifted the balance in favour of the Acute Admissions method of 
referral.
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This referral pattern may also explain why Morriston University 
Hospital complied better in a bivariate analysis with the "two week 
rule" - mean Hospital Delay = 14.94 days compared to 16.73 days for 
the Neath General Hospital - and endorses the opinion of Cann29 that 
the referrals under the "two week rule" or urgent ones should be made 
in a single pool of referrals, rather then in a departmental manner.
Another delay interval closely associated with the Hospital Delay 
interval is the delay in referral occurring at the General Practitioner 
level. I have noted that compared with the overall mean GP Delay 
value for this interval of 17.09 days and median = 0 days, the patients 
with previous digestive conditions were referred slightly quicker - 
mean GP Delay = 16.70 days - than those with surgical abdominal 
history - mean GP Delay = 34.14 days -. However, for the majority of 
the patients - 292 patients (66.4%) - the medical practitioner deemed 
necessary to refer the patient same day rather then attempting some 
form of treatment. I have noted another 110 patients (26.36%) who 
were not referred in the first 14 days after presentation and recalled 
for further examinations or even given some form of medication. One 
must assume that the symptoms elicited by these patients were 
atypical since they were not recognized at practice level. However, a 
ratio of non-referrals of 26.36% seems rather high when the medical 
practitioners were already alerted of the availability of the diagnostic 
fast track pathway.
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In a statistical analysis using the non-parametric Spearman's 
Rank Order Correlation it appears that the picture looks better for the 
Morriston University Hospital site - in 20%-25% of cases the GP Delay 
is more than 14 days - compared with the Neath General Hospital site 
- in 25%-30% of cases the GP Delay is more than 14 days However, 
the correlation is poor. These figures are particularly alarming since 
the Neath site had already implemented at that material time fully 
structured algorithms of referral and the patients belonged to the high 
risk group irrespective of presenting sinister symptoms or not.
The above picture may raise some questions with reference to 
the correct identification of patients for each referral pathway; since 
all the services were fully functional at the time of the case 
identification exercise and the patients suspected of cancer already 
benefited from priority in receiving appointments, staging and pre­
treatment assessments, one area that remains to be addressed is that 
of the symptomatic structure of patients' presentation and correct 
interpretation of worrying symptoms.
b) Presentation - still the key to late diagnosis
The patients in this cohort requested their consultation with the 
general practitioner after a long delay. This is not surprising, since 
many reports raise the same issue in relation with late diagnosis and 
poor outcome. 42% of our patients delayed their presentation for up to 
3 months whilst 6.1% of them for even more than one year. It must be
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stated though that, as a retrospective study based solely on data 
retrieved from medical records, the validity of these figures - some 
authors rate this to 40% and above - are questionable88. It is therefore 
difficult to make precise correlations with other variables such as 
staging or survival rate as the results may be quite imprecise. 
However, the onset interval may be substantiated as range of delays 
and correlated with a symptom or combination of symptoms the 
patients presented with.
I have looked at the range of symptoms the practitioners 
considered to be the most relevant for the individual patient's 
complaint. It appears that the first three most relevant symptoms are 
Dysphagia (309 cases), Weight Loss (219 cases) and Abdominal Pain 
(219 cases). I found it interesting to note that in the third position as 
frequency stands Dyspepsia (165 cases) followed by other worrying 
symptoms such as Lethargy (105 cases), Vomiting (42 cases) and 
Anaemia (36 cases). These symptoms are on the list of common 
symptoms in adult patients with cancer40 and have been endorsed by 
the British Society of Gastroenterology. In the referral letters we 
looked at the associated symptoms as well, since 311 patients were 
reported to present them. Interestingly, for the second line symptom - 
i.e. the symptom with less weight in doctors' referrals - we found the 
first five most frequent symptoms better correlated with the BSG’s 
guidelines. This aspect is difficult to interpret and the correlations we 
can make are very poor. We wonder if some of the symptoms do not
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“impress" the practitioners more than others or indeed the 
practitioners at large are not sufficiently aware of the possibility to 
judge the high index of suspicion for malignancy based on less 
prominent and obvious symptoms.
In this case mix dyspepsia was in the seventh position of 
frequency. I have decided to observe the combination of dyspepsia 
associated with one or more "sinister" symptoms since in the daily 
gastroenterological practice more than 30% of referrals are based on 
this symptom7*84; I found that in only 44 cases (10%) non-ulcer 
dyspepsia was present either alone (18 cases) or in combination with 
other less "sinister" symptoms; in these cases the suspicion of cancer 
was less obvious. Like many other authors107 I could not find 
dyspepsia alone an indicator for malignancy and in the majority of 
cases dyspepsia was either absent or associated with "alarm 
symptoms" which could trigger investigation of the gastro-intestinal 
tract on their own merits. Therefore, the question arises whether the 
referral should be placed under the "two week rule" or not.
In a non-parametric statistical analysis of the main symptoms I 
did not find sufficient evidence to suggest that more weight should be 
put on a certain combination of symptoms that might be more 
suggestive of malignancy. However, there are many authors14;32;54;79 
who are strong advocates for using dyspepsia as a triggering marker 
for endoscopy, even when it appears unassociated with other 
symptoms, but occurs in high risk age groups. Since the majority of
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our patients were above the age group of 45 I have to agree from this 
point of view with the opinion of Lambert79 that endoscopy is promptly 
recommended for dyspepsia in patients over 45.
One interesting aspect observed was the combination of 
previous abdominal history and onset of symptoms. I have noted in 
our case mix a number of 165 patients (37.5%) who had past medical 
history such as gastroenterological disorders of benign type (i.e. 
Barrett's, gastro-duodenal ulcers, GORD, etc.), abdominal surgical 
events (i.e. cholecystectomies, gastrectomies, hysterectomies, etc.) or 
other abdominal conditions or general diseases with abdominal 
expression.
I have compared the Onset Delay interval in these patients with 
the overall figures. Whilst the overall figures show that roughly 73% of 
patients presented to their doctor for consultation within the first 
three months of the clinical onset, in cases of patients with pre­
existing or past abdominal medical conditions these figures were 
significantly lower: those patients with previous surgical abdominal 
events presented within three months from onset in proportion of only 
57.2% of cases and those with pre-existent gastroenterological 
conditions presented within the same interval in only proportion of 
68.6% of cases. The patients with other conditions in their past 
medical history and previous symptoms related to the abdominal 
cavity had a higher than average threshold of presentation within 3 
months of onset (87.5%). These figures may suggest that the threshold
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for triggering a request for consultation might be more elevated in this 
group of patients than in the overall population who did not 
experience digestive and/or abdominal symptomatology earlier in life. 
The fact that the threshold of consultation request was much higher 
for patients with abdominal and/or digestive conditions may confirm 
that the patients in this group may know how "to live with the 
symptoms" and may distinguish with greater difficulty the change in 
the pattern of symptoms. This effect may also be affected by the self- 
medication issue so much discussed in the literature in conjunction 
with the delay in presentation.
In a x2 test analysis for past personal medical history and pre­
operative clinical TNM staging, I have found that for those patients 
with other previous abdominal conditions the stage of the disease was 
much more favourable but the correlation was poor (Pearson x2 = 
4.843, p = 0.184):
- 16.7% of patients with other medical history had early cancers
- 8.2% of patients with previous gastroenterological history had early 
cancers
I searched this case mix for any correlation between the prolonged 
Onset Delay interval and other variables. I did not find any correlation 
between the length of the symptomatic interval before presentation 
and stage of the disease; irrespective of the length of onset, there were 
approx. 7.4% of patients with early cancers in each range of onset 
interval, suggesting that for this length of delay there is not enough
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evidence for disease progression. This seems to endorse the view78 that 
it might take at least a year of progression for the malignant tumour 
to induce symptoms.
Not even in terms of operability the Onset Interval had statistical 
significance. A %2 test did not show any significant association 
between the Onset Delay and the type of operation performed, be it 
radical, non-radical or palliative. Operability was the highest when the 
Onset interval was recorded at less than 24 hours (20% of cases) - 
most likely this is related to emergency surgery - and smallest when 
the length of this interval was less than 1 month. The results confirm 
the impression of many authors that the longest segment of delay in 
the management of these conditions occurs before the patient is 
referred to the hospital. Although I have not been able to quantify 
accurately the presentation delay the patient is responsible for, there 
is strong indication that our case mix would match the opinion of Sue 
Ling et al.90 who found that the pre-hospital delay accounts for more 
than 50% of the patients' cancerous history?
c) Specialist care related delays
Normally the Diagnosis Delay and Treatment Delay intervals are 
not influenced directly by the methods of referral in use at the two 
hospital sites, nor by the pattern of referral from General Practitioners 
to one department or another. However, in this model of two hospital 
sites used for the diagnostic side of patients' pathway and a
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subsequent one hospital site with convergent surgical and oncological 
pathway for the therapeutic side of patients' management, some 
delays may occur if the referral pattern has changed and more 
patients are using the admission method or the surgical department 
as a choice of referral. Having said that, in normal circumstances the 
number of cases addressed by the Upper Gastro-Intestinal Surgical /  
Oncological team does not explain any major delay in managing these 
patients. The delays are generally explained by the infrastructural 
deficit as a whole rather than pressure coming from this group of 
patients alone.
In this cohort of patients the mean Diagnosis Delay was rather 
long at 38.95 days. However, a median delay of 10 days is quite 
acceptable since the majority of the patients had a positive diagnosis 
within this timeframe. It is difficult to lower further this delay interval 
as time is needed for tissue diagnosis - i.e to process the bioptic 
specimens and read the slides -. Examining the method of referral I 
was pleasantly surprised to see that the Open Access Endoscopy was 
the method of referral to allow the quickest positive diagnosis (mean 
Diagnosis Delay = 13.34 days, median = 0 days). However, the 
prolongation of this Diagnosis Delay is linked in most circumstances 
with false negative results which warrant a repeat of the endoscopy. 
This is surely an area where improvement in skills and training can 
bring the delay down further.
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Surprisingly I found the Diagnosis Delay longer at the Neath site 
(mean Diagnosis Delay = 48.64 days, median = 11.50 days) compared 
with the Morriston one (mean Diagnosis Delay = 30.62, median = 9.50 
days); comparing the diagnostic delays between the two hospital sites 
I have noted that within the 10 days timescale for the Neath site only 
49.04% of allocated patients were positively diagnosed whilst at 
Morriston University Hospital 51.79% of allocated patients were 
positively diagnosed; since the same pathology department was 
processing the specimens on both sites, I find it difficult to interpret 
this finding. One explanation could be related with the increased 
number of false negative biopsies delivered. It must be added that the 
10 days interval is arbitrarily chosen and is related only with the time 
needed to process the tissue samples.
Another explanation is related to the algorithm used for 
establishing the positive diagnosis. Since the current standard is that 
one of a tissue diagnosis, any other attempted method to refer and 
diagnose these patients through alternative methods may only prolong 
the Diagnosis Delay interval. I was not surprised to observe that, in 
spite of having referral algorithms distributed widely as well as the 
knowledge that the local Radiology waiting list was quite long, 107 
cases (24.31%) were referred to Barium Meal as a first line 
investigation and even more than that. 15 cases (3.40%) were 
examined only through clinical examination. The table in Fig. 8.10 
below shows the Diagnostic Delay interval for each type of the first
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examination the patients were subjected to when attending the 
hospital setting for the first time; it must be added that the first 
examination is the one the patient attended irrespective of the method 
of referral employed and reflects how the medical staff - General 
Practitioner or Specialist Hospital staff - considered to investigate the 
patient.
F irs t Exam ination 
requested  @ Hospital n
Mean
(days)
Median
(days) Std. Dev.
Barium Enem a 3 63.00 55 20.22
Barium Meal 107 41.03 19 63.97
Endoscopy 299 30.98 6 86.37
Clinical Exam 15 163.20 97 168.17
Abdominal U ltrasound 12 66.25 13 84.99
Laparotom y 4 12.75 5 17.15
Overall Diagnosis Delay 440 38.95 10 87.98
Fig. 8 .10  -  “D iagnostic Delay” & 1st investiga tion  requested
The table shows clearly the extent to which the Diagnostic Delay 
interval is prolonged simply by abating from the distributed 
guidelines. For an overall mean Diagnostic Delay of 38.95 days, 
simply by using Clinical Examination alone extends the positive 
diagnosis moment to 163.20 days and by choosing Barium Meal this 
interval extends to 41.03 days. A Chi-Square test (%2 = 9.57, p = 
0.002) shows that:
- 20% of cases examined by clinical exam only were early cancers
- 4.6% of cases examined by Barium Meal were early cancers
- 9.7% of cases examined firstly by Endoscopy were early cancers
U P P E R  S A S J R O m J E S J U N A U  G AN G ER?
G O  O U R  G U N iG A L  S E R V IC E S  W O R K
J O W A R G S  TH E  *?W O W E E R  R U L E "’ A N G  H O W ?
' 2 0 0 '
Chapter VIII; Discussion & Interpretation Serban  I  G heorghiu
All these situations, as well as a few cases where ultrasound or 
Barium Enema was the first line examination based upon patients' 
symptomatology, have prolonged the positive diagnosis interval. There 
is anecdotal evidence that some hospitals may enjoy a shorter 
radiological waiting list; however, there is wide spread agreement that 
for gastroenterological symptoms Upper Gastro-Intestinal Endoscopy 
is the investigative method of choice.
There is a progressive increase in the Treatment Delay from the 
35 to 44 years of age group upwards. However, it must be stressed 
that a number of patients, particularly the over 75 years of age, would 
fall outside the bracket imposed for this interval and this relates 
mainly with the staging and medical assessment investigations which 
are required for the surgical /  oncological management, where 
necessary. On a bivariate analysis of the Treatment Delay, I found no 
correlation between the Treatment Delay interval and the method of 
referral.
A note must be introduced about the global delay interval 
named by many authors as the "NHS Delay". This offers a more 
general view on the speed with which the patients are diagnosed and 
treated, without offering details as to where the bottlenecks are. In our 
case mix the NHS Delay interval was quantified for treated patients 
only and offered a slightly higher ratio than expected: mean NHS 
Delay = 117,88 days, median = 82 days for overall treated patients
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and mean NHS Delay = 105,52 days, median = 71 days for surgical 
patients alone. The significance of these figures is two fold: firstly, 
once presented to the General Practitioner, the patients are waiting 
much too long to have their treatment commenced; secondly, surgical 
patients are waiting shorter time than average, meaning that the 
bottleneck is related to the oncological services.
Many authors29;47;149 coming from a variety of specialties argued 
that based on clinical evidence the resources may be more effectively 
targeted at reducing the waiting times from diagnosis to treatment 
rather than reducing the time from referral by the general practitioner 
to diagnosis. There are a multitude of studies centred on the waiting 
times assessment and compliance with the "two week rule" in cancer 
services. The majority of these belong to certain subspecialties which 
benefited from structured screening programs, such as breast66; 106:138 
or colon465157. Very little evidence is found related to the investigation of 
waiting times and "two week standard" for cancer services in relation 
to the upper gastro-intestinal pathology.
D. Outcome & Survival
There are a few other variables that I looked at briefly when 
discussing the Diagnosis and Treatment Delay. These are only 
tangentially related with the scope of this study and are used mainly 
for quantification of the possible consequences of using the new 
methods of referral and algorithms presented in earlier chapters.
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Some of them have been indirectly discussed in the results part of this 
study and refer to pre- and post-operative stage, operability, etc.
The clinical TNM stage of these patients is one of the most 
important indirect tools in assessing whether the algorithms and the 
new referral methods have made any improvement in the way our 
patients had a positive diagnosis earlier during the natural history of 
their disease. Should these clinical services make any inroads into the 
early diagnosis of upper gastro-intestinal cancer and pick up an 
increased number of early cancers, one would expect to find the 
early/advanced cancer ratio tilted in favour of early cancers. Based 
upon the clinical T component of the TNM classification I found an 
early/ advanced cancer ratio 0/36/376=0.095. It is obvious that this 
ratio is very unfavourable from prognosis point of view and compares 
much less favourably with other reports available in the medical 
press 10;62;72;9°. If the prognosis of these patients is to improve, this 
figure should increase dramatically towards the unit, which is roughly 
where the Japanese expertise is at best these days.
I have also looked at the dynamics of the early/ advanced cancer 
ratio using a %2 test and tried to identify whether the new services 
have made any difference between the first year and last year of the 
study. Whilst in the first year the ratio was 0.16, in the last year this 
ratio diminished to 0.12 (Pearson %2 = 10.69, p = 0.469). The 
correlation of the test however was poor. The same picture applies if 
we look at the variable T of the TNM stage alone. It appears that in the
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last year of the study the proportion of cases picked up in stage T3 and 
T4 were more frequent than in the first year (80% compared to 54.2%).
In this cohort of patients 12 cases were submitted to down- 
staging radio/chemotherapy - 8 of oesophageal origin and only 4 of 
gastric topography. An analysis of the outcome of these cases shows 
that the pre-operative /  postoperative correlation was favourable only in 
three cases, all of them referred as Open Access Endoscopy referral 
method: one was converted from TNM stage I to stage 0 and two cases 
from TNM stage III to stage II; however, in the rest of 9 cases there 
was either no effect noted - one remained in TNM stage II and two 
cases remained in stage III - or progression of the disease was 
observed from TNM stage II to stage III in 5 cases. The result of 7 out 
of 12 cases with no effect or positive effect is encouraging but the data 
in the literature is so heterogeneous due to different trials and their 
interpretation in this case mix makes a valid conclusion impossible.
Although a comprehensive analysis of the surgical management 
of these patients is beyond the remit of this study, I would mention 
only a few facts related with the surgical outcome as part of our 
quantitative assessment of the services and methods of referral used. 
Beside the operability issues mentioned above, it is sufficient to point 
out that the 222 cases were subjected to the following types of 
surgical procedures:
- palliative procedures - 53 cases
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- non-radical procedures - 30 cases
- radical operations - 139 cases
The ratio of radical procedures of 31.55% of the whole 
uncensored cohort (or indeed 62.61% of all 222 cases deemed suitable 
for some sort of surgery) is quite high compared with the standards 
seen in the medical literature. It is obvious that this situation refers to 
an uncensored cohort of patients; the figures therefore cannot be 
compared with those from specialised centres in a “like-to-like” 
m anner where both referral pattern and standardized aggressive 
approach may be different. In a x2 cross-tabulation test (see Fig. 8.11 
below), although with a poor correlation, the cases referred through 
Open Access Endoscopy and Rapid Opinion clinic had a higher 
chance to be subjected to a Radical procedure (x2 = 33.63, p < 0.001):
Typo of Surgory and Mathod of Roforral
100%
A d m is s io n  O u t p a t i e n t s  O pan  A c c a s s  Rapid Opin ion
Clinic E n d o s c o p y  Clinic
Method of Roforral
Fig. 8 .1 1  - S u rg ica l T re a tm e n t &  M eth od o f  R eferra l D is tr ib u tio n
- 73.5% of 68 patients referred to Open Access Endoscopy had Radical 
operations
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- 71.4% of 7 patients referred to Rapid Opinion Clinic had Radical operations
- 57.6% of 85 patients referred to Outpatients Clinic had Radical operations
- 56.5% of 62 patients referred to Acute Admission had Radical operations
The largest group of patients who were subjected to palliative 
procedures came from the Outpatients Clinic group. This is a 
significant finding which endorses the idea that the patients referred 
to Open Access Endoscopy had a slightly more favourable stage of the 
disease. Whether this is due to rapid referral or due to less 
symptomatic disease which encourages general practitioners to refer 
to a department with a minimal waiting time but no immediate 
admission, is difficult to speculate. However, these findings are not 
significantly correlated with the stage of the disease.
Survival remains the most important outcome factor in 
assessing the benefits brought in by various new diagnostic 
algorithms, therapeutic techniques and after care measures. 
Alongside other variables such as staging and operability, we used the 
survival figures to assess whether the new referral methods and new 
clinical services provided an improvement in the life span of these 
patients. The crude survival figures were dealt with in earlier chapters 
and have shown that overall survival is quite reduced when compared 
with the current standard. An overall survival rate following positive 
diagnosis of 34.31% at 1 year and 15.00% at 5 years is quite low. The 
Japanese report figures in excess of 55% in non-specialized 
centres43*4; for Wales Pye et al.114 reported in a Welsh survey a
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mortality at 1 year of 34%, which makes us think that these results 
are equal with the Welsh median survival.
I have looked further at the survival figures from the perspective 
of the changes introduced in early 1990's with the advent of the new 
referral methods and open access services. Since all these services 
aimed and, partially achieved as previously shown, a substantial 
reduction in the waiting time the patients faced between presentation, 
diagnosis and treatment, I have tried to establish if survival as a 
variable was influenced by these services. It would be interesting to 
know if the overall survival has been influenced, and how, by the 
various intervals of delay considered in the study. For this purpose I 
have run a non-parametric correlation test using Spearman's Rank 
Order between survival and the following intervals:
-  GP Delay Interval: I have found that there is no correlation between this interval
and survival as more that 50% of the cases return a delay of 0 days; it seems 
that in our case mix and at the extent that this delay interval was shortened or 
perhaps lengthened by the distributed algorithms, the survival was not 
influenced;
- Hospital Delay Interval: there is only weak correlation between this delay and the
median survival (Spearman's Rank =  0.203); this is the only interval with 
significant impact on survival (p<0.001) but the correlation is weak; it may 
suggest that the longer the interval of delay is, the shorter the survival would 
become; the test showed also that 50% of the patients waited 16 days or 
more to be seen by the specialist in the hospital setting.
- Diagnostic Delay Interval: there is poor correlation because in more than 50% of
the patients the delay to reach a positive diagnosis is less than 12 days (i.e. 
11.5 days).
- Treatment Delay Interval: this interval has a small impact on the survival in the sub­
group of the treated patients; more than 50% of the treated patients are
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waiting more than the required 30 days between the positive diagnosis 
moment and start of the definitive treatment; however, the correlation 
between this delay interval and survival is quite weak (Spearman's Rank =  
0.205, p<0.001).
On the same note, the Spearman's Rank Order Correlation test 
showed some areas of possible improvement; for instance, the GP 
Delay interval is longer in 25% of the cases suggesting that these 
cases were referred 2 weeks later than expected. Also, in 65 out of 440 
cases the GP Delay interval is 37 days or more and 45% of patients 
are waiting for their first hospital appointment more than 14 days in 
both Neath General Hospital and Morriston University Hospital. In 
respect of the positive diagnosis, the Spearman's Rank Order 
Correlation test showed that 40% of the patients are waiting more 
than 14 days for their positive diagnosis.
I was intrigued by the long Onset Delay noted in the study, even 
if the absolute values were impossible to be collected. Using the 
Kruskal'Wallis test I found that there was no correlation between the 
onset delay and the survival at 1 and 5 years after the presentation to 
the General Practitioner.
The same Kruskal- Wallis test was employed to ascertain whether 
there is a relation between the modality of referral and survival. For 
the purpose of temporality in this test, I closed the episode for each 
patient at the date when the patient was last seen alive either at the 
Primary Care setting or in the hospital/outpatient. The test returned 
significant differences (p<0.001) in the median survival of those
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patients referred to the open access services (see table in Fig. 8.12 
below):
M ethod o f Referral Median overall survival(days)
Acute Admission 100
O utpatien ts Clinic 189
Open Access Endoscopy 333
Rapid Opinion Clinic 711
Fig. 8.12 - Median Survival & Referral Pathways 
However, if some patients actually live longer than the time introduced
in the test, which is quite likely, the significance of the test would be
even stronger and the correlation with the method of referral would be
emphasized.
Since the introduction of the referral guidelines and the 
subsequent modification of referral pattern at Primary Care level was 
a dynamic process, it would be interesting to find out how this 
adaptation process worked out and whether there was any difference 
between the first and the last year of the study; in a Mann-Whitney 
test I found no significant difference (p = 0.52) between the two sites in 
relation to the survival.
Continuing the investigation of the impact these referral 
modalities have on patients' survival, I looked further at the issue of 
whether the survival probability for these patients is actually 
influenced by the various modalities of referral. Due to the constraints 
of the statistical computation imposed by the reduced numbers in
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some cells -  i.e. Rapid Opinion Clinic independent factor -  I 
considered useful to amalgamate both the Open Access Endoscopy 
and Rapid Opinion Clinic pathways in a single spine as One-Stop 
Clinic; although at first sight this may deviate from the initial 
structure of the hypothesis, it will however test better the results of 
the new pathways of referral for the overall case mix.
Adm ission
(days)
O utpatien ts
(days)
One-Stop 
( O A E  + RO)
(days)
Mean 496.63 661.59 985.13
M edian 130 326.00 385.00
95% C I 367.53-625.73 265.37-386.63 771.43-1198.83
Total 147 180 105
No. Events 131 161 80
No. Censored 16 19 25
Fig. 8.13 - Survival Analysis & Referral Method
The Survival analysis using the Kaplan-Meier test (see Fig. 8.13 above) 
returned significant difference in survival rates between those patients 
referred to the Outpatient Clinic and the whole group referred as One- 
Stop Clinic (Log Rank = 22.88, Breslow = 45.22, p<0.001); there was a 
slightly higher probability for the patients in the one-stop group to live 
longer based on their median survival rates.
Finally, using a Kaplan-Meier test I looked at the probabilities of 
survival for these patients subject to the referral method used (see Fig. 
8.14 below) and the treatment method employed in their clinical 
management (see Fig. 8.16 on the next page); in my opinion these may
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be the two major factors which may influence the survival outcome in 
a way or another.
S urv iva l P ro b a b ility  
• method of referral
0.0
on«-&top 
-+ on«-&top-c«n&or*d
□ o u tp a tie n t 
■+ o u tp a tla n t-c o n to ro O
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-+ UmluloiMMMrMl
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Fig. 8 .1 4  -  S u rv iva l P ro b a b ility  &  R eferra l M eth od
The survival function shows a larger probability in survival for those
patients referred to the “one-stop services” (i.e. Open Access 
Endoscopy and Rapid Opinion Clinic). The smallest probability, as 
expected, is linked with the patients referred to the Outpatients Clinic, 
where the graph shows a dramatic steep downwards trend; this can 
be correlated with reduced mean survival figures.
It is however difficult to postulate that these statistical figures 
are solely the consequence of the referral pathway and the “hospital 
delay”; there are obviously other factors which may intervene in the 
equation, such as the stage of the disease at the time of treatment, co­
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morbidities, aggressivity of surgical treatment, etc. On the other hand, 
there is too much to be left to the element of chance by accepting that, 
on balance, the patients in the Outpatients Clinic group have already 
been in more advanced stages of their disease at the referral time and 
the onset symptomatology in their case was more silent than in the 
other groups.
Looking at the survival figures in conjunction with the 
treatment methods used, it appears that surgery offers the best overall 
survival in this group. The table below (see Fig. 8.15) represent 
uncorrected figures that refer to overall cases.
No
T reatm ent Surgery alone
Surgery + 
ChemoTh
ChemoTh
alone
Mean 160.15 995.42 884.74 364.13
M edian 66.00 387.00 568.00 236.00
95% C I 118.90-201.40 822.79-1168.06 678.80-1090.68 245.53-482.73
Total 166 163 59 5 0
No. E vents 164 118 46 48
C ensored 2 45 13 2
Fig. 8.15 ■ Survival Analysis & Treatment Method
The graph below (see Fig. 8.16) refers to the survival probability 
related to the method of treatment used. It clearly shows that the 
patients treated by surgery associated with chemotherapy have a 
higher probability to live longer and, for the same interval of time, in 
larger number, than the patients subjected only to surgical 
management; in the long run, however, the patients subjected only to 
surgery seem to stand a higher probability of survival.
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Fig. 8 .1 6  - S u rv iva l P ro b a b ility  &  T rea tm en t M eth od
It is quite difficult to accurately interpret the above graphs. They
represent only a potential statistical probability, but the median 
figures, and particularly the mean survival figures back up the idea of 
an increased survival for patients receiving multifactorial treatment. 
However, the figures shown above need to take account of the fact 
that the confounding factors, particularly the mean patients’ age at 
presentation and the anatomical site, are not consistently distributed 
across the four groups of the independent factor. This lack of 
distribution may be the basis for the rejection of the results seen 
earlier in respect of both the mean survival figure as well as the 
survival probability. One fact on the other hand may minimise this 
negative impact, and this is related with the large num ber of cases
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introduced in the case mix and the length of the follow up period 
which is large enough to allow for inclusion of the actual survival 
interval. I wonder though if the particular trends seen in the above 
graphs are not related to the combination between the distribution 
within the age groups of these patients and the favourable prognostic 
in a few, irrespective of the treatment applied.
From a different perspective, there are strong indications from 
various reports that standardized treatment has a positive influence 
on survival4*97. And not lastly, part of the promising trend in these 
graphs may be related to other factors, such as the inclusion in the 
survival probability computation of the gastric lymphoma cases (n = 
23) - they are recognized for offering a better prognosis than 
carcinomas -  or the variation in time of the adjuvant therapy regimens 
-  their impact has not been considered as their efficiency is still under 
review -.
Having said that, these results seem to be encouraging; 
associating standardized treatment with improvement in the 
early/advanced cancer detection ratio may bring some answer to the 
higher incidence and reduced prognostic of these advanced Upper 
Gastro-Intestinal Cancers. Reducing the number in the first instance 
of advanced cancers and improving the prognosis of those patients 
who sadly have the disease may ultimately represent the first step in 
the battle against this disease.
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CONCLUSIONS
The Upper Gastro-Intestinal Cancers represent a pathological 
entity with high incidence and prevalence in Britain. It is well known 
that the diagnosis and treatment of these cancers pose a serious 
problem for the medical professional and health care organisations 
alike. Beside the costs associated with the delivery of care for these 
patients, the reality remains painfully obvious: too many patients are 
diagnosed in a late stage of their disease, the efficacy of the treatment 
remains in many circumstances questionable and the survival of these 
patients is seriously reduced compared to other forms of cancer. There 
were a number of papers that concluded that the advanced stage of 
these patients' disease at diagnosis time is related to a certain extent 
to their wait for diagnosis and treatment. The connotation was that by 
speeding up their diagnostic and therapeutic management it might be 
possible to reduce the ratio of advanced stages of the disease at 
diagnosis time and improve the post-care results, including patients' 
survival.
In this study I have tried to scrutinize some of the innovative 
services introduced at the beginning of the 1990's in two neighbouring
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NHS Trusts and investigate whether they may bring in any benefit, not 
only in speeding the patients' throughput and early cancer detection, 
but also potential gains in their outcome. Since the medical literature 
does not show clear evidence that these services - originally aimed at 
speeding gastroenterological patients' diagnosis and treatment - may 
actually improve their outcome and survival, I have examined a cohort 
of uncensored 440 patients and assessed the impact Open Access 
Services may have on the patients' outcome.
One of the first observations I made has implications in the 
provision of service for cancer. It is related with the model of two 
neighbouring trusts which have joined forces to a certain extent and 
provide together for the diagnosis and treatment of Upper Gastro­
intestinal Cancer patients in a sequential manner. There were 
significant benefits in using a common pathway for both surgical and 
oncological treatment phases, not least represented by unified 
standardized approach to the individual cases and better service 
provisioning for the individual patient. This model does have its major 
strengths in the fact that it can be replicated throughout the country 
and can introduce standardization of the patients' management.
Other observations I made are related with the speed of 
diagnosis, where the strength of the new clinical services shows its 
major impact. Although there is strong evidence that the advent of 
open access services is followed in time by a huge increase in the 
volume of referrals, - per se this is not a bad thing since this is
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increasing the probability to detect sinister pathology the result of 
the increase is contrary to that one of a blockage of the service as 
suggested initially by some authors. In fact it seems that the Open 
Access Service can also improve indirectly the waiting times for the 
conventional referral pathway, such as the Outpatients Clinic, since 
some patients with gastroenterological symptoms may not need to be 
seen in the clinic again. A mean delay of 15.96 days for all cancer 
patients to receive the first hospital appointment and Upper Gastro­
intestinal Endoscopy at the same time represents an important 
development in the provision of service. Although this Hospital Delay 
is slightly above the targeted "two week rule" for cancer, the median 
delay o f 11 days is within the limits o f the imposed standardt signalling 
that at least 50% of patients are seen within this interval. Also, it 
must be noted that the mean Diagnosis Delay for those patients 
diagnosed through Open Access Endoscopy is smaller compared to the 
conventional referral methods, suggesting that the standardized 
diagnostic algorithm is more efficient for speedy throughput of 
patients.
The best by far based on the Hospital Delay and the Diagnosis 
Delay intervals fares the Rapid Opinion Clinic, but the end results o f 
clinical TNM stage, operative ratio and outcome are poor, this may 
signal a higher ratio of advanced cancers filtered through this method 
of referral and their identification based on symptomatology which 
correlates with advanced disease.
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It must be mentioned here that the Treatment Delay is quite 
long, adding on average a month and a half to the natural history of 
these patients; there is evidence of a prolonged Treatment Delay for 
those patients treated with chemotherapy or surgery associated with 
chemotherapy; this may signal a bottleneck at the interface between the 
diagnostic and oncological interface.
Although the facts mentioned so far show clearly that these 
services may have a positive impact on the management of these 
patients, there are numerous other observations with less positive 
connotation. Firstly, the statistical figures show that the 
Admission/Open Access Endoscopy ratio of 33.9% vs. 21.4% remains 
quite high with too many patients still referred as Admission but 
subsequently investigated as Outpatients modality. This may be related 
to the difficulty o f a more accurate interpretation o f patients' symptoms. 
The British Society of Gastroenterology has issued referral guidelines 
suggesting the prevalence of certain symptoms in Upper Gastro­
intestinal Cancer patients, but these guidelines do not seem to bring 
the clarity needed in pointing to the patients with high index o f 
suspicion. As a consequence, the identification of those patients at 
risk and potential candidates for urgent and targeted referral to open 
access services is lacking accuracy. This is followed by an increased 
number of patients referred to these services, with potential rebound 
effect on the speed of diagnosis delivery through this method of 
referral. Based on this cohort of cancerous patients, I could not make
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any significant correlation between patients' symptoms or association o f 
symptoms and predisposition to be diagnosed with upper gastro­
intestinal malignancy. Even when I removed the non-ulcer dyspepsia 
as a first line symptom from the list, there was no association of 
symptoms that may give a higher index of suspicion for cancer. The 
only palpable finding was the dominance of the so-called "sinister 
symptoms" which were already emphasized in the BSG guidelines.
Another observation with questionable connotation is that a 
number of patients are still examined after presentation only by clinical 
examination or indeed radiologically by Barium Meal examination. This 
approach might exclude the diagnostic accuracy in borderline cases 
and rules out tissue diagnosis at first examination. This contrasts 
painfully with the reality whereby in most hospital situations the 
waiting lists are traditionally longer in the Radiology Departments.
There are a few words to be said about the outcome of these 
patients in conjunction with the measures taken to speed up their 
throughput. Although the introduction of Open Access Services aimed 
at diagnosing more early cancers, sadly this was not the case in this 
cohort. Not only the crude figure of advanced cancers remained as 
high as ever, but the ratio early/  advanced cancer in this cohort actually 
deteriorated. There is direct evidence that the Open Access system has 
not delivered local expectations in detecting early cancers more often 
than before. As a matter of fact, no improvement was noted to other 
general parameters such as clinical TNM stage or operability figures.
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However, the statistical analysis o f survival probability indicates that the 
cases diagnosed through Open Access Services may have a higher 
probability o f longer survival in the long run, but the correlation is quite 
poor. A note must be added that, similarly with other studies, the 
same higher probability of survival in the long run appears to be 
observed for those cases treated by surgery alone; it may be that 
under current standardized treatment, these cases are not advanced 
anyway, i.e. they present with lower T stages and are lymph-node 
negative; in the short term it appears that the survival probability is 
better for those cases receiving combined surgical and adjuvant chemo- 
± radio- therapy treatment.
When planning for the optimisation of these cancer services one 
may consider introducing several measures to improve the early 
detection of Upper Gastro-Intestinal Cancers based on the findings 
shown in this study. The substance of these measures would need 
further adjustment but in essence might be as follows:
- there is a need for further prospective research into the early
symptomatology of the patients with Upper Gastro-Intestinal 
Cancer; certain combinations of symptoms must be highlighted 
and on statistical grounds may trigger the investigation of 
patients' upper digestive tract;
- implementation of some form of supra-selection method based on the
initial referral; for fine-tuning of the process for the identification 
of a potential cancer patient certain measures can be of help, 
such as the telephone interview with the patient immediately 
after the referral is received, increased role for the Upper 
Gastro-Intestinal Specialist Nurse, establishment of priority slots
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on the lists for patients with high index of suspicion that can be 
examined within a day or two;
- Open Access Endoscopy service to represent a single pool for all
referrals and from all sub-specialties for those patients noted 
with suspicious symptoms in their initial referral;
- protocols to enable cases to by-pass the Outpatients Department for
those cases with a hint in the referral letter suggesting Upper 
Gastro-Intestinal pathology;
- further research programme into the ways to organize with minimum
funding Japanese-style nwalk-inn settings for patients 
complaining of any symptoms within the list o f "alert symptoms”.
It is hoped that such measures may increase the selection 
process of those patients suitable for urgent referral to Open Access 
Endoscopy and Rapid Opinion Clinic, increasing at the same time the 
yield of cancer diagnosis much earlier in the natural history of these 
patients.
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Routine referral to the Department of Gastroenterology, Neath General Hospital. SA11 2LO 
‘lease use this referral form for all routine referrals for open access endoscopy. It may also Tel: 01639 762304
De used for non-urgent outpatients. For all urgent cases please use our urgent referral form. Fax: 01639 641293
1 Patient details:
Name:
Address:
Post Code: 
Hospital No:
DOB:
Sex:
Tel no:
Preferred service (please tick)
□  Open Access Gastroscopy
(procedure report only)
□  Open Access Flexible
S ig m o id O S C O p y  (procedure report only)
□  Outpatients
(consultation/investigations/management)
NHS No:
2  History, findings, current medication, reason for referral:
3  Other relevant information (for endoscopy referrals - please tick boxes or write free text) 
a Current diagnoses:
□  Diabetes
□  Ischaemic heart disease/Recent Ml/Current CCF
□  Chronic obstructive airways disease
□  Family history of stomach or colon cancer
□  Valvular heart disease
□  Neutropenia
□  Other:
d Is the patient taking:
□  Acid suppressants (stop before first OGD if  possible)
□  Anticoagulants
Past procedures:
□  Gastric surgery
□  Colonic surgery
□  Other:
Family history:
□  Gastric cancer
□  Colorectal cancer
□  Aspirin/NSAIDs
□  Insulin/Oral hypoglycaemics
4 Referring doctor details:
Signature:
Address & tel no for report:
Address:
Name: 
(please print)
Date of referral: Tel no:
Day Ward use only: 
Received date:
(Form version 14/2/2001)
! Booked date: 1 Appointment & information sent date:
DNA/UTA/Performed date: If LTTA -  rebooked date:
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